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Abstract 
Passive immunisation of fish was carried out to determine whether anti-Vibrio 
anguillarum antibodies (AVA), anti-Streptococcus sp. antibodies (ASA), and anti-
Paramoeba sp. antibodies (APA) raised in sheep, rabbits and rainbow trout 
(Oncorhynchus mykiss) were persistent and biologically active in rainbow trout. 
Results of passive immunisation were compared with results of active immunisation in 
which fish were immunised by immersion in or injection with formalin-killed cells. 
Assessments of passive and active immunisation were undertaken concurrently for up 
to three months in order to demonstrate their relative efficacies and, especially, to 
evaluate the practical potential of passive immunisation. 
_Sheep and rabbit antibodies were detected in fish sera by enzyme-linked 
immunosorbent assay (ELISA) for up to 70 days after intraperitoneal (i.p.) injection. 
The relative percent survival (RPS) of fish challenged with virulent V. anguillarum 
after an i.p. injection (0.1 ml 100 g-1 fish body weight) of sheep, rabbit or fish AVA 
was 93.3, 86.6, 40% at one month; 25, 18.7, 12.5% at two months and 13.3, 4.1, 9.0% 
at three months post-immunisation (p.i.) respectively. In order to obtain equivalent 
protection to undiluted fish serum, rabbit and sheep sera had to be diluted 1: 8 and 1: 
50 respectively. Protection conferred by immune sera was shown to be due to the 
specific antibodies alone. Also inactivation of complement from sera had no effect on 
the potency of either immune or non-immune sera. Affinity purified sheep and rabbit 
AVA sera were demonstrated to have equivalent protective potential as whole antisera 
in rainbow trout. Fish actively immunised by immersion showed RPS of 86.6, 93, and 
81.8% after one, two and three months p.i. respectively in the same trials. Fish 
immune responses to sheep and rabbit antisera were determined (using specific 
ELISA) with the greater response being to the rabbit serum. 
Rainbow trout given sheep AVA conjugated to LTB (the GM-1-binding subunit 
of Escherichia coli heat-labile toxin) orally had a RPS of 37.5% at 15 days and a RPS 
of 27% after one month post-immunisation. In contrast, sheep AVA conjugated to 
TraT (an internal membrane of E. coli) and Quil-A had RPSs of 18.7 and 6.2% after 
fifteen days and 13.3 and 0% after one month p.i. respectively. 
The relative percent survival of rainbow trout challenged with virulent 
Streptococcus sp. after an i.p. injection (0.1 ml 100 g -1 fish body weight) of sheep, 
rabbit or fish anti-Streptococcus sp. antibodies was 88.8, 50, 0.0% after one month ; 
33.3, 6.8, 6.8% after two months and 13.3, 0, 6.6% after three months p.i. respectively. 
Fish immunised actively had RPS of 88.8 and 11.1% after one month, 38.1 and 4.7% 
after two months 36 and 0.0% after three months p.i. for the injection and immersion 
routes respectively. Thus, passive immunisation shows potential as a therapeutic and 
prophylactic against streptococcosis as it gives similar results to active intraperitoneal 
vaccination and would be expected to provide immediate protection. 
In one trial Atlantic salmon immunised i.p. with Paramoeba vaccines showed 
marked humoral responses. In another trial, Atlantic salmon were immunised 
passively with an i.p. injection (0.1 ml 100 g -1 fish body weight) of sheep APA. 
Immunised fish (both actively and passively) were exposed to a natural infection (by 
cohabitation with infected Atlantic salmon) one month post-immunisation. 
Transmission of the disease was successful. No unequivocal protection was 
demonstrated in any of the immunised fish in this experimental challenge trial. 
Moreover, local antibody against Paramoeba sp. in gill mucus of experimentally 
infected Atlantic salmon was not detected (by ELISA)., 
It is shown in this study that passive immunisation has significant potential in 
disease prevention when given to fish at strategic times, especially in the face of an 
outbreak when there is not enough time for an active immune response. Thus, there 
should be a future for the use of mammalian hyperimmune sera against fish diseases, 
in particular, those for which useful immunity by active immunisation is not available. 
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General introduction 
There are a limited number of vaccines for active immunisation of fish against 
important systemic diseases that cause serious economic loss in fish culture. Even 
these vaccines have limitations in their use. There is evidence that antisera produced in 
mammals could be useful in controlling important diseases of cultured fish if given at 
strategic points in the growth cycle. Harrell et al. (1975) showed that rabbit or trout 
antiserum made against Vibrio anguillarum appeared protective against experimental 
vibriosis for more than two months. In another experiment, brook trout were 
immunised passively by intraperitoneal injection against Aeromonas saltnonicida and 
infected with a virulent strain of A. salmonicida at the time of immunisation; passive 
immunisation was concluded to be efficacious in preventing the disease (Marquis and 
Lallier, 1989). Protection of fish was achieved by injection of an anti-A. salmonicida 
hyperimmune serum (purified immunoglobulin G), and this lasted from 110 to 150 
days when applied either prophylactically or therapeutically (Turgeon and Elazhary, 
1992). These promising results encouraged the author to look at more critically at 
passive immunisation using a variety of systems. 
It is therefore worthwhile to introduce passive immunisation (hyperimmune sera 
from homeotherms and poikilotherms when given to poikilotherms) as an effective 
method of protection against diseases that are economically important to cultured fish. 
Additionally, passive immunisation studies can provide important information about 
immunogenic proteins, requirement for multiple vaccine strains, pathogenesis of 
microorganisms, and titre of antibody required for protection (LaPatra et al., 1994). 
The principal aim of this research was to demonstrate the value of this approach 
using an organism, V. anguillarum about which much is known. The techniques 
developed were also applied to a specific Steptococcus sp. of rainbow trout which at 
present can not be controlled by vaccination (Carson and Munday, 1990), and a 
Paramoeba sp. of salmonid fish. In this study, the aims were to investigate passive 
immunisation of rainbow trout with hyperimmune sera of mammals and fish and 
demonstrate the longevity and protectiveness of these antibodies for up to three 
months in comparison with active immunisation, and evaluate the therapeutic and 
prophylactic efficacies in order to demonstrate the practical implications and 
feasibility of this vaccination method. A sensitive enzyme linked immunosorbent 
assay was employed to detect longevity of conferred antibodies about which little such 
data has been reported previously. Unlike antimicrobial substances that last 10 days or 
less, hyperimmune sera provide protection for 22 to 359 days against furunculosis 
(Turgeon and Elazhary, 1992). As they are immunoglobulins, there is no danger of 
drug resistance development, medication residue, or the need for withdrawal times 
(Turgeon and Elazhary, 1992). However there is likely to be an active immune 
response against the foreign immunoglobulins which may limit their persistence and 
efficacy. 
vii 
General aims of this study: 
Now that commercial wild fish stocks are overexploited and with the potential 
for extensive disease outbreaks in the developing aquaculture industry all over the 
world, there may be a difficulty maintaining current yields of fish proteins. Vibriosis, 
streptococcosis and paramoebiasis can be financially catastrophic and a major 
determinant of fish farms viability. Therefore, the need for disease control and 
management is obvious. It would be of great significance to provide effective methods 
of immunisation and introduce new vaccines to aquaculture, so in this project, a series 
of experiments was performed to assess how long the passively transferred antisera 
persist and how effective passive immunisation can be to protect fish against vibriosis, 
streptococcosis and paramoebiasis. 
A small number of studies used an agglutination test for detecting the injected 
antibodies. However, in this study the rate of clearance of these antibodies was carried 
out using ELISA. This project addresses the following objectives in relation to 
vibriosis, streptococcosis and paramoebiasis with a view to providing practical, 
alternative disease control strategies. 
I To passively immunise fish at serious risk of disease, when there is insufficient time 
to immunise them actively. 
II To compare the efficacy of passive and active immunisation. 
III To immunise fish orally using purified immunoglobulins conjugated to different 
vaccine carriers. 
IV To provide non-chemical therapies for these infectious diseases. 
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CHAPTER 1.0 
GENERAL LITERATURE REVIEW 
1.1 Passive and active immunisation of fish: 
1.1.1 Passive immunisation: 
Several studies have been conducted on passive immunisation including the use 
of fish or mammalian antisera. Some of these reports indicate acceptable levels of 
protection (Harrell, 1975; Olivier et a/., 1985; Turgeon and Elazhary, 1992). However, 
very few attempts have been made to evaluate the longevity of passively transferred 
antisera, the level of protection and, also, the feasibility of this method of 
immunisation in commercial fish industries. By using pre-prepared specific antiserum, 
fish become immune several hours after the administration of immune serum in 
contrast to several weeks required for active immunisation to become effective. 
Passive immunisation has been used mainly against furunculosis in order to 
study antigenic components of the virulent Aeromonas salmonicida for producing an 
effective vaccine and to a lesser extent against vibriosis, edwardsiellosis and some 
other fish diseases as summarised in Table 1.1.1. 
Early results using passive immunisation against furunculosis were not 
encouraging, however, additional research proved it to be effective. Passive protection 
against A. salmonicida was produced in coho salmon (Oncorhynchus kisutch) using 
serum from rainbow trout (Oncorhynchus mykiss) containing antibodies produced 
following intraperitoneal (i.p.) vaccination (Spence et al., 1965). 
In another study, rabbit immunoglobulins produced against A. salmonicida did 
not provide protective immunity in salmonids, but Atlantic salmon (Salmo salar) 
passively immunised with antiserum prepared in a closely related salmonid were 
resistant to challenge (Cipriano, 1981). Also, in another successful experiment, brook 
trout (Salvelinus fontinalis) passively immunised with antiserum from rainbow trout 
prepared against virulent A. salmonicida were protected (Cipriano, 1982). 
McCarthy et al. (1983) studied protection against A. salmonicida by passive 
immunisation and showed that antiserum to a rough, virulent strain of A. salmonicida 
(AS-IR) prepared in rabbits passively protected sockeye salmon, (Oncorhynchus 
nerka) against a virulent challenge, while antisera to a boiled AS-IR, and an avirulent 
smooth strain of the same isolate (AS-IS) were not protective. It was shown that the 
AS-IR cells contained an additional antigen not present in boiled AS-IR and AS-IS 
cells. 
Antisera produced in coho salmon and in rabbits against A. salmonicida antigens 
(formalin killed cells and extracellular antigens), were tested for their efficacy in 
protecting coho salmon against experimental furunculosis (Olivier et al., 1985). 
Results indicated that an avirulent strain was inferior to a virulent strain in its ability to 
stimulate antibody production for effective passive immunisation of coho salmon. 
Thus, even though avirulent cells possessed an immunogen that was shown to be well 
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recognised by rabbits, the immunogen was not relevant to salmon since they received 
only feeble and inconsistent protection from the antisera. 
Passively transferred antiserum which was prepared in rainbow trout to a 
protease of a virulent strain of A. salmonicida provided protection against 
experimental furunculosis in Atlantic salmon (Shieh, 1985). 
Significant protection was provided by a rabbit antiserum to a protease-
proficient strain of A. salmonicida, particularly against challenge by the heterologous 
and more virulent protease-deficient strain (Ellis et al., 1988). 
In studies to determine the therapeutic and prophylactic efficacy of passive 
immunisation against A. salmonicida infection, rabbit hyperimmune serum was 
produced against a virulent strain of the bacterium, purified and injected 
intraperitoneally into brook trout at the time of experimental infection or at various 
periods after experimental infection. Passive immunisation of brook trout was 
effective when effected at zero, 24 or 48 h post-infection. Purified immunoglobulins 
and whole antiserum from rabbits were similarly protective in an experimental bath 
challenge 35-41 days post-immunisation (Marquis and Lallier, 1989). 
Similarly, anti-A. salmonicida hyperimmune serum (mammalian 
immunoglobulin G) was protective for 110 to 150 days post-immunisation (Turgeon 
and Elazhary, 1992). 
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Table 1.1.1: Passive immunisation of fish against microbial diseases as conducted by several researchers 
Reported 	Disease 	 Source 	Fish species 	Route of Earliest detection 	Degree of protection in challenge* 
by particular 	of passively Administration of antibody** 
bacterial immune 	immunised 	 Duration of protection 	% Mortality 
preparation 	sera 
Control 	Immunised 
Spence et al. 
(1965) Furunculosis 
virulent A.S 
Rainbow trout Coho-salmon i.p. ND 4 days 	40 	 10 
Cipriano Furunculosis 1)Rabbit Rainbow trout i.p. ND -Rabbit Igs did not provide protective immunity 
(1981) virulent A.S 2)Salmonid fish Atlantic salmon +Rainbow trout provided protective immunity 
Cipriano Furunculosis Rainbow trout Brook trout i.p. ND +protective 	70-90 	15-20 
	
(1982) 	virulent A.S 
McCarthy et al. 
(1983) 	Furunculosis 	Rabbit 	 Sockeye salmon 	i.p. 	ND 	 NG 
1)As-IR virulent strain 1) +14 days 
2) As-IR 	" 	"(boiled) 
	
2) -not protective 
3) As-IS avirulent 3) -not protective 
Table 1.1.1: (continued) 
Reported Disease Source Fish species 	Route of Earliest detection 	Degree of protection in 	challenge* 
by particular of passively 	Administration of antibody** 
bacterial 
preparation 
immune 
sera 
immunised Duration of protection 	% Mortality 
Control Immunised 
Olivier 
et al. 
Furunculosis 
virulent A.S 
Rabbit Coho salmon i.p. ND 	+protective 	90 10 
(1985) 
Shieh 
(1985) 
Furunculosis 
virulent A.S 
Rainbow trout 
antiserum to 
protease 
Atlantic salmon i.m. ND 	+Protective NG 
Ellis et al. Furunculosis Rabbit Rainbow trout ND 
(1988d) 
1)E.0 protease proficient strain 	 i.m. heat inactivated anti-sera 1)Significant protection 	NG 
2)E.0 protease deficient strain + bacteria(F.I)+ i.p. unheated 	2)Marginal protection 
serum(each 0.1 ml) 
Marquis 	Furunculosis 	Rabbit 	Brook trout 	i.p. 	ND 	35-41days 	90 	 10 
and virulent A.S 
Lanier (1989) 
Turgeon 	Furunculosis 	SHAAS 	Speckled trout 	i.p.(0.4 ml/kgBW) 	110-159 days 	90 	0 
and 	virulent A.S 
Elazhary(1992) 	 Atlantic salmon 	i.p. 	ND 	 87.3 	7.3 
Table 1.1.1: (continued) 
Reported 
by 
Disease 
particular 
bacterial 
preparation 
Source 
of 
immune 
sera 
Fish species 	Route of 
passively 	Administration 
immunised 
Earliest detection 
of antibody** 
Degree of protection in 	challenge* 
Duration of protection 	% Mortality 
Control 	Immunised 
Harrell Vibriosis 1)Rainbow trout Rainbow trout i.p. 10 min-lh(peak) 	64 days 	1)100 5 
et al.(1975) 2)Rabbit (0.5m1/30-75g fish) *** 2)100 10 
Gunnels Vibriosis Rainbow trout Chinook salmon i.p. ND 30 days 	82 18 
et ad.(1976) 52 days 93 75 
Viele et al. Vibriosis Rainbow trout Rainbow trout i.p. ND 
(1980) 1)Immune plasma 1) 16 days 	50 17.2 
2)Immune leucocyte 2) 20-21 days 	81.3 31.3 
Groberg Vibriosis Coho salmon Coho salmon i.p. 8 h 
(1982) 1) serum 1)challenge immediately 46 0 
2) spleen cells 2)after pass. imm. 	38 20 
Salati et al. Edwardsiellosis 1)Eel Glass eel Immersion ND 5 days 
(1989) 2)Rabbit 5 days(higher degree protection) 
Gutierrez Edwardsiellosis Hen's egg yolk Japanese eel Oral ND 40days 	75-100 40-60 
et al. (1993) Ig Y anti-E. tarda (Up to 3.8x 106cfu bacteria in challenge) (prophylactic efficacy) 
Table 1.1.1: (continued)  
Reported 	Disease 	 Source 	Fish species 	Route of Earliest detection 	Degree of protection in challenge*  
by particular 	of passively Administration of antibody** 
bacterial immune 	immunised 	 Duration of protection 	% Mortality 
preparation 	sera 
Control 	Immunised 
Fulcuda 	Pseudotuberculosis 	Rabbit 	Yellowtail 	i.p. 	12h(peak) 	8 days 	100 	30 
and Kusuda 	(P. piscicida) (highly protective within 24h) 
(1981) 
Olesen 	E.R.M 	 Rainbow trout 	Rainbow trout 	i.p. 	ND 	+protective 	91 	 20 
(1991) 
Houghton Pancreas disease 	Affected 	salmon parr 	i.p., 	ND 
(1993) 	(viral aetiology) 1)Atlantic salmon 
(Homogenised kidney material) 
2)Experimentally infected fish sera 	i.p. 	ND 
Hedrick Channel catfish 	Experimentally 	juvenile catfish 	i.p. 	ND 
and 	virus infection infected adult 
McDowell 	 channel catfish 
(1987) 
+significant protection (9 months) 
+significant protection 
protective 	66-71 	1 
LaPatra 	IHN 	 Rainbow trout 	Rainbow trout 	i.p. 	ND 	 69 
et al..(1994) 
*Either water-borne or i.p. challenge ** Antibody detection by agglutination test i.p.= Intraperitoneal injection of hyperimmune serum 
***protected, but how long not exactly stated C=Control i.m.=intramuscular injection E.R.M=Enteric red mouth 	A.S= A. salmonicids 
ND=Not done +=Resistant at challenge but its duration was not investigated -=Not resistant at challenge E.C=Extracellular products NG=Not given 
p.i.= Post-immunisation 	F.I=Formalin inactivated cells SHAAS= An anti-A. salmonicida 	IHN= Infectious haematopoietic necrosis 
With respect to passive immunisation against vibriosis, Harrell et al. (1975) used 
anti-Vibrio anguillarum serum from rainbow trout (Oncorhynchus mykiss) which 
provided protection against experimental vibriosis in rainbow trout for more than 2 
months. Passively transferred anti-V. anguillarum rabbit serum also protected rainbow 
trout. Harrell et al. (1975) noted the appearance of serum antibody (measured by 
agglutination) as early as 10 min after i.p. injection. 
Similarly anti-V. anguillarum antiserum produced in rainbow trout protected 
chinook salmon significantly at 30 days post-immunisation. However, the protection 
was only marginal at 52 days post-immunisation (Gunnels et al., 1976). 
Viele et al. (1980) immunised rainbow trout by the immersion method against 
V. anguillarum, and used these fish as donors of plasma and cells for transfer to 
unimmunised trout. Immunity was successfully conferred by plasma taken from 
donors 16 days post-immunisation (p.i.), and by pronephric and spleen cells from 
donors 20 and 21 days post-immunisation. Plasma was most effective in transferring 
protection followed by pronephric cells. Splenocytes gave variable results, while 
thymic cells were not protective 
Whole serum and splenic cells from coho salmon actively immunised against V. 
anguillarum bacterin were injected into non-immunised juvenile coho salmon which 
were subsequently challenged. The results showed that only serum from parenterally 
immunised fish (agglutination titre 1:1024) provided complete protection (0% 
mortality) and splenic cells from the same fish conferred a moderate level of immunity 
(20% mortality). The mortality rate in control fish when injected with non-immune 
serum and spleen cells, was 46% and 38% respectively (Groberg, 1982). 
The possibility of using passive immunisation with antisera prepared in rabbits 
as a preventative measure and a medicinal treatment for pseudotuberculosis in cultured 
yellowtail (Seri°la quinqueradiata) was investigated by Fukuda and Kusuda (1981). It 
was suggested that passive immunisation of yellowtail against this disease using rabbit 
antisera was highly effective for at least 24 h after immunisation. 
Salati et al. (1989) immunised glass eel against Edwardsiella tarda by 
immersion in aqueous solutions of either eel or rabbit hyperimmune sera to E. tarda. 
They concluded that the procedure provided a degree of protection which increased up 
to the 5th day post-immunisation. Higher degrees of protection were obtained using 
rabbit hyperimmune serum. Anti-E. tarda IgY from hens vaccinated by injection with 
formalin-killed cells reduced mortality due to edwardsiellosis in Japanese eel 
(Anguilla japonica) when it was administered orally (Gutierrez et al., 1993). Also, 
rainbow trout serum from survivors of a challenge with Renibacterium salmoninarum 
(11343) was used to passively immunise a group of stock fish. On challenge, these fish 
showed significantly lower mortality rates than non-immunised fish (Campbell et at., 
1994). 
It was shown that rainbow trout fry injected with serum from previously 
vaccinated and infected rainbow trout were partially protected against enteric 
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redmouth (Yersinia ruckeri ) infection, since only 20% died from the disease 
compared with 91% of the fry injected with normal trout serum (Olesen, 1991). 
Concerning viral diseases of fish, it was shown that injection of homogenised 
kidney material taken from Atlantic salmon with pancrease disease (possible viral 
etiology) into Atlantic salmon parr and post-smolts induced very strong protection 
which was maintained for at least 9 months. No evidence was obtained for a carrier 
state being established in immune fish. Passive immunisation of salmon parr and post-
smolts using convalescent sera from fish experimentally infected with pancreas 
disease conferred significant protection, suggesting that protection was mediated by 
antibodies (Houghton, 1993). Nonetheless, it is probable that passive immunisation of 
this kind may cause the distribution of a viral disease unless the serum is appropriately 
treated. 
Juvenile channel catfish (Ictalurus punctatus) were found to be protected against 
experimental infections with channel catfish virus (CCV) after passive transfer of 
adult sera containing anti-CCV neutralising activity. This study demonstrated that 
serum with anti-CCV neutralising activity (presumably due to anti-CCV antibody) 
obtained from adult channel catfish can protect juveniles from lethal challenge with 
CCV (Hedrick and McDowell, 1987). 
In a recent study, LaPatra et al. (1994) injected rainbow trout (mean weight, 4.3 
g) with 100 11.1 of anti-infectious haematopoietic necrosis virus (I1-INV) rainbow trout 
immune serum (IHNV neutralising titre 640) immediately following water-borne 
exposure to 105 plaque-forming units m1-1 of 1HNV, relative protection was 91% 
compared to fish injected with normal serum (titre< 20). Fish injected with immune 
serum at 24 and 48 h post-exposure to virus exhibited relative protection of 88 and 
75% respectively. It is suggested from this study that this immunotherapy may have 
the immediate benefit of reducing mortality. 
The possibility of transfer of maternal immunity in young plaice (Pleuronectes 
platessa) (By et al., 1986b) was investigated . The study showed that high molecular 
weight agglutinating antibodies can be induced in the serum and eggs of plaice. Since 
it is unlikely that plaice oocytes are capable of synthesising antibodies in response to 
an antigenic stimulus, it can be assumed that antibodies detected in the egg yolk were 
maternal in origin. Also, maternal immunity in eggs of tilapias (Mor, 1988), in embryo 
of tilapias (Mor, 1990) and white spotted char (Salvelinus leucomaenis) (Kawahara et 
al., 1993) was investigated. In a recent study, vertical transfer of passive immunity via 
eggs was examined (Brown et al., 1994). Antibodies produced against V. anguillarum 
in rabbits and in chinook salmon were injected into female coho salmon 11-26 days 
before spawning. Rabbit antibodies were then detected in eggs. It is suggested from 
this study that passive vertical transfer of immunity occurs within salmonids but 
protection is not maintained long after the yolk sac is absorbed. 
It is obvious from the previous studies that levels of immunoglobulins (Ig) has 
rarely been measured after transfer, and the responses of fish to the foreign proteins 
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(Ig and other proteins) have never been measured. In this study, rate of clearance of 
antisera transferred to fish, fish response to the antisera and protection conferred by 
passive immunisation of fish were investigated. 
1.1.2 Active Immunisation: 
Active immunisation is based upon an immune response (both antibody and cell 
mediated immunity) of an animal to foreign molecules (antigens) e.g. preparations of 
whole cells or cell extracts. It has been used to combat bacterial, viral and parasitic 
diseases in fish but requires that there is enough time prior to the probable occurrence 
of the disease for Ig production (about one month). Active immunisation has worked 
successfully in particular against vibriosis and enteric redmouth disease. 
Active immunisation against vibriosis, streptococcosis and paramoebiasis is 
discussed at the beginning of each relevant chapter in this thesis. 
1.1.3 Routes of immunisation : 
Vaccines may be administered by different routes. They have been applied to 
fish by injection, anal and oral intubation (impractical for large number of fish), on 
food (oral administration), by bathing/ immersion spray or shower. Although there are 
at least 20 recognised bacterial diseases of salmonids, there are only a limited number 
of commercial vaccines for the control of the diseases e.g. vibriosis, cold water 
vibriosis, enteric redmouth, edwardsiellosis and furunculosis. These vaccines, which 
are mainly whole cell bacterins, are composed of Gram-negative organisms delivered 
by immersion and intraperitoneal injections (Wong et al., 1992). 
Injection: 
Intraperitoneal injection: It is usual that fish are anaesthetised not only to 
facilitate handling but also to avoid excessive stress. The vaccine is usually injected 
using a multi-dose syringe. Fish are presented ventrally to the needle with the head 
facing away from the operator so that the needle slides easily beneath the scales. The 
point of insertion is 2 cm anterior to the pelvic fins, and fairly shallow (<1 cm) with 
the syringe held at an angle of about 45° to the body surface in order to have minimum 
risk of damaging the underlying organs. It is also possible to choose an insertion point 
between the anus and the pelvic fins (Akhlaghi et al., 1993). Injection is not always 
practical on a large scale and is restricted by the size of fish being immunised. 
Most of the time, i.p. injection gives the best results compared to other routes 
with respect to level and duration of protection (Horne and Ellis, 1988). However, for 
practical reasons this route has its limitations. Unfortunately, the technique is thought 
to be slow, and seemed feasible only for large and valuable fish. Intraperitoneal 
injection is used currently in Norway for commercial vaccines. 
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Intramuscular (i.m.) injection: In using this route, dorsal muscles may be 
injected. Leakage of the inoculum before adsorption and muscle necrosis following 
use of adjuvanted vaccines restrict i.m. injection. 
Oral administration: 
In this method the antigen is added to the food over a suitable time course. Oral 
delivery of vaccines has been described as the most desirable method for vaccinating 
fish (Amend and Johnson, 1981). For extensive aquaculture where fish are farmed in 
very large ponds and handled only when harvested, oral vaccination is compellingly 
simple and attractive to many fish farmers. However, the level of protection by oral 
vaccination has been inferior to other vaccination methods (Gunnels et al., 1976; 
Gould et al ., 1978; Amend and Johnson, 1981; Dec etal., 1990). 
In immunising fish by oral route many antigen particles are probably digested by 
the stomach and gastro-intestinal tract enzymes, especially in carnivorous fish. To 
evaluate this problem, Johnson and Amend (1983) incorporated a vaccine into gelatin 
and applied it both orally and anally. They found reasonable protection 59 days post-
vaccination by a water-borne challenge with V. anguillarum which resulted in 55% 
mortalities in the control, 0% mortality in the anally vaccinated and 46% mortalities in 
the orally vaccinated fish. Oral vaccination was the first mass vaccination method used 
to protect fish against vibriosis (Wong et al., 1992). Effectiveness of an oral enteric 
coated Vibrio 21 (vaccine for use in salmonid fish) (Wong et al., 1992) and uptake of 
V. anguillarum bacterin in the posterior intestine of rainbow trout, sea bass 
(Dicentrarchus labrax) and turbot (Scophthalmus maximus) after oral administration 
(Vigneulle and Baudin-Laurencin, 1991) have been reported. Micro-encapsulation 
techniques may also be important for bypassing the deleterious effects of the upper 
region of gastro-intestinal tract and development of successful oral vaccines. 
Immersion method: 
Bath vaccination: The ease of addition of vaccine directly to the tank or pond 
without netting or handling has led to the increasing use of the bath method (Horne 
and Ellis, 1988). The water level of the holding tank is lowered to the minimum level 
tolerated by the fish. Vaccine is added to this volume to achieve a dilution usually of 
(depending on the brand of vaccine) one part in 500 and fish are left for a specific 
amount of time. Bath vaccination is easy to carry out since it is not labour intensive. 
Antigen is in direct contact with the body surfaces and gills and thus available to be 
translocated into the body. Many researcher have reported the benefits of immersion 
vaccination (Egidius and Andersen, 1979; HAstein et al., 1980; Song et al., 1980; 
Amend and Johnson, 1981). This method is preferred with salmon as the fish need 
not to be netted 
Immersion vaccination for 30 s at 1/10 dilution is usually called dip vaccination. 
This appears to be the most popular method for trout. With the use of a small tank 
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containing vaccine in close proximity to the holding tanks, netted fish are immersed in 
the diluted vaccine for 20 s to 1 min according to the vaccine manufacturer's 
recommendation. According to several workers, immersion of fish in hyperosmotic 5- 
8.5% NaC1 before immersing in the vaccine has provided a high level of protection in 
comparison with simply dipping fish into vaccine. Apparently the vaccine solution 
substitutes for fluids which have been lost in the hyperosmotic solution. As a result, 
more bacteria cross the fish's body external barriers. 
Formerly, considerable attention was focused on hyperosmotic infiltration (Croy 
and Amend, 1977; Aoki and Kitao, 1978; Nakajima and Chikahata, 1979; Antipa et 
al., 1980). It is now appreciated that the technique is extremely stressful to fish (Busch 
et al., 1978), and that the level of protection is not greater than the much simpler direct 
immersion method (Antipa et al., 1980). 
Treatment of fish with formalin and pH from 6-8 did not affect protective 
immunity and fish can be equally immunised in fresh water or salt water (Amend and 
Johnson, 1981). Field experience has also indicated that different levels of water 
hardness does not influence effective immunity (Amend and Johnson, 1981) but other 
chemicals need evaluation to verify that they do not interfere with uptake of the 
antigen by the fish. 
Automated vaccination: 
This was attempted by Gould et al. (1978) using a spray applicator which has 
since been extensively used on large farm units in the USA. In this method of 
vaccination, fish are drawn onto a conveyor belt and passed beneath a spray set or 
dipping process to ensure at least a 5 s exposure to the diluted vaccine. 
1.2 Fish defence mechanisms: 
The fish immune response to many diseases is well defined. The resistance is 
specific to the challenging pathogen and persists for a relatively long period of time 
(Ellis, 1988a). 
Thymus , kidney and spleen (Ellis, 1988b) and gut (Rombout et al., 1993) are 
the major lymphoid organs of teleost fish. During the first few weeks post-hatching 
the rate of growth of these tissues in rainbow trout is faster than the rest of the body 
and the weight of the lymphoid organs, relative to body weight, reaches a peak at 2 
months of age, when fish are 0.5 g (Tatner and Manning, 1983a) and after that their 
relative weights decrease with age. The immune responses of fish can be divided into 
non-specific and specific components: 
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1.2.1 Non-specific defence mechanisms: 
Integumentary defence mechanism: 
The integumentary system of the fish forms the primary defence barrier between 
the fish and its environment. The fish body is covered by a slippery layer of protective 
mucus which is physically shielding against osmotic imbalance and against pathogens. 
The mucus layer provides important mechanical protective functions preventing 
bacteria from gaining intimate contact with the living epidermal cells (Austin and 
Austin, 1993). Internally, mucus also coats the wall of the alimentary tract. 
The inflammatory response: 
The inflammatory response is the other non-specific defence mechanism which 
provides a site of interaction with the cells and humoral factors best able to destroy or 
limit the spread of injurious agents such as living organisms or non-living agents such 
as trauma, radiant energy, chemicals and toxins. The inflammatory responses are 
vasodilation and increased blood flow and vascular permeability. Exudation of plasma 
and migration of monocytes, macrophages, neutrophils and cytotoxic cells into the 
tissues occur to facilitate removal of foreign particulate material. 
Macrophages have a vital role in many aspects of the immune response in fish. 
As well as being accessory cells important in initiating specific immune responses, 
they are also potent effector cells capable of killing a wide range of pathogens 
(Secombes, 1990). In vivo and in vitro studies have demonstrated that macrophages 
are highly phagocytic for inert and antigenic material (Ellis et al., 1976; McKinney et 
al., 1977). 
Elevated levels of antibodies specific to antigens can enhance phagocytosis in 
fish (Griffin, 1983; Sakai, 1984; Scott et al., 1985; Honda et al., 1986). In rainbow 
trout immunised with V. anguillarum, phagocytic activity of macrophages increased 
significantly 5 weeks after immunisation as compared to the activity of macrophages 
from normal fish (Honda et al., 1985). 
Neutrophils have been reported to have no phagocytic properties (Ellis et al., 
1976; McKinney et al., 1977) or to be only weakly phagocytic (Young and Chapman, 
1978). Ellis (1981) has suggested that the fish neutrophil may carry out a bactericidal 
role extracellulary rather than intracellulary. 
Regarding the protective role of pigment-containing macrophages and 
melanocytes which are found in the lymphoid tissues of most teleosts, it is postulated 
that the melanin contents of these cells in fish viscera may provide a means of 
protection from free-radical damage, similar to its function in protection from 
radiation-induced free-radicals in the skin (Ellis, 1981). 
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The complement system: 
The complement system of higher vertebrates plays a prominent role in humoral 
and cellular immunity against pathogens and the inflammatory process which results 
in the killing and elimination of cellular antigens (Ingram, 1990a). Harrell et al. (1976) 
demonstrated that heat-stable (presumably antibody) and heat-labile (presumably 
complement) components were necessary to prevent the growth of V. anguillarum in 
an in vitro experiment with trout immune serum and mucus. The complement 
functions either as an enzyme or binding protein in 1) classical (or antibody-
dependent) pathway, 2) alternative (or antibody-independent) pathway (Ingram, 
1990a). For example, the sera of brown trout (Ingram, 1987), albacore tuna (Fujii et 
a/., 1979; Giclas et a/., 1981), rainbow trout (Sakai, 1983a) and several other teleost 
species, contain complement components capable of fixing Ig via the classical 
pathway. Carp (Kaastrup and Koch, 1983), and rainbow trout sera (Nonaka et al., 
1981; Sakai, 1981b, 1983b) also display spontaneous antibody-independent 
haemolysis indicative of an alternative pathway (AP) (Ingram, 1990a). Jenkins and 
Ourth (1993) also determined that the alternative complement pathway functions in 
opsonophagocytosis in catfish and the ingestion by neutrophils was especially 
enhanced. Because complement is constitutively present in vivo, its opsonic function 
via the AP may be of greater importance than opsonins such as C-reactive protein 
(Kodama et al., 1989). 
The complement activity of fish serum has been pointed out as an important 
innate defence against bacterial pathogens (Trust et al., 1981). Nonaka et al. (1981) 
have demonstrated the ability of trout IgM to fix trout complement and activate its 
lytic properties. It is suggested that for antibody-activation of complement the two 
components must be derived from fairly closely related species (Sakai, 198 lb). 
However, Ingram (1990a) reported that brown trout antibodies are capable of fixation 
of guinea pig complement as well as trout serum in a complement fixation test. 
Purified factor D of carp (Cyprinus carpio) complement homologous to mammalian 
factor D was proven to be an alpha-globulin with a molecular mass of 29 lcDa and the 
serum concentration was estimated to be 6 gg m1 -1 (Yano and Nakao, 1994). 
Regarding the opsonising effect of anti-V. anguillarum rainbow trout serum, 
Honda et al. (1985) showed that the opsonising effects of the serum increased with 
increasing amount of antibody in cultures. These workers also showed that rainbow 
trout complement enhanced the opsonising effect of the antibody, phagocytic activity 
then increased significantly in the presence of antibody. Fish antibody also, in the 
presence of normal serum as a complement source is capable of lysing target cells 
(Nonaka et al., 1981). 
Opsonisation and the related complement-binding are of major importance in 
optimising phagocytosis. Phagocytosis by fish leukocytes increased following 
opsonisation of bacteria with specific antibodies alone (Song and Kou, 1981; Griffin, 
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1983) or with specific antibodies and complement (Sakai, 1984). However, Olivier et 
a/. (1986) concluded that the principal opsonin in fish serum is complement. 
Honda et al. (1985) demonstrated that the phagocytosis of V.anguillarum by 
normal peritoneal macrophages was enhanced in the presence of antibody and 
complement. The optimum temperature to inactivate complement of fish sera differs 
between species, e.g. 44°C for rainbow trout, 45°C for coho salmon and goldfish 
(Carassius auratus) and 47°C for tilapia (Sarotherodon nilotica) all for 20 minutes 
(Sakai, 1981a). 
The other non-specific defence factors: 
A number of non-specific defence factors have been identified in fish ova 
including C-reactive protein and lectin-like agglutinins (Ingram, 1980). 
Lysozyme, which is a mucolytic enzyme capable of destroying the 
mucopeptides in bacterial cell walls, exists in rainbow trout at a concentration about 
15 times higher than the concentration found in brown trout and Atlantic salmon (Lie 
et al., 1989). Lysozyme has been purified from plaice (Fletcher and White, 1976), and 
from rainbow trout (Grinde, 1989). Macrophages may actively secrete various 
substances such as lysozyme and interferon (which confer viral resistance) (Agius, 
1985). 
Many factors may influence the function of non-specific defence mechanisms in 
fish such as age, nutritional status, endocrine function, etc. For example, Durve and 
Lovell (1982) found that feeding a level of ascorbic acid higher than minimum dietary 
requirement for normal growth provided increased resistance of channel catfish 
fingerlings to the pathogenic bacterium Edwardsiella tarda, especially at low 
temperatures (23°C). 
Fish depend more heavily on non-specific defence mechanisms than do 
mammals (Anderson, 1992). This is especially true for short-lived fish living in cool 
or cold waters because the development of a specific immune response is temperature 
dependent (Avtalion, 1981). 
1.2.2 Specific defence mechanism: 
Teleost fish may not become immunologically competent until some weeks 
post-hatching. It seems that in this period the lymphoid system is still developing. 
While the vaccination of salmonids of 4 g or larger resulted in durable immunity (a 
year or longer), vaccination of 1 g fish resulted in a much shorter term of protection 
(Amend and Johnson, 1981; Johnson et al., 1982a, b). In fish, the ability to establish 
immune memory and to produce antibody to T-dependent antigens develops by about 
8 weeks post-hatch (Ellis, 1988b). Also, the ability of salmonid fish to develop 
prolonged duration of protection (long term memory) after vaccination is achieved 
when fish are about 4 g (Ellis, 1988b). 
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The specific immune response occurs in deep-lying lymphoid tissues in the 
kidney and spleen which collect the antigen and are stimulated to produce antibodies 
that are released into the circulation (Chiller et al., 1969). 
The kidney is the main antibody-producing organ. It contains a generalised 
haemopoietic tissue rich in lymphocytes and plasma cells as well as many 
macrophages which phagocytose antigens (Ellis, 1988b). The spleen contains fewer 
haemopoietic and lymphoid cells than the kidney, being composed mainly of blood 
held in sinuses. It, however, contains specialised capillary walls, termed ellipsoids, 
which are composed of reticulin fibres and macrophages (Ellis, 1988b). The reticulin 
fibre network is specialised for trapping immune-complexes while the macrophages 
are highly phagocytic (Ellis, 1980). 
Immunoglobulins (Ig) are found in most of tissue fluids in fish (plasma, lymph, 
skin and gut mucus and bile) since the blood vascular system of fish is evidently quite 
permeable to serum Ig (Ellis, 1982). 
Ig comprise 40-50% of the total blood serum proteins (Ellis, 1982). The total 
protein of uninjected brown trout (Salmo trutta) was 5.11± 0.71 g 100 ml -1 (Ingram 
and Alexander, 1977). Wardle (1971) demonstrated that the protein content of the 
serum and that of lymph from the neural lymphatic duct of the plaice was qualitatively 
identical and lymph contained as high as 80% of the protein concentration of the 
plasma. 
Fish Ig exist as only one class that resembles mammalian IgM (Litman, 1975). 
It is tetrameric in species such as salmonids and carp (Shelton and Smith, 1970; 
Litman, 1975), composed of 4 subunits each with 2 heavy and 2 light chains (Ellis, 
1982). Chondrichthyean fish also possess only IgM but in pentameric and monomeric 
forms (Ellis, 1982). The half-life of serum antibody in fish is as long as 12.5 days in 
carp (Avtalion et al., 1976) and 16 days in the sheepshead (Archosargus 
probatocephalus) for both high and low molecular weight Ig (Lobb and Clem, 1981a). 
In contrast, it was as short as 49 h in coho salmon (Voss et al., 1980). 
Anti-bacterial and anti-hapten antibody activity has been ascribed to a tetra-
meric (-800,000 daltons) immunoglobulin found in sera of coho salmon (Voss et a/., 
1980). Agglutinating activity is useful towards particulate antigens such as bacteria, 
and precipitating activity is particularly important in neutralising soluble toxins. 
Agglutinating antibody is readily demonstrated in fish serum whereas precipitating 
antibody activity is not (Ellis, 1982). Hodgins et al. (1967) found rainbow trout 
possessed only HMW IgM and could detect passive haemagglutinating antibodies to 
bovine serum albumin early in the response but precipitating activity was not detected 
until much later. Ingram and Alexander (1986) investigated immune responses in trout 
injected with haemocyanin. It was concluded from that work that the formation of 
precipitins seems to depend upon the nature, size and dose of antigen. High doses of 
antigen are often required to stimulate precipitin formation (Ingram and Alexander, 
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1986). However, elevated level of antibodies specific to antigens do not necessarily 
relate to protection against disease (Munn et al., 1982; Cipriano, 1983). 
Active vaccination by i.p. injection results in enhanced levels of antibodies in 
cutaneous mucus and perhaps in intestinal mucus. Rainbow trout injected with heat-
killed V. anguillarum cells in adjuvant (Harrell et a/., 1976) and injected with R. 
salmoninarium in adjuvant (Paterson et al., 1981), produced elevated levels of 
antibodies in the skin mucus as well as in serum. Fletcher and White (1973) and 
Paterson et a/. (1981) also examined the intestinal mucus for its antibody content; 
antibodies were detected but the titre were only marginally enhanced by injection of 
antigen. 
With respect to Ig in fish secretions, Fletcher and Grant (1969) reported that the 
mucus IgM of plaice was similar to serum IgM. Antibody production could be 
stimulated systemically or locally, depending on the method of antigen administration 
(Fletcher and White, 1973). In another study Harrell et al. (1975) found anti-V. 
anguillarum agglutinins with titres of 1: 240 in the ovarian fluid of rainbow trout, 
however, none was found in the eggs. Also mucus and bile of the sheepshead 
contained IgM and although it was not derived by exudation from the serum Ig pool, it 
was antigenically identical to the serum Ig (Lobb and Clem, 198 la,b). 
Regarding maternal antibodies and the reason why fry of some species are 
relatively resistant to the pathogens, this has been postulated to be related to humoral 
substances (maternal antibodies) which may play a defensive role. However, 
immunoglobulin does not appear to be present in the ova of salmonid (Ellis, 1988b). 
Apart from the humoral immune response, cell-mediated immune (CMI) 
responses are often a factor in the protection of fish against disease (Smith et al., 
1980; Aoki et al., 1984). CMI detected by using a mixed leucocyte response in 
Atlantic salmon developed at day 42 post-hatch, (Ellis, 1977) and allograft rejection 
responses developed in carp and rainbow trout by 16 days (Botham and Manning, 
1981) and 14 days (Tatner and Manning, 1983b) post-hatch respectively. Thus, CMI 
matures a little earlier than the humoral immune response (in 2-4 weeks post-hatch) 
particularly to T-dependent antigens, e.g. HGG, and functions through the production 
of cytotoxic T-like cells (Ellis, 1988b). 
The delayed-type hypersensitivity (DTH) skin reaction provides a convenient 
indicator of sensitised T lymphocytes in mammals. Rainbow trout immunised with 
seal worm extract produced a typical DTH reaction to live sealworm challenge which 
supports the existence of T-cell function with anamnesis in fish exposed to sealworm 
antigens. However, when the test fish were immunised with live sealworm and later 
challenged with live sealworm, the secondary response was poor and showed no 
difference from control fish (Ramalcrishna et al., 1993). 
Thomas (1988) observed a swelling response 72 h after sonicated Cryptobia 
antigen was injected subcutaneously at the peduncle of rainbow trout previously 
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infected with the parasite. Histological examination of the swelling reaction 
demonstrated the presence of mononuclear cell infiltrates 
With respect to acute hypersensitivity responses in fish, it was reported that 
immediate hypersensitivity skin reactions occurred in several flatfish species induced 
by C-polysaccharide substances (Baldo and Fletcher, 1975). However, typical 
mammalian-like mast cells are not present in fish (Ellis, 1982) and the role of 
histamine has not been definitively demonstrated. In a recent work, mast cells are 
demonstrated in the swimbladder of Atlantic salmon (Reite and Evensen, 1994). 
With respect to the immune tolerance, rainbow trout fry gave good protective 
immune responses to V. anguillarum when vaccinated by direct immersion and i.p 
injection, from a weight of 0.4 g onwards. Prior exposure to the antigen did not lead to 
tolerance induction. Possibly before that time (0.4 g), the immune system is capable of 
becoming tolerant and the external exclusion of antigens in the water is a protective 
mechanism by the fry to protect its immature immune system. Indeed a period of 
unresponsiveness to the vaccine antigen occurs before fish reach the critical weight 
(Tatner and Horne, 1984). The phenomenon of oral tolerance in rainbow trout has 
been investigated by Davidson et al. (1994). It was found that pre-exposure to antigen 
daily via the oral route for 5-10 days or by a single i.p injection was found to have no 
effect on the systemic response to human gamma globulin (HGG) administered i.p. 35 
days later. When the same oral route experiment was performed using A. salmonicida 
as an antigen no suppression of the systemic antibody response was observed, indeed, 
an enhancement of the response was apparent. 
Immersion vaccination provides protective immunity against vibriosis up to one 
year (Alexander, 1990). In contrast, the activation of most of the non-specific defence 
mechanisms may not last as long as the specific immune response ( Finn and Nilsen, 
1971; Gosting et al., 1981) 
1.3 Immunostimulants and role of adjuvants in fish vaccines: 
Irnmunostimulants or adjuvants are substances which enhance the non-specific 
defence mechanisms or the specific immune response generating elevation of 
circulating antibody titres. They may be used alone inducing elevated activities in the 
non-specific defence mechanisms such as increased oxidative activity of neutrophils, 
augmented engulfment activity of phagocytic cells or potentiation of cytotoxic cells so 
as to increase the resistance of fish to various infectious diseases (Anderson, 1992). 
Different adjuvants have been investigated by Duier (1985) in fish. The results 
of this study indicated that the use of a suitable adjuvant can maintain the antibody 
titre at a high level for many months, protecting trout throughout nearly all of its 
economic life with no need of a booster injection. 
In cases where disease outbreaks are cyclical or predictable, or prior to stressful 
events, losses can be reduced by use of immunostimulants to enhance non-specific 
defence mechanisms (Anderson, 1992). Zeeman (1986) found the stress of smolting 
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depressed the immune response in coho salmon and suggested immunostimulants 
could be used to restore normality at this time. 
Oil based adjuvants, such as Freund's complete adjuvant (FCA) and Freund's 
incomplete adjuvant (FIA), act as depots or reservoirs for holding the antigens in 
tissues after injection. The Mycobacterium sp. component of FCA is a T-cell 
stimulator. In fish the immunomodulatory effects of these adjuvants on the humoral 
immune response, especially to T-dependent antigens, can be considerably enhanced 
by administering the antigen with adjuvants (Ellis, 1988c). Simple mineral oil-based 
adjuvants (FCA and FIA) resulted in protection against furunculosis, vibriosis and 
enteric red mouth disease. The addition of whole cell bacterin to the adjuvant doubled 
protection (relative per cent survival= RPS) to about RPS= 40% and increasing the 
administration volume also improved protection (Adams et W., 1988). Fish as small as 
1.2 g produced antibodies as early as 4 weeks after i.p. administration of A. 
salmonicida cells in Freund's complete adjuvant. High levels of antibody persisted for 
at least 1 year after injection and provided juvenile coho salmon with protective 
immunity against furunculosis (Paterson and Fryer, 1974). 
Bacille Calmette Guerin (BCG), an attenuated bovine strain of Mycobacterium 
tuberculosis in combination with a Y. ruckeri bacterin has been injected into rainbow 
trout. Bacterial clearance was increased, however, enhancement of other 
immunological parameters, such as agglutination and serum bactericidal activity, was 
inconclusive (Grayson et al., 1987). It was concluded that while BCG is a well 
recognised immunostimulant in mammals, the colder environment of the fish may 
slow its action (Anderson, 1992). 
From the experiments conducted by Horne et al. (1982) it was shown that 
vaccination of fish annually with vaccine containing 2.5% w v -1 potassium aluminium 
sulphate adjuvant early in the season, before the occurrence of temperatures at which 
vibriosis outbreaks become frequent, was a worthwhile procedure. 
Quil-A and other detergents and quaternary ammonium compounds may affect 
the cell membrane or epidermis, and loosen intracellular junctions. Therefore, the 
absorption of antigen can be facilitated (Maharaj et al., 1986). The potential of 
enhancing enteric uptake of orally and anally delivered antigen (human gamma 
globulin; HGG) with Quil-A saponin adjuvants in tilapia (Oreochromis mossambicus) 
was investigated by Jenkins et al. (1991). They successfully enclosed the HGG protein 
in the form of micelles or immune stimulatory complexes (ISCOMS) and 
administered it to the fish orally and anally. Maximal concentrations of the antigen 
occurred in intestinal tissues six hours later when given orally; whereas, the antigen 
given by the anal route reached maximal levels in 1 hour after administration. 
The effect of oral administration of different immunostimulants on the defence 
mechanisms of fish have still to be confirmed. However, immunomodulatory effects 
of immunoactive peptides from the fermented products of chicken egg (EF 203) 
administered orally to rainbow trout resulted in increased chemiluminescent responses 
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of kidney phagocytes and increased resistance to both natural and experimental beta-
haemolytic streptococcal infection (Yoshida et al., 1993). 
Levamisole is known to be a T-cell stimulator and immunomodulator. It can act 
alone to elevate the non-specific defence mechanisms in fish, or it can be used as an 
adjuvant with a vaccine. Levamisole protected rainbow trout against V. anguillarum at 
a dose of 5 mg kg -1 (Kajita, 1990). The induced protection seemed to be due to a 
combination of serum bactericidal activity, complement activation, phagocytic 
elevations, and natural killer cell enhancement. 
Adams et al. (1988) evaluated the potency of bath vaccine in Atlantic salmon. 
Booster vaccinations using A. salmonicida whole cells were effective against 
furunculosis (RPS= 48.5%), when given 4 weeks after the primary vaccination. A 
single vaccination using whole cells extracted with the non-ionic detergent Triton-X-
100 resulted in protection against furunculosis (RPS= 29.9%) while bacteria treated 
with ethylenediamine tetra acetic acid (EDTA) gave little or no protection. Untreated 
whole cells gave RPS of 9.9%. Extracellular products (ECP) from A. salmonicida 
were effective in protection when presented in particulate form, by binding ECP to 
polystyrene beads (RPS= 35.6%). Soluble ECP vaccine provided no protection at all. 
Lipopolysaccharide (LPS) extracted from gram-negative bacteria such as 
Salmonella typhimurium are used as an immunostimulant. LPS stimulates B cell 
proliferation in vivo or in vitro in appropriate doses (Anderson, 1992). 
Phagocytic activity of leucocytes of fish treated with chitin as an 
immunostimulant was investigated by Sakai et al. (1991a). No increase was observed 
in the lysozyme and haemolytic activity of fish injected with chitin. The LD50 of V. 
anguillarum in chitin-injected fish was about 10 times higher than in control fish. 
Glucan, a long-chained polysaccharide cell wall extract from yeast, is reported to 
be a stimulator of non-specific defence mechanisms in animals, including fish (Yano 
et al., 1989; Robertsen et al., 1990). 
Chen and Ainsworth (1992) reported that B-1, 3 glucan administration enhances 
the phagocytic activity and bactericidal ability of anterior kidney phagocytes in 
channel catfish challenged with Edwardsiella ictaluri. Jorgensen et al. (1993) found 
that yeast glucan injected intraperitoneally in Atlantic salmon increased the ability of 
anterior kidney macrophages to kill a virulent strain of A. salmonicida. The 
macrophage response of injected glucan was evident 2 days post-injection. They also 
found that the increased phagocytic activity of macrophages was the result of 
increased activity rather than increased numbers. 
In a recent study, Ramadan et al. (1994) studied the effects of feeding ascogen 
on the immune response of tilapia to Aeromonas hydrophila vaccine. The results 
showed that ascogen had a marked immunopotentiating effect (both humoral and cell-
mediated) after i.p. injection as well as after direct immersion. 
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Immunostimulants, adjuvants, and vaccine carriers and their functions, used 
routinely and experimentally in fish and other animals are summarised in appendix 
VIII. 
1.4 Uptake of Antigen and other substances: 
Antigen uptake may occur through the skin, lateral line, the gill, or even by the 
fish drinking small amounts of antigen (ingestion). Fish skin including mucus, 
generally forms a three layered barrier between the host and its external environment. 
Fin tissues of fish, because of their membranous form, provide concomitant 
accessibility to blood. Fish nares are blind pits where water is channelled over sensory 
nerves. Figure 1.1 shows the possible sites of uptake of antigens. 
Observed site of entry of antigen 
Figure 1.1: Possible sites of fish body surfaces for the uptake of antigen 
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Amend and Johnson (1981) observed that protective V. anguillarum antigen 
(LPS) can induce a specific immune response in fish by short simple immersion or 
shower. Antigen is somehow taken up across the external surface (body surface) and 
results in stimulation of lymphocytes which release the antibody into the serum. 
However, it is not known precisely how the antigen attaches to the surface of the fish 
and how it is transported to the immune sites within the fish. 
Moore et al. (1994) exposed 1-5 g rainbow trout with a continuous or 'flush" 
exposure to 107 particles m14 for 24 h in a solution of fluorescent latex beads 
covalently conjugated with bovine serum albumin. Beads were observed primarily 
within cells in the epithelium of gill filaments and scaled epidermis, where the greatest 
uptake occurred adjacent to the lateral line. 
Using both light and electron microscopy Zapata a al. (1987) examined the 
uptake of antigen by salmonid gill cells after bath immunisation with a Y. ruckeri 0- 
antigen bacterin at different doses. The particulate antigen was observed in the gill 
mucus, adhering to and within the pavement cells covering the gill filament and in 
mononuclear phagocytes below the epidermal gill cells. They also found a direct dose-
response correlation in the observed immune response according to the number of 
splenic antibody-producing cells 14 days after immunisation. 
Other evidence for permeation of gills by bacteria is work by Tamer and Home 
(1983) following hyperosmotic infiltration of bacterial immunogen. Filaments and 
secondary lamellae of gill tissues increase the surface-area-to-volume ratio for gas 
exchange and offer a readily accessible supply of blood to a diversity of pathogens. 
The lateral line, is a sensory canal system underlying the epidermis of some fish 
and has numerous pores opening to the epidermis. Amend and Fender (1976) 
postulated that the perfusion of immunogen in hyperosmotic infiltration was via the 
lateral line system, then by cross-diffusion into neighbouring lymph ducts and so into 
the venous system. 
Juvenile rainbow trout were immersed (10-60 s) in a bath containing 2.5 mg 
horse- radish- peroxidase (HRP) in order to determine the tissue localisation of HRP. 
was detectable within all tissues examined as early as 5 min post treatment regardless 
of immersion period. Peak net tissue accumulation of HRP on a per g wet weight basis 
was found to be of the order; spleen > kidney >heart> liver. Peak tissue level of HRP 
was recorded following 60 s exposure to the antigen (Mclean et al., 1989). 
Many factors seem to affect the efficacy of the uptake of a 14C-labelled V. 
anguillarum cells by direct immersion of rainbow trout including duration of 
immersion and the concentration and temperature of the vaccine bath (Tatner and 
Horne, 1983). 
Several studies have been conducted on uptake of vegetable enzymatic protein 
and HRP in the gut of fish without digestion (Watanabe, 1982). Observations by light 
and electron microscopy of the uptake of rabbit immunoglobulin against HRP by the 
columnar epithelial cells of the gut of rainbow trout suggested that the columnar 
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epithelial cells took up the protein by pinocytosis through the pits between microvilli 
without enzymic digestion and the most active uptake was found in the posterior gut 
(Fujino et al., 1987). 
However, antigen administered orally is partially inactivated by the digestive 
enzymes in the upper alimentary canal prior being able to reach the intestine where 
antigen uptake can take place. This is shown from results of studies for common carp 
(McLean and Ash, 1986) and for rainbow trout (McLean and Ash, 1987) which 
revealed that in both cases, the tissue presence of orally administered HRP is 
significantly (1000-fold) greater in the "agastric" carp than in the "gastric" trout. 
Therefore, a method of protecting the antigen from the digestive enzyme in the 
alimentary canal is required, for instance, conjugation with carriers and micro-
encapsulation of an antigen by coating with cellulose derivatives can be investigated. 
McLean and Ash (1990) examined the protective effects of the antiprotease, soy-bean 
trypsin inhibitor (SBTI) and a synthetic detergent which enhanced both tissue and 
plasma levels of HRP, enhanced accumulation of HRP was noted when it was 
delivered in SBTI- HRP-detergent form. 
Jenkins et al. (1991), investigated the potential of enhancing enteric uptake of 
orally and anally delivered antigen (human gamma globulin) with Quil-A saponin 
adjuvants in tilapia. They used several sensitive immunohistochemical and immuno-
electronmicroscopical techniques. The results demonstrate the ability of the intestine 
of tilapia to absorb and to have potentially relevant immune interactions with protein 
antigens delivered by these routes and the potential of enhancing antigen absorption 
with saponin adjuvants. 
Several factors influence antigen uptake, including pH and salt concentration 
of the vaccine solution, vaccine concentration, length of vaccination time, water 
temperature during vaccination, stress, size of fish, anaesthetics, and the physio-
chemical characteristics of the antigens, such e.g. (particulate or soluble) (Tatner, 
1978; Tatner and Horne, 1983). 
1.5 Effects of temperature on the immune responses of fish: 
It is well documented that as fish are poikilothermic animals, temperature has a 
profound effect on the length of the induction period of immunity. Generally, the 
colder the water temperature, the longer the time for the development of protective 
immunity. It takes 14 to 21 days in salmonids for the development of protective 
immunity after administration of V. anguillarum vaccine at 15°C. If the temperature is 
lowered to 5°C this time will be extended to at least 40 days. At very low 
temperatures, for example 4°C and less, the immune system will not react at all, while 
higher temperatures will shorten the induction period (Smith, 1988). However, 
Lillehaug et al. (1993) showed that groups of Atlantic salmon parr vaccinated either 
by injection or immersion against cold water vibriosis caused by V. salmonicida and 
kept initially at 2, 4, 6°C for five weeks and then 10°C, showed better protection 
against infection than fish vaccinated at higher temperatures (8 or 10°C). The mean 
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levels of antibodies against V. salmonicida were not higher in the low temperature 
group, indicating that mechanisms other than antibody also play a role in protective 
immunity. 
Temperatures which are low but still within the normal physiological range of a 
particular species of fish (e.g. less than 6°C for rainbow trout or 12°C for carp) can 
depress the adaptive immune response in a variety of ways (Avtalion, 1981). 
However, phagocytosis seemed less affected by temperature change (Avtalion, 1981). 
The first appearance of humoral antibodies in coho salmon injected with killed 
V. anguillarum cells occurred after about 25 days at 6°C but after only about 10 days 
at 18°C (Groberg, 1982). This phenomenon must be taken into consideration when 
planning vaccination so that the fish are immune by the time they are exposed to the 
pathogen. 
In an attempt to understand the interrelation between environmental 
temperature and immune competence, Bly and Clem (1991) found that in vivo 
exposure to an "ultra-low temperature" (when temperature can drop to as low as 2°C 
and fluctuate as much as 9°C during a 12h period) can have profound suppressive 
effects on immune function in channel catfish. Furthermore, this form of suppression 
was not a typical stress-induced response, i.e blood serum chemistry and blood cell 
counts did not change in a manner consistent with transport induced stress. 
Yamaguchi et al. (1981) showed that the rainbow trout immune system could be 
affected by seasonal changes in temperature. According to their results it seems that 
the immune system of the fish responds more effectively in the spring than in the 
autumn under apparently uniform conditions of light. When the environmental 
temperature is constant, antibody synthesis in fish is still affected by the season. 
The occurrence of circulating antibodies against V. anguillarum 01 antigen was 
highly variable in vaccinated rainbow trout and was closely related to season but not 
geographic location. Percentages of seropositive fish generally ranged from 0-40%. 
Circulating antibodies tended to be undetectable in fish sampled in spring. Maximum 
percentages of seropositive fish occurred in summer and autumn (Williams and 
Lindqvist, 1992). 
1.6 Immunological assays: 
Many assays have been employed for detection of the fish antibody response. 
Bacterial agglutination (Roberson, 1990), fluorescent antibody test (Anderson, 1990a), 
passive hemolytic plaque assay for detecting antibody-producing cells (Anderson, 
1990b), complement-fixation test (Ingram, 1990a), immunoelectrophoresis (Ingram, 
1990b), and counter-current electrophoresis (Ingram, 1990c) have been employed in 
fish immunological studies. 
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ELISA (enzyme-linked immunosorbent assay): 
The enzyme linked immunosorbent assay is currently receiving the most 
attention due to its sensitivity, specificity , speed, versatility, low cost, and reagent 
stability. In the indirect ELISA, antigens are adsorbed to the solid substrate and the 
sera (antibody) to be measured is added. The secondary antibody (anti-antibody that is 
usually loosely referred to as the conjugate) which is already conjugated to an 
appropriate enzyme is then added and if any antibody in the sera has been bound, it 
will attach to it. 
The sensitivity of ELISA was several times higher than that of agglutination test 
to detect anti-A. salmonicida antibody (Kodama et a/., 1985a). The result of 
agglutination and ELISA tests for detection of anti-V. anguillarum antibodies in 
salmonids after different routes of vaccination showed that the agglutination test was 
less accurate than the ELISA (Munday et al., 1992). ELISA proved to be more 
sensitive than the agglutination test for detection of antibodies to Y. ruckeri in rainbow 
trout (Olesen, 1991). 
ELISA fulfills all the requirements of a rapid, sensitive, simple, and highly 
reproducible assay. The reagents are also inexpensive and do not have a limited shelf-
life or the health hazards associated with utilising radio-isotopes (McArthur and 
Sengupta, 1982). 
Over the last two decades, ELISA has been used a great deal for immunological 
surveys and with a variety of procedures. Following are examples of different ELISAs 
that have been used. 
Roberson (1981) used thin-layer ELISA for the detection of fish antibody 
against V. anguillarum and Y. ruckeri 0-antigen. The sensitivity of the enzyme-linked 
reaction was found comparable to passive hemagglutination. 
Also, two indirect ELISAs were developed to evaluate specific antibodies 
against Y. ruckeri and Egtved virus in rainbow trout. The sensitivity and specificity of 
each ELISA were compared with agglutination and seroneutralisation (Cossarini-
Dunier, 1985). 
Hamilton et al. (1986) successfully monitored antibody production during 
experimental A. salmonicida infection in rainbow trout with a modified ELISA. 
Using ELISA, Hongslo et al. (1987) showed that both vaccination by i.p. 
injection and vaccination by immersion induced a high degree of protective immunity 
against vibriosis which lasted for at least 46 weeks. At each experimental infection the 
proportions of seropositive fish were lower than the proportions of fish with protective 
immunity. However, seropositive individuals were found in both experimental groups 
throughout that study. 
Intraperitoneal vaccination of rainbow trout with V. anguillarum at varying 
temperatures and seasons was conducted by Thorburn et al. (1989), who classified fish 
as sero-negative (low titre) or sero-positive (high titre). They tested for anti-V. 
anguillarum serotype I antibodies with ELISA. A high percentage 75%) of trout in 
24 
all i.p-vaccinated groups were sero-positive during most of the growing seasons. This 
percentage was lower (5. 27%) among dip vaccinated trout prior to the occurrence of 
vibriosis. 
Monoclonal antibodies have been used in fish immunology, e.g. against serum 
Ig of channel catfish (Lobb and Clem, 1982), rainbow trout (DeLuca et al., 1983) and 
carp (Secombes et al., 1983) for the detection of leukocytes, such as non-specific 
cytotoxic cells (Evans et al., 1990). 
Monoclonal antibodies to rainbow trout IgM were prepared and applied in an 
ELISA for measuring humoral antibodies to V. anguillarum in trout (Thuvander et al., 
1990). It was found that the monoclonal anti-rainbow trout IgM antibodies 
discriminated seropositive fish from controls more efficiently than polyclonal rabbit 
anti-trout IgM antibodies. 
Other assays, for example the enzyme-linked immunospot assay (ELISPOT) for 
quantification of antibody secretory sells (Davidson and Secombes, 1992) have been 
used. The optimised ELISPOT assay is at least as sensitive as the plaque assay, and is 
usually more sensitive (Heyman et al., 1991). 
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CHAPTER 2.0 
GENERAL MATERIALS AND METHODS 
2.1 Introduction: 
The following materials and methods were established 1) to prepare bacterins, 2) 
to produce antisera, 3) to purify antisera, 4) to develop assays for serological 
monitoring of the immune response of animals and also monitoring persistence of 
transferred antisera in fish sera, 5) to quantify a lethal dose of bacteria for challenge 
for the experiments undertaken in this research project. In this chapter, general 
materials and methods often used for all experiments are discussed. Any specific 
method used for a particular experiment is discussed later with that experiment. 
2.2 Growth of bacteria and Paramoeba sp. for antigen (vaccine) 
preparation. 
V. anguillarum:  
Origin: V. anguillarum serotype C (01), strain 85-3954-1 isolated from rainbow 
trout on 18. 3. 86. The V. anguillarum serotype C (01), strain 85-3954-1 is a 
Tasmanian strain of the organism that was serologically identical with serovar C (also 
designated 01) supplied by Dr. Jeremy Carson (Fish Health Unit, Mt. Pleasant 
Laboratories, Department of Primary Industry and Fisheries, Launceston, Tasmania). 
Streptococcus sp.:  
Origin: Streptococcus sp. (biovar 1), strain No. 88.598 isolated from rainbow 
trout supplied by Dr. Jeremy Carson (Fish Health Unit, Mt. Pleasant Laboratories, 
Department of Primary Industry and Fisheries, Launceston, Tasmania). 
Paramoeba sp.  
Origin: Paramoeba sp. (PA-016) isolated from Atlantic salmon supplied by MS 
Teresa Howard (Fish Health Unit, Mt. Pleasant Laboratories, Department of Primary 
Industry and Fisheries, Launceston, Tasmania). 
2.2.1 Antigen preparation for injection vaccination: 
V. anguillarum and Streptococcus sp. antigens  
The Vibrio antigen consisted of a 24-h culture of V. anguillarum grown initially 
on sheep's blood agar (BA) and then in Vibrio nutrient broth (Oxoid) at temperature 
of 25°C. Streptococcus sp. was grown on BA, and then inoculated in Todd-Hewitt 
broth (Oxoid) for 48h on a shaker at room temperature(25°C). The pH was maintained 
at 6.8- 7.3 with 1 N NaOH. Glucose was added after 18 h incubation (final 
concentration, 1.0%). Bacteria were grown to a density of approximately 10 10 viable 
cells per ml. The suspensions containing Vibrio and Streptococcus cells were treated 
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with formalin (37% formaldehyde) to a final concentration of 0.5% v v -1 and left 
overnight at 4°C. Each suspension was washed three times [with phosphate-buffered 
saline(PBS, pH= 7.2)] by centrifugation (at 4000 rpm for 20 min) at 10°C and the 
sterility of the washed bacteria was tested by cultures on BA. Loss of bacterial 
viability was confirmed by lack of growth on BA before injection into fish. The 
washed formalin killed bacterial cells were resuspended in PBS to a density of 2 mg of 
cells (dry weight) in 1 ml of PBS and emulsified with an equal volume of either 
Freund's complete adjuvant (FCA) or Freund's incomplete adjuvant (FIA) (Sigma) and 
stored at -20°C until used. 
Live washed V. anguillarum and Streptococcus sp. cells were also sonicated (3x1 
to 3x3 cycles or disrupted in a French press [(Elizabeth Macarthur Agricultural 
Institute (EMAI) for Streptococcus cells)], centrifuged and filtered through 0.211 filter 
for coating the ELISA plates. Protein concentration of the supernatant was determined 
by a Corrnnassie Blue dye binding assay (for V. anguillarum antigen) (Bradford, 1976) 
and a Lancer Microprotein rapid stat diagnostic kit (for Streptococcus sp. antigen). 
Paramoeba sp. antigens: 
Paramoeba sp. was maintained on a bacterial lawn of Pseudomonas maltophilia 
grown on malt yeast extract seawater agar. Paramoeba were harvested from the plate 
and suspended in sterile seawater and homogenised. The harvested Paramoeba were 
used for preparing sonicated antigen. Both Paramoeba cells and sonicated cells were 
treated with formalin (37% formaldehyde) to a concentration of 0.5% v v -1 and 
emulsified with either an equal volume of FCA or FIA for vaccination as explained 
previously. 
Live Paramoeba sp. was also sonicated (3x1 to 3x3 cycles) and filtered through 
0.2 11 filter for immunisation of fish and coating the ELISA plates. The protein content 
was then measured using a Lancer Microprotein rapid stat diagnostic kit. 
2.2.2 Antigen Preparation for immersion vaccination: 
V. anguillarum were grown in vibrio nutrient broth (Oxoid) while 
Streptococcus sp. was grown on BA and then inoculated in Todd-Hewitt broth 
(Oxoid) at a temperature of 25°C for 48 h. Both organisms were grown to a density of 
approximately 1010 viable cells m1 -1 as explained in the previous section treated with 
formalin (37% formaldehyde) to a final concentration of 0.5% v v -1 and stored 
overnight at 4°C. The formalised cultures were kept at +4°C until used. 
2.3 Animals : 
Experimental animals included sheep, rabbits and fish: Sheep were maintained 
at the Department of Primary Industry and Fisheries, Mt. Pleasant Laboratory, 
Launceston, Tasmania. New Zealand white rabbits (approximately 2 kg) were 
maintained in the animal laboratory unit at Elizabeth Macarthur Agricultural Institute 
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(EMAI), NSW and Animal House Unit, University of Tasmania, Hobart campus. Fish 
were rainbow trout (Oncorhynchus mykiss, Walbaum) and Atlantic salmon (Salmo 
salar L) (weight range of 50 - 620 g). Fish were maintained in freshwater (rainbow 
trout) or seawater (Atlantic salmon at the time of exposure to Paramoeba) in 
temperature controlled tanks at the Aquaculture Key Centre, Department of 
Aquaculture, University of Tasmania. 
2.4 Production of antiserum. 
Two sheep, two rabbits, fifty large rainbow trout and forty Atlantic salmon were 
used for producing antisera against V. anguillarum or Streptococcus sp. The same 
number of animals were used for anti-Streptococcus sp. antisera production. Antisera 
production against Paramoeba sp. is described in chapter 5.0. 
Sheep were injected subcutaneously in the cervical area with a 2 ml dose (2 mg 
dry weight of formalin killed cells) of vaccine containing FCA at week 0, and 2 ml of 
the same vaccine in FIA at week 4. Animals were bled from the jugular vein at the end 
of week 4 before administration of the booster dose in order to assess their humoral 
antibody response to the antigen. At the end of week 6 blood samples were collected 
and sheep were euthanised. Serum was collected after allowing the blood to clot 
overnight at 4°C and centrifuged (1400 g) and was stored at -20°C. 
Similarly, rabbits were injected subcutaneously with antigens but were bled by 
incising the ear veins. 
Fish maintained in 4000 L fibreglass tanks at a temperature of 15°C were used 
for raising antisera. All fish were starved 12 hours then anaesthetised for experimental 
procedures with 40 mg 1 -1 benzocaine (10% w v-1 ethyl-4-aminobenzoate in ethanol, 
or acetone). Fish were anaesthetised in a 20 L fish bin with aeration and a flow 
through aerated 450 L recovery bin was used for recovery of the anaesthetised fish. A 
volume of 0.1 ml dose (0.1 mg dry weight of formalin killed cells) of each prepared 
vaccine containing adjuvant was injected intraperitoneally (midway between the 
pelvic fin and the anus) at week 0 and at week 4 respectively. Fish were bled via the 
caudal vein. Unless stated otherwise, sera were all tested by ELISA prior to the 
immunisation and found to be free of specific antibodies. 
2.5 Purification of antisera: 
2.5.1 Ammonium sulphate (Amm.Sul) precipitation of antisera 
In order to precipitate antibodies, each serum was centrifuged at 3000g for 30 
min and supernatant was used for the next step. While the serum was being stirred 
gently, saturated ammonium sulphate solution was slowly added to 50% v v -1 and the 
mixture was transferred to 4°C overnight. After centrifugation of the precipitate at 
3000g for 30 min, the supernatant was carefully discarded and the pellet was 
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resuspended in 0.3-0.5 volumes of the starting volume in PBS (Harlow and Lane, 
1988). 
The solution containing antibodies was placed into dialysis tubing and dialysed 
versus 25 mM tris pH 7.2, 0.15 M NaCl overnight. Samples were removed from the 
tubing and centrifuged to remove any remaining debris. Aliquots containing 
antibodies were stored in the presence of 0.02% sodium azide at -20°. Sera of sheep, 
rabbit and fish were precipitated with this method for further use. 
2.5.2 Affinity purification of sheep immune serum on protein G -sepharose: 
Protein G-sepharose 04 Fast Flow (Pharmacia®) (5 ml, preswollen in 20% 
ethanol) was used for purification of sheep antisera according to the method 
established by Dr Richard Whittington (EMAI). The swollen gel was poured smoothly 
into an emptied PD-10 column (Pharmacia) and packed using 150 ml of starting 
buffer. Serum (1-2 ml) was centrifuged at 3000 g for 10 min in a microcentrifuge. The 
supernatant was mixed with an equal volume of starting buffer [(25 mM Tris-HC1, pH 
7.2, 0.15 M NaC1, 0.01% sodium azide) (all reagents' formula in appendix V) , loaded 
onto the column and washed through with 25 ml of starting buffer at a flow rate of 10 
ml hr-1 . Immunoglobulins (Ig) were eluted with 30 ml of 0.1 M glycine-HC1 pH 3, 
0.15 M NaC1, at a flow rate of 30 ml/hr. Fractions of 2.5 ml were collected using a 
Gilson model 202 fraction collector and immediately neutralised by the addition of 35 
pi of 2 M Tris. Pooled fractions were dialysed overnight against starting buffer, and 
concentrated by dialysis against Aquacide II (Calbiochem) to the original volume of 
serum. The yield of Ig (dry weight) was 9 mg m1 -1 . Resulting antisera was evaluated 
for specific activity by ELISA. Purified Ig were stored at -20°C for further use. 
Protein content was estimated by the Microprotein rapid stat kit (Lancer, Oxford 
Labware, St. Louis. MO.63103 USA). The protein content of pooled affinity protein-G 
purified sheep anti-V. anguillarum was 9.4 mg m14 . 
2.5.3 Affinity purification of rabbit immune serum Ig on protein A -sepharose: 
Protein A-sepharose CL-4B (Pharmacia®) (1.5 g) was swollen in 20 ml of 
starting buffer, for 15-20 min and poured into an emptied PD-10 column (Pharmacia). 
The remainder of the procedure was as described above for protein G. 
The yield of Ig (dry weight) was 14 mg m1 -1 . Resulting antisera was evaluated 
for specific activity by ELISA and SDS-Page. 
Gels (protein G, A-sepharose) were then regenerated using Tris regeneration 
buffer (0.1 M Tris-HC1, pH 8.5, 0.5 M NaC1), acetate regeneration buffer (0.1 M Na 
acetate pH 4.5, 0.5 M NaCl) and starting buffer. 
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2.5.4 Purification of fish immune serum Ig on washed formalin inactivated Vibrio 
anguillarum cells. 
The following method for purification of fish immune serum was attempted 
using formalin killed V. anguillarum cells. Fish AVA serum was precipitated with 
ammonium sulphate and concentrated as described before. Several dilutions from 1 to 
500 gl m14 were prepared. Washed formalin-killed V. anguillarum cells were then 
added, mixed and left overnight at 4°C. The suspension was centrifuged (1400 x g) 
and the elution buffer (glycine-HC1, pH 3) was added and mixed. The suspension was 
then centrifuged (1400 x g) and the supernatant was neutralised and concentrated. 
Several efforts were undertaken not only to use different concentration of 
antibodies as explained, but also several dilution of washed killed bacteria with the 
same elution buffer. 
ELISA was run to verify fish Ig activity. All the ELISAs were negative 
therefore, this method of fish serum purification was unsuccessful. 
2.5.5 Assessment of the purity of ammonium sulphate precipitated and affinity 
purified serum samples by sodium dodecyl sulfate - polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Different sera were assessed by SDS-PAGE (Laemmli, 1970) in an 8 cm, 12% 
resolving, 4 % stacking gel. The gel was run at 60 mA and 138 volts for one and a half 
hour. Protein bands were stained with 0.2% Commassie brilliant blue for 50 minutes. 
A volume of 15 Ill of each serum sample with a 10 1.1.g protein content was assessed 
(Plate 2.5.5). 
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L chain 
1 2 3 4 5 
SDS-Page for sheep antisera. 
For sheep: 
1- MW standards. 
2- Sheep whole non-immune serum (15 j.i1 of 1:20 dilution of serum). 
3- Sheep whole serum immune serum (15 111 of 1:20 dilution of serum). 
4- Sheep ammonium sulphate non-immune serum (10 gg protein). 
5- Sheep ammonium sulphate immune serum (10 1.tg protein). 
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SDS-Page for rabbit antisera 
1- MW standards. 
2- Rabbit whole non-immune serum (15111 of 1:20 dilution). 
3- Rabbit whole immune serum (15 Ill of 1:20 dilution). 
4- Rabbit ammonium sulphate non-immune serum (10 gg protein). 
5- Rabbit ammonium sulphate immune serum (10 jig protein). 
6- Rabbit affinity immune serum (10 lig protein). 
7- Rabbit affinity immune serum (10 jig protein). 
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Plate 2.5.5: SDS-Page of sheep and rabbit sera 
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2.6 Enzyme-linked immunosorbent assay (ELISA) 
Detection of antibodies in sera  : 
The test used to detect anti-V. anguillarum, anti-Streptococcus sp. and anti-
Paramoeba sp. antibodies in immune sera, and sera of passively immunised fish, was 
a specific indirect enzyme-linked immunosorbent assay developed by Dr. Richard 
Whittington (EMAI). 
Solid phase: The microtest plates used were flat bottom polystyrene ELISA 
microtitration plates Linbro/ Titertek, (CAT.N0.76-381-04), Flow Laboratories, Inc. 
USA. 
Antigens: 
To perform indirect ELISA, whole cell bacteria (WCB) and soluble antigen 
(SA) were used for coating the plates. 
1-Whole cell antigens 
Bacteria were grown on sheep blood agar for 24 h and harvested from the plate 
by flushing with sterile saline. Harvested cells were washed twice in sterile saline 
(3500 rpm, 20 min.) and the pellet was resuspended in a known volume of PBS. 
The absorbance of the washed bacteria was measured at 650 nm and the 
bacteria were resuspend in a volume to achieve an A650 of 4 in both TSGM and TS 
methanol (ELISA reagents, appendix III). 
2- Soluble antigens 
Soluble antigens were prepared by sonication of live washed bacteria as described 
in section 2.2.1. Several 1 ml solution of the antigens was prepared, diluted 1: 10 in 
TSGM and was stored at -20°C. 
General ELISA method: 
Microtitre plates were coated with 100 p.1/well of WCB antigen diluted 1: 750- 
1: 1000 in TS methanol and were centrifuged for 10 min at 2500 rpm at 10°C. 
Alternatively, plates were coated with 1-5 lig soluble antigen diluted in borate coating 
buffer, pH 8.4 (100 mM boric acid, 25 mM disodium tetraborate, 75 mM NaC1) 
incubated 16 h at 4°C. The antigen was then flicked off and remaining free binding 
sites were blocked with 100 p.1 well-1 of 1% w v -1 gelatin ( Oxoid) in PBS+ 0.05% 
Tween 20 (PBST) for 30 min at room temperature (RT), then washed 5 times by 
distilled water+ 0.05% Tween (DWT) using Titertek® microplate washer 120 (Flow 
Laboratories, UK). Serially diluted test sera (primary antibody), were added (100 in 
well-1 ) to the wells and incubated for 90 min at RT. Duplicate wells were used for 
each serum sample. 
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After washing with DWT, either conjugate (labelled anti-species antibody) 
(sheep ELISA; KPL® anti-sheep-HRP and rabbit ELISA; Dako® anti-rabbit-HRP) 
diluted 1: 2000, or mouse monoclonal antibody (mAb) anti-trout (fish ELISA) 
(Deluca et al., 1983), supplied by Dr. Richard Whittington, EMAI as secondary 
antibody diluted 1: 1000 (in PBS containing 0.5% Tween and 0.1% gelatin) was added 
and incubated for another 90 min at RT. 
Fish ELISA required one more step for attachment of specific conjugate 
(Dalco® rabbit anti-mouse) to monoclonal antibody and incubated for 90 min at RT. 
After washing, 100 p1 well - I of 2,2'-azino-bis (3-ethyl benzen thiazoline-6-sulfonic 
acid) Diammonium salt (ABTS) in 100 mM citrate phosphate pH 4.2, 2.5 mM 
hydrogen peroxide was added (Fig 2.6.1.1). The reaction was stopped after 20 min at 
RT by the addition of 50 p.1 of 0.015 sodium azide in 0.1 M citric acid and optical 
density (0.D) was measured at 405 nm using an automated microplate reader model 
EL 309 (Bio-Tek Instruments Inc., USA). The obtained optical densities were 
compared with the developed colour in wells visually for any possible variation due to 
edge effect. A negative and positive control serum was included on each plate. 
Sheep 	Rabbit Fish ELISA 
• .10%.‘0%.%•%0i0%.%•%•%•%0000.%06.%.10%.%•% 
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%0.060i0A010%...0%.0.00.0000,%•%•%•%•%•%•% 
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Colour reaction 
	 Substrate + H202 
	 HRP-conjugated anti-sp. 
HRP-conjugated anti-sp. Mor oclonal antibody 
Sheep, Rabbit antiserum Fi antiserum 
Whole cell bacteria or soluble 
Antigen 
Figure 2.6.1.1: Configuration of sheep, rabbit and fish ELISAs. 
Control positive and negative sera were included in triplicate in every plate. 
These sera originated from stock fish before immunisation. Positive control sera was 
the pooled sera of trout that had been repeatedly immunised with formalin-killed 
bacterins. The known serum containing a final dilution equivalent to the final dilution 
of the test sera was used in 4 dilutions; highly positive, medium positive, low positive 
and negative. The diluent for control was negative sera. This was to ensure that the 
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concentration of background proteins in the sera (test sera) and controls (control sera) 
are similar. By use of these control, it was possible to correct the optical densities 
(explained later). 
In this test, antibody (serum) dilution was variable and antigen and marked 
antibodies (conjugate, monoclonal) were usually held constant. The pH of all diluents 
for serum, monoclonal antibody and conjugate in both sheep and rabbit ELISA were 
adjusted to 7.2-7.4 and in fish ELISA adjusted to 8.0. Due to the small amount of fish 
blood and therefore small amount of sera instead of using 100 .1.1 well -1 antigen, serum 
and etc. 50 IA well was used (in fish ELISA). The optimal concentration of antigen, 
conjugate and monoclonal antibody were titrated upon their use in ELISA before 
running the test (explained later). 
A positive serological result was defined as an 0.D greater than mean+ 2 S.D of 
the OD of control fish sampled at the same time. 
Plate 2.6.1: ELISA plate showing colour reactions at different dilutions of 
antiserum 
2.6.1 ELISA for detecting sheep anti-V. anguillarum antibodies: 
A standard, indirect, enzyme-linked, immunosorbent assay was used to detect 
antibodies against V. anguillarum. This procedure was applicable to detect anti-Vibrio 
antibodies (AVA) both in sheep serum and in sera of fish which were passively 
immunised with immune sheep serum. The reagents were rabbit antibody against 
sheep Ig, conjugated to HRP and ABTS chromogen with hydrogen peroxide as 
substrate for the enzyme. In this test the sheep non-immune and immune AVA were 
examined. 
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Procedure for running ELISA for sheep anti-Vibrio antibodies:  
In this test AVA in sheep serum (pooled sheep sera) were detected. All washes 
were distilled water+ 0.05% v v -1 Tween 20. Diluent (PBSTG) for serum and 
conjugate was at pH 7.2-7.4. Samples were run in duplicate on each plate (summarised 
ELISA procedure is in appendix IV). No edge effect was observed after reading 
ELISA plates. 
A number of parameters required optimisation since the method was being 
transferred from EMAI where different equipment and apparatus was used, as well as 
different batches of reagents. Sheep antibody response to V. anguillarum antigens 
using whole cell bacteria (constant dilution 1: 750), conjugate ( constant dilution 1: 
2000) and variable level of antibody is shown in Figure 2.6.1.2. 
Figure 2.6.1.2: Optical density vs dilutions of sheep serum (sheep non-immune and 
immune sera) 
The results show that ammonium sulphate cut serum had higher 0.D suggesting 
higher antibody level of the precipitated immune serum. 
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Signal noise ratio (without any unite) was calculated by dividing optical density 
of immune serum (mean of the duplicate wells) by 0.D of non-immune serum (mean 
of the duplicate wells). Therefore the higher the signal noise the higher ELISA activity 
at that particular dilution of sera etc. Signal noise of sheep sera at different dilutions 
showed that an optimum dilution of 250 (Figure 2.6.1.3). 
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Figure 2.6.1.3: Signal noise vs dilution of sheep AVA 
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Regarding optimisation of antigens, different dilutions of antigen (WCB) with 
constant dilution of immune serum were used. 
The results comparing the binding activity of whole cell bacteria and soluble 
antigens with 1: 200 dilution of serum and different dilution of conjugate (conjugate 
titration) are shown in figure 2.6.1.4. 
—CI- Non-immune sheep serum --A-- 
(conjugate dilution 1: 1000) 
0 	Immune sheep serum 
(conjugate dilution 1: 1000) 
Non-immune sheep serum 	--.0-. - . 
(conjugate dilution 1: 2000)  
Immune sheep serum 
(conjugate dilution 1: 2000) 
Non-immune sheep serum 
(conjugate dilution 1: 3000) 
Immune sheep serum 
(conjugate dilution 1:3000) 
Figure 2.6.1.4: Optical density vs dilution of bacterial antigen (WCB) in 
different dilutions of conjugate 
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Signal noise of the dilutions of antigen (WCB) in different dilution of conjugate 
and constant dilution of sheep sera (1: 200) is shown in figure 2.6.1.5. 
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Figure 2.6.1.5: Signal noise vs different dilutions of antigen (WCB) and conjugate 
The results showed that dilution 1: 200 of whole cell bacteria (WCB) 
had the best binding property to the plate and the dilution of 1:2000 of conjugate 
demonstrated a higher activity in sheep ELISA. 
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In order to optimise the concentration of soluble antigen, different 
concentrations of soluble antigen and conjugate with constant dilution of sheep sera 
(1: 200) were used (Figure 2.6.1.6). 
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Figure 2.6.1.6: Optical density vs concentration (i.tg m1 -1 ) of soluble antigen in 
different dilution of conjugate 
Dilution of antigen in 1-10 jig m1 -1 had a high binding property to the ELISA 
microplate and conjugate at the dilution of 1: 1000 showed the highest activity. 
In comparing the binding activity of two types of antigens (WCB and soluble 
antigens), both showed high binding properties. However, soluble antigen showed 
higher activity in detecting sheep AVA. 
Prozone (presence of inhibitors of antigen-antibody binding which are diluted 
out, resulting in higher signals at higher dilutions of serum, up to the point where 
further dilution reduces the antibody enough to suppress the signal) was observed in 
undiluted and low diluted sera. Therefore, in all sheep ELISAs, dilution of 1: 200 of 
either non-immune and immune sheep sera was used. 
It can be deduced from the results that different biological reagents which were 
used in ELISA had to be titrated in order to use the most active amount of the reagents 
before testing the test sera. 
2.6.2 ELISA for detecting rabbit anti - V. anguillarum antibodies: 
ELISA was run for detecting AVA in rabbits sera (pooled rabbit sera). Two non-
immune and two immune rabbit sera were tested as well as those ammonium sulphate 
treated sera. A standard, indirect, ELISA was employed. Reagents were Dako swine 
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against rabbit Ig, conjugated to horse-radish peroxidase (dilution of 1: 250) and ABTS 
chromogen with hydrogen peroxide as substrate for the enzyme. In this test the non-
immune and immune sera of sheep were examined for their AVA levels. In addition, 
ammonium sulphate purified immunoglobulin was also tested (summarised ELISA 
procedure for detecting rabbit antibodies in appendix IV). No edge effect was 
observed after reading ELISA plates. 
—1:1— Rabbit 1 whole non- 
immune serum • 	 Rabbit 1 non-immune 
serum 
(ammonium sulphate cut) 
Rabbit 1 whole immune 
serum 
Rabbit 1 ammonium 
sulphat cut immune 
serum 
Rabbit 2 whole non- 
immune serum 
Rabbit 2 whole immune 
serum 
Dilution of rabbit serum 
Figure 2.6.2: Optical density vs dilution of rabbit serum. 
In rabbit ELISA, all immune sera showed a great deal of anti-Vibrio antibodies. 
However the amount were not as high as sheep's. It seems that sheep responses to V. 
anguillarum were higher than that of rabbit. The prozone effect was observed in 
whole and low diluted sera. 
Optimum dilutions of conjugate, antigen (WCB) and soluble antigen in this 
ELISA were 1:500 and 1:100 and concentration of 5 pg protein respectively. Soluble 
antigen showed higher activity in detecting AVA when compared with whole cell 
antigen. Signal noise was also calculated to find out the best concentration of each 
reagents as those of sheep ELISA (as described previously). Dilution of 1: 200 of 
rabbit sera showed the best activity. Therefore, in all rabbit ELISAs these dilutions 
were used. ELISA 0.D results, maximum, minimum and cut-off values of fish 
antibody responses after i.p. injection of 1 mg (dry weight) formalin killed Vibrio 
cells are summarised in appendix VI. 
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2.6.3 ELISA for detecting fish antibodies 
2.6.3.1 ELISA for detecting fish antibodies to V. anguillarum antigens: 
ELISA was run for testing non-immune and immune sera (pooled fish sera) 
produced in the Aquaculture Key Centre and also those from EMAI. The specific 
reagents were mouse monoclonal antibody against trout IgM heavy chain, rabbit 
antibody against mouse IgG conjugated to HRP and ABTS chromogen with hydrogen 
peroxide as substrate for the enzyme. 
In this test the non-immune and immune sera of fish were examined for their 
anti-Vibrio antibodies levels. Mouse mAb (anti-trout IgM) was added to attach to 
anti-Vibrio antibodies and then conjugate (Dako rabbit anti mouse-HRP is added to 
react with it (summarised procedure in appendix IV). 
The amount of antiserum and reagent were reduced to half amount because of 
relatively small volume of antisera taken from fish. ELISA for detecting fish response 
to Vibrio antigen was set up using dilutions of antigen (WCB), 1:1000 mAb, 1:10 in 
PBSTG and conjugate dilution in 1:750. 
i II !fill 
0 100 200 300 400 500 600 700 800 9001000 
Dilution of fish sera 
Figure 2.6.3.1: Optical density vs dilution of fish sera 
The results of this test showed that fish had responded to V. anguillarum. 
markedly at a dilution of 1: 100. The titres in dilution up to 1: 1000 still showed 
significant antibody level. Optimisation of other parameters was also carried out to 
determine the best dilutions as described previously. Using whole cell antigens (1: 
750) and soluble antigen 10 jug m1 -1 showed that whole cell antigen resulted in higher 
detection of fish antibodies. Therefore, for coating the plates in fish ELISAs, whole 
cell antigen was used. 
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2.6.3.2 ELISA method for detecting fish antibodies to heterologous sheep and 
rabbit antisera: 
Microtitre plates were coated with 50 ill of 1 lig protein m1 -1 either ammonium 
sulphate purified sheep or rabbit AVA (diluted in borate coating buffer). Plates were 
sealed and incubated at + 4°C overnight. Plates then were washed 5 times with DWT 
and remaining free binding sites were blocked with 100 ml well -1 of 1% WA' gelatin 
(Oxoid) in PBS + 0.05% Tween 20 (PBST) for 30 mm at room temperature (RT). 
Plates were washed 5 times in DWT and 1: 100 dilution of fish sera (collected 
from fish after injection of sheep and rabbit AVA) were added (50 Ill well 4 ) to the 
wells and incubated for 90 min at RT. Duplicate wells were used for each serum 
sample. After washing in DWT, mouse monoclonal antibody anti-trout was added and 
plates were incubated for 90 min at RT. Rabbit anti-mouse-HRP was then added and 
plates were incubated for another 90 min at RT. After washing, 50 Ill well -1 of ABTS 
in 100 inM citrate phosphate pH 4.2, 2.5 mM hydrogen peroxide was placed into the 
wells. The reaction was stopped after 20 min at RT by the addition of 50 gl of 0.015 
sodium azide in 0.1 M citric acid and optical density (0.D) was measured at 405 nm. 
In order to confirm binding of the sheep/rabbit Ig to the microtitre plates, control 
wells were included in the last column in each plate in duplicate. Fish serum was not 
added to these wells, which were reacted directly with rabbit anti-sheep-HRP 
conjugate (for sheep plate) and swine anti-rabbit-HRP (for rabbit plate), for 90 min at 
RT. After washing, 50 Ill well-1 of ABTS was added and the assay continued as 
above. A positive result in these wells confirmed the binding of either sheep or rabbit 
Ig. 
2.6.4 ELISA for detecting anti -Streptococcus sp. antibodies (ASA): 
A standard, indirect, enzyme-linked, immunosorbent assay was established for 
detecting anti-streptococcal antibodies in sera. Optimising of reagents (antigen, 
conjugate and monoclonal antibodies) was carried out to establish a sensitive ELISA 
as described in the Vibrio ELISA. In this test non-immune and immune serum of 
sheep rabbit and fish against Streptococcus sp. were examined. 
Antigen preparation: 
The bacteria were grown on blood agar for 48 h and harvested from the plate by 
flushing with sterile saline or from broth by centrifuging. Harvested cells were washed 
twice in sterile saline(4000 rpm, 20 min) and the pellet was resuspended in a known 
volume of sterile PBS. 
1- Whole cell bacteria: The absorbance of washed bacteria was measured at 650 nm 
and the solution was resuspend in a known volume of TS-methanol to achieve an 
absorbance (650 nm) of 4 (neat antigen) as described in section 2.6. Plates were 
coated with this antigen from non-diluted to dilution of 1: 750. Results of the ELISA 
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using sheep anti-streptococcal antibodies in order to optimise the antigen is shown in 
figure 2.6.4.1. 
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Figure 2.6.4.1: Optical density vs dilution of whole cell Streptococcus sp. 
antigen 
The results showed that neat WCB had the best binding property to antibodies in 
the serum. Nevertheless, this dilution was not always consistent. This is probably 
because anti-Streptococcus sp. antibodies (ASA) does not react enough to the antigen 
because of low affinity. Therefore, this assay needs a high concentration of the whole 
cell bacterial antigen in order to monitor the specific ASA. 
2- Soluble antigen: Bacterial lawns were harvested, washed and centrifuged in the 
same manner as described above for whole cell bacteria. The pellet was suspended in a 
volume of PBS and disrupted by French press as described in section 2.2.1. 
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Figure 2.6.4.2: Optical density vs concentration of soluble antigen (gg m1 -1 ) with 
conjugate dilution of 1: 1,500 
Higher optical density was observed at a concentration of 200 lig m1 -1 of soluble 
antigen (Figure 2.6.4.2). This suggests that the ASA show high affinity to the 
sonicated antigen as it is likely that the immunogenic antigen was relatively enriched 
in the sonicated antigen relative to the whole cell antigen. Also, the sonicated antigen 
may have bound to the plate more efficiently. The results suggest that both WCB and 
soluble antigen have very poor binding to the plates. In subsequent assays a high 
concentration of antigen was used 
Also ELISAs were run using high absorbance plates (NUNC Maxisorb) with 
both WCB and sonicated Streptococcus sp in different dilutions. There was no 
significant difference between Linbro ELISA plates and NUNC Maxisorb plates. 
Covalent plates may be required. 
ELISA for sheep, rabbit and fish anti-Streptococcus sp. antibodies was run to 
optimise different dilution of reagents as described for the Vibrio ELISA. 
Anti-Streptococcus sp. antibodies activity was determined in sheep, rabbit and 
fish sera immunised intraperitoneally by streptococcal vaccine. Non-immune and 
immune sera were compared. Microplate was already coated with the neat (absorbance 
= 4.0) whole cell antigen. Conjugate was used at a dilution of 1: 1,500 after 
optimisation in a series of Streptococcus sp. ELISA experiments. No edge effect was 
observed after reading ELISA plates. Optical densities were reported for each well 
together with the mean of these for each sample. These results are shown in figure 
2.6.4.3. 
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Figure 2.6.4.3: Optical density vs dilution of sheep, rabbit and fish anti-Streptococcus 
sp. sera 
Signal noise ratio was calculated as it is described for Vibrio ELISA in order to 
find out the best dilution of either antiserum, conjugate and monoclonal antibodies 
(The graphs for these dilutions are not shown because of their similarities to what was 
done for Vibrio ELISAs). Anti-Streptococcus sp. antisera of sheep, rabbit and fish 1: 
200, 1: 200 and 1: 100 respectively; whole cell antigen as neat for all ELISAs; 
monoclonal antibody (1: 10 dilution, fish ELISA); conjugates, rabbit anti-sheep HRP 
1: 2000, swine anti-rabbit-HRP 1:1000 and rabbit anti-mouse 1: 1500 had the highest 
signal noises. ELISA 0.D results, maximum, minimum and cut-off values of fish 
antibody responses after i.p. injection of 1 mg (dry weight) formalin killed 
Steptococcus sp. cells in 50% v v -1 FCA are summarised in appendix VI. 
2.6.5 ELISA for detecting anti -Paramoeba sp. antibodies : 
ELISA was run with sonicated Paramoeba sp. as antigen and using absorbed 
anti -Paramoeba sp. antiserum to determine the animals response to the organism. In 
this ELISA, all parameters were titrated in order to optimize the test as described 
previously for other ELISAs to find out the best dilution of each reagent. The ELISA 
used for detecting antibodies against Paramoeba sp. was a modification of the ELISA 
described by (Bryant et al., 1995). The test sera was absorbed both with sonicated 
antigen and live P. maltophilia cells. 
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Preparation of sonicated Paramoeba sp. antigen: 
The method used for preparation of sonicated Paramoeba vaccine was as 
described in section 2.2.1. 
Preparation of bacterial antigen: 
Soluble antigen was prepared by washing, resuspending in PBS and sonicating 
P. maltophilia cells by 3 x 3 minute cycles. Bacterial sonicate was filtered (0.211m) 
and its protein concentration was determined and stored at -20°C for further use. 
Serum absorption: 
Paramoeba injected into the sheep, rabbit and fish had been feeding on P. 
maltophilia, and as such, upon sonication, it was likely that bacterial contamination 
existed. To ensure that results were not perturbed due to the presence of anti-
Pseudomonas antibodies, the serum was absorbed prior to conducting an ELISA. To 
do this, diluted sheep anti- Paramoeba sp. sera in PBS (1: 100) was absorbed with 
PBS-washed sonicated P. maltophilia cells (final concentrations of 10 mg protein ml -
1 of sera) for 1.5 h at room temperature and gently mixed intermittently. Also, washed 
live P. maltophilia cells were diluted to a relative concentration of the McFarland 
standard number 2- 4 and added to the tubes that already contained serum and 
sonicated P. maltophilia and incubated at room temperature for another one hour. 
This was to absorb all anti-Pseudomonas antibodies. 
The solution containing APA was centrifuged at 1000g for 10 minutes and the 
supernatant was collected for measuring its antibody level. Efficacy of absorption after 
each absorption was determined by ELISA (using several different dilutions of antigen 
and antibody). 
Performing ELISA: 
Soluble antigen was coated to plates ranging in concentration from 0.1 to 20 gg 
protein per ml solution in borate coating buffer. Coated plates were left for incubation 
at 4°C for 16-24 hours. After incubation antigen was flicked off and wells were _ 
blocked by 100 RI blocking solution (1% gelatin for 30 minutes at 25°C). Plates were 
washed 5 times with DWT. 
The absorbed sera was added to wells and plates were incubated for 90 minutes. 
Plates were washed and the appropriate antibody conjugated with HRP was added and 
after 90 minutes incubation and after washing, ABTS was added and the assay 
continued according to the general method described previously. 
In order to ascertain the reactivity of specific antibody to Paramoeba, in each 
plate absorbed sera and non-absorbed sera was used. Also in each assay one plate was 
coated with sonicated Paramoeba while another plate was coated with sonicated P. 
maltophilia. Absorbed serum in P. maltophilia coated plates did not show activity 
suggested the optimal absorption of the serum. 
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In the Paramoeba ELISA, the dilutions of antigen, sera and conjugate used 
were similar to Vibrio and Streptococcus ELISAs. Soluble antigen was used in a 
dilution of 1-10 gg m1 -1 , sera were diluted 100-200 times and monoclonal antibody 
and conjugate usually diluted 10 and 500-1500 times respectively. Humoral response 
of sheep, rabbit, and rainbow trout immunised with sonicated Pararnoeba sp. antigen 
in 50% v v -1 FCA is shown in Figure 2.6.5. Immunisation of animals against 
Paramoeba is discussed later in this thesis (section 5.2). 
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Figure 2.6.5: Optical density vs dilution (1: 2- 1: 4096) of sheep, rabbit and fish anti- 
Paramoeba sp. 
2.6.6 Correction of ELISA's optical density (0.D) readings: 
Unless otherwise stated all ELISA's optical densities were corrected by the 
method of plate correction factor (PCF) described by Whittington (1992). In each plate 
positive (high, medium and low positive) and negative controls were included as 
mentioned previously. 
Target 0.D A/Actual 0.D A + Target 0.D B/Actual 0.D B+ Target 0.D C/Actual 0.D C+TargetO.DD/A.O.D 
PCF= 
4 
A, B, C and D respectively indicate ODs of highly positive, medium positive, 
low positive and negative; Target 0.D, is mean 0.D for each control over a period of 
time (at least 20 ELISA plates) and actual 0.D is the mean of actual reading of 
duplicated wells. 
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The coefficient of variation for within daily test did not exceed more than 15% 
otherwise the test was repeated. 
The ELISA positive-negative cut-off was defined as the mean 0.D (405 nm) of 
negative sera plus 2 standard deviation. Sera with optical densities more than this 
reading were classified as seropositive. 
2.7 Agar Gel immunodiffusion (AGID) test: 
In order to observe antigen-antibody precipitation reaction between different 
sera and soluble antigens in the gel. Antigen (20 pi) with a concentration of 1 mg/ml 
was placed in centre well and immune bleed sera (20 IA each) of all three species 
were put in six peripheral wells (Figure 2.7). 
The covered petri dish was incubated in a moist chamber overnight. The 
precipitation reaction in the gel was apparent between the immune sera and the 
antigen. 
All sheep and rabbit antibodies against V. anguillarum and Streptococcus sp. 
showed strong precipitation reactions. However, precipitation of fish antibodies was 
not observed suggesting a lack of fish precipitin antibodies. 
1- Antigen 
2- Rabbit antibodies 
3- Sheep antibodies 
4- Fish antibodies 
Figure 2.7: Configuration of agar gel immunodiffusion test 
2.8 Slide agglutination test: 
In order to observe agglutination reactions between antigen-antibody, this test 
was performed. Firstly sera were serially diluted up to dilution of 1: 200. Then one 
drop of serum from each dilution was put on the slide and a drop of antigen 
homogenised in PBS was added. The slide was rotated gently for 2-3 minutes and 
closely watched for evidence of an agglutination reaction. 
The same procedure was conducted with 1: 20 dilution of antigen and bacterial 
suspensions from fresh colonies of bacteria (24 h. cultured) for optimising the test. 
By using low magnification with a stereo microscope agglutination could be seen at 
high dilutions. 
48 
Fish AVA showed higher agglutination up to dilution of 1024. This is while 
sheep and rabbit did not show agglutinating antibodies more than the titre of 1: 100 
(Table 2.8.1). 
Table 2.8.1: Agglutination titres of sheep, rabbit and fish AVA 
Dilution Sheep Sheep Rabbit Rabbit Fish Fish 
of sera Aggl. titre ELISA Aggl. titre ELISA Aggl. titre ELISA 
OD OD OD 
1:2 +++ 2.312 +++ 1.212 +++ 1.441 
1.4 +++ 2.451 +++ 1.218 +++ 1.504 
1:8 +++ 2.514 +++ 1.311 +++ 1.512 
1: 16 +++ 2.511 +++ 1.307 +++ 1.451 
1:32 ++ 2.614 +++ 1.318 +++ 1.513 
1:64 + 2.741 ++ 1.510 +++ 1.118 
1: 128 - 2.762 + 1.618 +++ 0.819 
1: 256 - 2.851 - 1.567 +++ 0.551 
1:512 - 2.231 - 1.101 +++ 0.253 
1: 1024 - 1.741 - 0.891 ++ 0.221 
1: 2048 - 1.231 - 0.602 - 0.163 
1: 4096 - 1.214 - 0.526 - 0.154 
Aggl. titre= Agglutination titre 
+++= highly positive ++= moderate positive += low positive -= negative 
The results showed that ELISA is more sensitive than agglutination in detecting 
Ig against V. anguillarum in sera of sheep and rabbits but in the case of fish, 
agglutinating activity persisted to high titre. This result is explicable in terms of the 
nature of the Ig in the three sera. Fish with IgM would be expected to agglutinate 
much more efficiently than sheep/ rabbit where the Ig would have been mostly IgG. 
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Anti-Streptococcus sp. agglutination antibody titres were low in 
intraperitoneally immunised fish. However, agglutination titres in both sheep and 
rabbits' serum were detectable up to dilution of 1: 64. It is obvious that ELISA showed 
more sensitivity in three species detecting anti-streptococcal antibodies (Table 2.8.2). 
Table 2.8.2: Agglutination titres of sheep, rabbit and fish ASA 
Dilution Sheep Sheep Rabbit Rabbit Fish Fish 
of sera Aggl. titre ELISA Aggl. titre ELISA Aggl. titre ELISA 
OD OD OD 
1: 2 +++ 2.212 +++ 0.534 ++ 0.341 
1.4 +++ 2.201 +++ 0.504 + 0.304 
1:8 +++ 2.314 +++ 0.518 - 0.212 
1: 16 +++ 2.310 +++ 0.521 - 0.151 
1:32 + 2.310 ++ 0.517 - 0.113 
1:64 - 2.401 + 0.542 - 0.109 
1: 128 - 2.512 - 0.621 - 0.110 
1:256 - 2.110 - 0.541 - 0.099 
1:512 - 2.612 - 0.482 - 0.111 
1: 1024 - 1.402 - 0.392 - 0.087 
1: 2048 - 1.321 - 0.311 - 0.092 
1: 4096 - 1.210 - 0.272 - 0.095 
Aggl titre= Agglutination titre 
+++= highly positive ++= moderate positive += low positive -= negative 
2.9 Fish husbandry 
For all experiments fish were taken from the stock tank and acclimatised in 
temperature controlled (15°C) 4000 L fibreglass tanks (water flow of 25 L min-1 ). 
Each tank had its own biofilter and temperature control system (Plate 2.9). Fish were 
fed (1.0% their body weight) commercial trout pellets (Gibson) twice daily . The 
protein and lipid contents of the diet were 45 and 17.5% respectively. 
Water exchanges of 20-30% were conducted daily and tanks were cleaned every 
week (Table 2.9.1). All water added were dechlorinated with sodium thiosulphate 
when the water appeared to contain chlorine. Water quality parameters (pH, ammonia 
and nitrite) were measured and recorded usually prior to water exchange. For all 
experiments two temperature controlled tanks were used (for two replicates, each 
replicate for a treatment consisted of 10-12 fish). Fish were all identified individually 
using plastic T-bar anchor tags (Hallprint, Pty. Ltd, South Australia). The efficacy of 
these tags on fish was 98%. It was noted from different experiments that not more than 
2% of tagged fish lost their tags up to 3 months post-tagging. 
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Table 2.9: Everyday husbandry of fish 
Feeding* 	 at 9.00 a.m 
Ammonia and nitrite test (if required) 	 9.30 a.m 
Water changes (20-30%) 	 10.00 a.m 
Cleaning and scrubbing of tanks 	 10.00 a.m 
(if required; usually twice a week) 
Feeding (2nd time) 	 3.30 p.m 
Final check of electricity, pumps and etc. 	4.30 p.m 
* 1% body weight 
In those experiments for determination of the rate of clearance of antisera from 
fish serum, fish were kept in tanks and at particular intervals, the required number of 
fish were taken out. After blood collection, fish were returned to their tanks or 
euthanised. 
Plate 2.9.1: Temperature controlled tanks with their own biofilters 
In those experiments for determination of protection, fish were immunised in 
replicate groups and maintained in two tanks. Two days before the time of each 
challenge the required number of fish were taken out and transferred to an isolation 
unit "disease unit". 
The disease unit consisted of two series of tanks (each tank 200 L), each series 
with its own biofilter system outside the unit (Plate 3). Biofilters outside of the unit 
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were insulated in order to keep the temperature constant (water flow of 15 L min-1 in 
each series of tanks). Every day the tanks were cleaned twice and the water change did 
not exceeded 20-30%. Fish in the disease unit were fed with commercial trout pellets 
twice daily. They were observed to 14 days post-challenge for disease signs and 
moribund fish were euthanised and collected for bacteriological tests. Surviving fish 
also were euthanised and sampled at the end of each experiment for isolation of 
pathogens. 
Plate 2.9.2: Isolation (disease) unit (temperature controlled) 
For Atlantic salmon used in the Paramoeba protection trial, two temperature 
controlled tanks inside the trout room were used. At the time of challenge of 
immunised fish, diseased fish from SALTAS fish farm were introduced into these tank 
and fish were watched for behavioural responses and samples (blood collection and 
direct gill samples) were collected. Gills were collected finally for confirmation of 
paramoebiasis after euthanising the fish. 
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2.10 LD70 determination 
This section describes the materials and methods employed for LD70 
determination trials of V. anguillarum and Streptococcus sp. including validation of 
the trials. The section applies to all protection experiments later in the thesis. 
2.10.1 LDR, determination for V. anguillarum 
Freeze dried V. anguillarum which was previously characterised and used in the 
production of anti-V. anguillarum antisera, was used as the challenge strain in all 
protection experiments for vibriosis. All challenge trials including Lapp determination 
and experimental challenge for determination of the rate of protection were conducted 
in freshwater. 
2.10.1.1 Reconstitution and culture of V. anguillarum 
The bacteria were reconstituted in nutrient broth, plated on blood agar or 
subcultured into tryptose soy broth (TSB) after two days incubation at 25°C. 
2.10.1.2 Preparation of inoculum for LD70 determination  
V. anguillarum was passaged four times through rainbow trout before use in the 
challenge experiment. Each time 5 fish (mean weight of 85 g) were anaesthetised and 
0.1 ml of the bacterial inoculum (each fish with definite number of bacteria) was 
injected i.p into each fish. The kidney of several moribund fish was sampled and 
cultured on blood agar (BA). V. anguillarum was isolated after 48 h and subsequently 
injected to another group of five fish as mentioned above. The results of the 
enhancement of pathogenicity (disease signs in the inoculated fish) following multiple 
passages of the bacteria on fish are shown in Table 2.10.1. 
Table 2.10.1: Induction of V. anguillarum pathogenicity following multiple 
passages on rainbow trout. 
Passage. 	 LD 70■611.= 
through cfu* 	d.c** 
Normal Rainbow trout 	 cells/ 0.1 ml 	cells/ 0.1m1 
1 6.1 x107 3.53x108 
2 5.2 x106 3.48x 107 
3 4.3 x106 2.53x107 
4 1.0x106 1.1 	x107 
* Colony forming unit ** Direct microscopic count 
Table 2.10.1 demonstrates that the virulence of V.anguillarum for rainbow trout 
was enhanced nearly ten fold after four passages through the susceptible host. The 
results of this study were consistent with those of Song et al. (1980) who stated that 
the V. anguillarum infection level which killed at least 60% of control fish was not 
less than 107 cells m14 . 
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2.10.1.3 Calibration of the absorbance standard curve against viable bacterial count  
and direct microscopic count 
In order to determine the definite number of passaged V. anguillarum with an 
Lam, a two-day subculture on blood agar of passaged V. anguillarum was 
homogenised in PBS, pH 7.2 and the number of bacteria was adjusted to an expected 
number (to achieve LI370) from 5x10 6-6x107 tn1-1 in ten dilutions by direct count and 
the density of bacterial cells were determined spectrophotometrically at 550 nm using 
an spectrophotometer. Ten groups of rainbow trout each group consisted of 10 fish 
were inoculated i.p. with each dilution. Also, a serial 10-fold dilutions of each 
inoculum (each of the dilutions mentioned above) was prepared in PBS and cultured 
(0.1 ml) on BA using a modified Miles and Misra (1938) method. 
Figure 2.10.1.1 shows per cent mortality of fish with different direct count, 
absorbance and number of colony forming unit obtained during the course of 
optimising the LD70 for V. anguillarum.. 
Number of bacteria (log 10) 
Figure 2.10. 1.1: Per cent of mortality vs number of bacteria [(cfu) (logio)], 
corresponding absorbance and direct count 
The challenge was conducted so that a minimum of 70% of fish (unvaccinated) 
died of vibriosis. General linear analysis was used to fit responses with the proportion 
of fish that died as the dependent variable and log of dose (number of bacteria injected 
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i.p.) as the independent variable (Figure 2.10.1.2). A probit analysis computer package 
developed by A. Woods (University of N.S.W, Sydney) was employed to estimate the 
LD70 and its confidence limits. The obtained formula (Y= -3.081+ 5.194 X) was used 
to plot a straight line on the graph with Y on the vertical axis and X (log of dose) on 
the horizontal axis (Salsburg, 1986). 
Figure 2.10.1.2: Dosage-mortality and confidence limits for Vibrio anguillarum 
Therefore, an optical density of 0.016- 0.018 (550 nm) corresponding to 
approximately lx 107- 4x 107 colonies forming units (cfu) 0.1 m1 -1 was determined as 
L1370 value for V. anguillaium. 
2.10.1.4 Preparation of V. anguillarum inoculum to achieve LThofor experimental  
challenges:  
For challenge of experimental fish, viable cells were taken from BA (passaged 
bacteria in fish and reisolated on BA), resuspended in PBS and transferred to a glass 
tube containing 5 ml sterile saline. The suspension was homogenised by vigorous 
agitation with a vortex mixer for 1 min to break up any bacterial clumps. Absorbance 
of cultures prior to challenge were determined spectrophotometrically as mentioned 
before and cell suspension was then adjusted to a turbidity of 0.D of 0.016- 0.018 at 
550 nm. Vibrio anguillarum cells were suspended to achieve a concentration of about 
107 cfu m1 -1 . 
Viable count was carried out from the inoculum as described previously. This 
was to ensure that the number of bacteria injected into fish was in the desired range. A 
direct microscopic count was also carried out using a Helber counting chamber. 
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However, in each preparation of the desired number of cfu, an approximate number of 
bacteria was obtained e.g. 2x 107 or 4x 107 etc instead of exact number of bacteria due 
to time to time differences. 
After each challenge, several sterile kidney samples were collected from 
diseased fish in aliquots and frozen for the use in the next challenge. In the next 
challenge, the frozen samples were thawed and passaged i.p. into 5 naive fish. V. 
anguillarum was reisolated from kidney samples and the number of bacteria was 
adjusted to the known absorbance and direct count. This bacterial suspension was used 
as inoculum in the experimental challenge. 
2.10.1.5 Experiments to determine the relative per cent survival (RPS): 
In the first challenge test, all the experimental fish, as well as the unvaccinated 
controls were injected i.p. with 0.1 ml of a dilution of live, virulent bacteria, which 
corresponded to 2x 107 cfu per fish. Therefore, the mortality rate between trials had a 
range (70- 85%). The challenge was accomplished using a single i.p injection of 
viable cells in PBS. Challenged fish were observed for 14 days and dead fish were 
collected, identified and counted daily. Mortalities were examined grossly for visible 
lesions and examined microscopically by the use of fresh tissue preparation. Tissue 
impression smears were stained by Gram's method. Kidney samples of recent 
mortalities were examined by culture on BA (containing 1.5% NaCl at 25°C for 2 
days) and agglutination test of isolated colonies with morphology consistent with 
control V. anguillarum cultures was carried out with rabbit anti-V. anguillarum to 
verify that the V. anguillarum was responsible for the death. Mortalities were 
attributed to V. anguillarum only when the organism was isolated in pure culture from 
the dead fish. 
Diseased fish were those that showed common clinical signs as follows; swam 
slowly and ignored food, laboured swimming, postural disturbances, tachybranchia, 
abdominal distension, congestion of the fin bases and vent, mucoid yellow faecal casts 
and marked cutaneous blackening. Of the fish that died of vibriosis, gross lesions were 
observed in about 50% of the mortalities. The most consistent finding was blackening, 
reddening of vent and presence of excessive volumes of peritoneal fluid (Plate 2.10.1). 
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Plate 2.10.1: Freshly dead fish due to peracute vibriosis after i.p. injection with 
virulent V. anguillarum (LD70) showing haemorrhages in the base of fins, red and 
swollen vent 
Two weeks after the commencement of each challenge test, the surviving fish 
were counted and euthanised and their kidney materials were cultured on BA plates in 
order to monitor the carrier status of the fish. 
Relative per cent survival was determined by the percentage of mortality. 
Immunity against V. anguillarum in actively and passively immunised animals was 
expressed in terms of relative per cent survival (RPS) as described by Amend (1981). 
% Mortality in vaccinated 
RPS=11- 	 x100 
% Mortality in control 
2.10.2 LD70 determination for streptococcosis 
The Streptococcus sp. isolated in 1987 (the same strain used for raising antisera) 
was passaged six times through rainbow trout (mean weight of 75 g) to enhance its 
virulence and an LD70 was determined as described for LD70 determination for V. 
anguillarum. with some differences as follows: 
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2.10.2.1 Effect of passage on pathogenicity of Streptococcus sp.  
During the passage procedure it was noticed that the injected dose of 
Streptococcus sp. decreased markedly from 2000 to 5 cells. This demonstrates that the 
virulence of Streptococcus sp. for rainbow trout was enhanced significantly through 
the susceptible host. The results of pathogenicity increment through healthy rainbow 
trout are shown in Table 2.10.2. 
Table 2.10.2: Induction of Streptococcus sp. pathogenicity following multiple 
passage on rainbow trout 
Passage 
Normal Rainbow trout 
LD 70 value 
cfu 
cells/0.1 ml 
1 2000-3000 
2 2000 
3 1000 
4 250-350 
5 30-40 
6* 3-5 
*Dilution of 10 -6 of density of 0.099 (350 nm) of Streptococcus sp. 
2.10.2.2 Calibration of absorbance standard curve against viable bacterial count 
For i.p. inoculum, a two-day subculture on BA was homogenised in PBS. 
Bacterial suspension was adjusted to an optical density (at a wavelength of 350 nm). 
Since large numbers of bacteria were expected in the solution, it was necessary to 
make a wide range of dilutions in order to obtain a countable plate from this 
suspension. Therefore serial 10-fold dilutions (ten dilutions) in PBS, pH 7.2 was 
prepared from the suspension with a known optical density. Ten groups of fish (each 
group consisted of 10 fish) were injected with the 10 different dilutions of known 
bacterial density. 
As streptococci form chains of cells, it is impossible to know the actual 
individual viable count. Therefore, it is more appropriate to consider the number as 
colony-forming units, rather than individual cells (Rasheed and Plumb, 1984). Per cent 
mortality of groups of fish challenged i.p. by different number of bacteria (3-100 cfu) 
is shown in Figure 2.10.2.1. 
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Figure 2.10. 2.1: Percent mortality due to streptococcosis vs number of bacteria 
(cfu) 
Passaged bacteria (> 50) often gave high per cent mortality. Number of less 
than 50 the bacteria often resulted in mortalities of 70-90 per cent. Probit mortality for 
streptococcal 70% lethal dose was plotted using general linear analysis as described in 
previous section (Figure 2.10.2.2). The formula for calculation of Y was Y= -4.595 + 
7.965 X as described previously. 
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Figure 2.10.2.2: Dosage-mortality and confidence limits for Streptococcus sp. 
2.10.2.3 Experiments to determine relative per cent of survival  
Experimental fish were injected i.p. with 0.1 ml of various dilutions of bacteria. 
Inoculated fish were kept in the isolation unit in tanks supplied by freshwater at 
temperature of 18°C and the fish were watched for 14 days and dead fish were 
removed daily. In spite of the careful attention for achieving a desired number of 
bacteria for each challenge, a variation in the number of bacteria appeared that 
resulted in LD more than 70-75 per cent in most of the challenge trials. 
Following inoculation, fish were observed twice daily for 14 days. Clinical signs 
often began after 72 h with mortalities subsequently which ceased 8 days later. 
Activity, response to feeding, development of lesions and mortalities were recorded. 
Dead or moribund fish were removed from tanks twice daily. 
Any fish that died within the first day after challenge were not counted as 
having died of streptococcosis, as the trauma of injection was considered to be more 
likely responsible. 
Freshly dead fish from each group were collected and their kidneys inoculated 
aseptically onto blood agar for the isolation of Streptococcus sp. Gross lesions were 
observed in about 95% of the mortalities. The most consistent finding was blackening 
and presence of exophthalmos (popeye) and severe eye haemorrhage outside and 
inside eyes. Streptococcal disease produces a typical septicemia and pronounced 
exophthalmos (popeye) often leading to complete degeneration of the eye (Plate 
2.10.2). In acute cases fish become dark, swim sluggishly and cease feeding. Fungal 
invasion (saprolegniosis) was often observed on the skin of moribund fish All 
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moribund fish were examined by autopsy and kidney samples were inoculated on 
brain heart infusion agar (BHI). The bacteriological procedure used, consisted of 
streaking of kidney material on BHI and BA followed by identification of the isolates 
by means of colony appearance, haemolysis, Gram's stain and confirmation by rabbit 
anti- Streptococcus sp. antiserum by the slide agglutination test. 
Plate 2.10.2: Freshly dead fish due to streptococcosis after i.p. injection of 
virulent Streptococcus sp. (LD 70), showing typical exophthalmia and haemorrhages 
in eyes. 
As it is documented (Boomker et al., 1979; Bragg and Broere, 1986; Carson, 
1990; Munday et al., 1993) there was a very obvious relationship between water 
temperature and the occurrence of clinical streptococcosis in rainbow trout. The 
importance of water temperature in precipitating outbreaks of streptococcosis of 
rainbow trout was obvious in these experiments. 
In real terms, the results indicated that very few bacteria were required to kill 
fish. The pathogenicity of the Streptococcus sp. with regard to it's low lethal dose 
concentration may be attributed to the fact that Gram-positive bacteria produce 
exotoxins which can be highly toxic at very low concentration. In gulf killifish, the 
LD50 of a non-haemolytic group B Streptococcus sp. was 1.4 x 104 cells at 96 h and 
7.5 x 10 cells at 168 h. 
It is for the first time that the LD70 of the Streptococcus sp. cells used for these 
experiments is reported as low as 5 cfu. 
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Relative per cent survival for resisted fish in challenge was calculated as 
described for V. anguillarum challenge. After each challenge, several kidney tissues 
from freshly dead fish due to streptococcosis were frozen as the source of bacteria for 
the next challenge as described in previous section. 
2.11 Horizontal transmission of vibriosis and streptococcosis 
This section describes method of horizontal transmission of vibriosis and 
streptococcosis in freshwater. The method and the results obtained are described here 
which applies to all protection experiments later in the thesis. 
2.11.1 Horizontal transmission of vibriosis. natural transmission (cohabitation) of fish  
with the diseased fish: 
In order to evaluate what percentage of mortalities was due to the horizontal 
transmission of V. anguillarum, 20 rainbow trout (non-immunised) in two replicates 
were cohabited with the i.p. challenged fish (LD75). 
Results of the cohabitation of fish with the diseased fish showed 20% mortality 
due to vibriosis (positive results from kidney culture of all mortalities). Mortality of 
these fish happened at 6-8 days post-cohabitation which was longer than the 3 days 
incubation period for those fish which were challenged by i.p. route. The remaining 
survivors of this group were negative in culture 14 days post-challenge. 
Results of this experiment showed 20% mortality of the cohabited fish and the 
organism was not isolated from the kidney of survivors .The results from the 
cohabitation of fish suggest that the disease can be transmitted horizontally through 
freshwater via contaminated excretion of fish or feeding fish with contaminated 
materials. Although, vibriosis is usually regarded as a marine disease, it is pertinent 
that outbreaks have been reported in freshwater (Ross et al., 1968; Hacking and Budd, 
1971; Giorgetti and Ceschia, 1982). 
2.11.2 Horizontal transmission of streptococcosis  
In order to evaluate the horizontal transmission potential of Streptococcus sp. in 
the contaminated water, 20 non-immune fish were cohabited with the i.p. injected fish 
with Streptococcus sp (LD85) in freshwater. The results showed 40% mortality in non-
immune fish. Mortalities happened 7-8 days post-challenge and the bacteria were 
isolated from both kidney and brain. Survivors were all negative in culture after 14 
days after challenge. This shows that the pathogen spreads horizontally via the water 
column. 
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2.12 Cumulative mortality of experimental fish in challenge 
2.12.1 Cumulative mortality of experimental fish in challenge with V. anguillarum 
The pattern of mortality of fish after i.p. challenge with the virulent V. 
anguillarum in all experiments determining LD70 and those evaluating the protection 
rates of immunised fish (protection experiments described later) which applies to all 
protection trials for vibriosis is shown in Figure 2.12.1. 
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Figure 2.12.1: Cumulative mortality of experimental fish in challenge experiments 
with V. anguillarum 
It was noted that the fish either die up to 5 days post-challenge (mainly non-
immune fish) or survive the challenge (mainly immune fish). 
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2.12.2 Cumulative mortality of experimental fish in challenge with Streptococcus sp.  
The pattern of mortality of fish after i.p. challenge with the virulent 
Streptococcus sp. in all experiments determining LD70 and evaluating the protection 
rates of immunised fish (protection experiments described later) which applies to all 
protection trials for streptococcosis is shown in Figure 2.12.2. 
Days post-challenge 
Figure 2.12.2: Cumulative mortality of experimental fish in challenge with 
Streptococcus sp. 
2.13 Statistical analysis: 
ELISA 0.D: A paired t-test was employed to compare two observations (mean ELISA 
0.D) within a group of fish. Comparisons between more than two groups of fish 
(mean ELISA 0.D) in a treatment and between treatments in an experiment, were 
carried out using one way analysis of variance (ANOVA) (JMP software package for 
Macintosh computer). Prior to performing ANOVA, homogeneity of variance was 
determined using Cohran's test. If variance were heterogeneous, the data were 
transformed, using either square root and log(x+1). Unless otherwise stated, a 
probability level of less than 0.05% was considered significant. 
Relative per cent survival (RPS): At the end of each challenge trial, mean RPS was 
calculated from RPSs of replicates and showed with its S.E (±S.E.). The percentage 
mortality in each group was compared statistically with the percentage mortality of 
other groups within an experiment using a chi-squared test and pairwise comparisons 
were done with the Mann-Whitney Rank Sum Tests. 
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CHAPTER 3.0 
VIBRIOSIS, PASSIVE AND ACTIVE IMMUNISATION AND EVALUATION 
OF PROTECTION 
3.1 Introduction /literature review: 
Vibriosis is an infectious disease of many marine and estuarine fishes of the 
world. The disease is often the major problem in rearing salmonid fish in seawater, 
causing considerable economic losses in the marine fish farming industry particularly 
infections with V. anguilarum (Austin and Austin, 1993). The severity of vibriosis has 
increased proportionately with the development and expansion of fish farming 
worldwide. In severe cases of vibriosis there may be up to 40 per cent mortality. 
Recent figures suggest that in Japan alone annual losses due to the disease exceed 11 
million pound sterling (Smith, 1988). 
3.1.1 Vibrio anguillarum infection: 
The causal agent of 'red-pest' in European eels (Anguilla anguilla) was first 
isolated by Canestrini (1893) who described the organism as Bacterium anguillarum. 
In 1907 further cases among eels in Sweden were investigated by Bergman (1909) 
who coined the name of Vibrio anguillarum. For many years all pathogenic vibrios 
were ascribed to this taxon (Austin and Austin, 1993). 
Vibriosis as a bacterial disease of salt-water and estuarine fish has gained 
considerable notoriety in mariculture, where it has become a major limiting factor in 
the successful rearing of salmonids (Mahnken, 1975). Evidence is also accumulating 
that the disease may occur in freshwater (Muroga, 1975; Ohnishi and Muroga, 1976; 
Ghittino and Andruetto, 1977; Giorgetti and Ceschia, 1982). This suggests that 
vibriosis is an extremely widespread problem. 
However, it would appear that in particular geographical areas and culture 
systems, vibriosis is in fact, a syndrome caused by a multiplicity of Vibrio species 
such as V. anguillarum (Listonella anguillarum; proposed by MacDonell and Colwell, 
1985), V. alginolyticus, V. carchariae, V. cholerae (non -01),V. damsela [(Listonella 
damsela proposed by MacDonell and Colwell, 1985) and reclassified as 
Photobacterium damsela (Smith et al, 1991)1, V. fischeri, V. harveyi, V. ordalii, V. 
salmonicida, V. splendidus, and V. vulnificus biogroup 2 (Austin and Austin, 1993). 
V. anguillarum itself and the two species subsequently designated V. ordalii 
(Schiewe et al. 1981) and V. salmonicida (Egidius et al. 1986) appear to be the most 
pathogenic. V. ordalii and V. salmonicida are principally associated with disease in 
Pacific and Atlantic salmon respectively (Inglis et al, 1993). 
This discussion will be restricted to vibriosis caused by V. anguillarum. 
However, confusion has resulted from the multiplicity of names used to describe the 
disease. Some workers use 'salt-water furunculosis' (Rucker, 1963), 'boil-disease' 
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(Kubota and Takakuwa, 1963) and "ulcer disease" (Bagge and Bagge, 1956) as well 
as the universally accepted name of 'vibriosis'. 
3.1.2 Characterisation of the pathogen: 
The taxonomy of V. anguillarum has had a long history. The complexity in the 
taxonomic understanding of this organism began with the recognition by Nybelin 
(1935) of two biotypes which where differentiated on the basis of biochemical 
properties; there was some serological cross-reactivity between species. A further 
group, i.e biotype C was recognised by Smith (1961) and two further biotypes, i.e D 
and E, were later described. However, in view of modern thought and approaches on 
bacterial taxonomy these descriptions are inadequate (Austin and Austin, 1993). 
Type C deserves special mention because this was proposed for Japanese strains 
derived from rainbow trout, V. piscium var. japonicus (Hoshina, 1956). Researchers 
who were involved in characterisation of Vibrio species isolated from fish had found 
a necessity to rectify the taxonomic chaos surrounding the fish pathogenic vibrios. 
Hastein and Smith (1977) and Bryant et al. (1986) established a numerical 
classification of species of Vibrio and related genera. These researchers examined 
1091 swains of the Family Vibrionaceae with a set of 142 characters. Nowadays, many 
laboratories which are involved in the isolation of fish pathogens use these guidelines 
to characterise isolates. 
V. anguillarum serotype C (01) is the only type which has been isolated from 
rainbow trout and Atlantic salmon in Tasmania. The serovars of V. anguillarum 
isolated from other locations in Australia are not known but serotype B (03) has been 
isolated in New Zealand (Munday, 1988; Carson, 1990). V. anguillarum serotype C 
(01) isolated from Tasmania was used in this research project. 
3.1.3 Epidemiology: 
V. anguillarum, the causative agent of the disease has been isolated from 
salmonids and mullet in Australia (Carson, 1990). Isolation of V. anguillarum and 
other fish pathogenic Vibrio sp. from farmed salmon in Tasmania indicates the 
distribution of these Vibrio species along the entire eastern seaboard in habitats where 
water temperatures range from 9-31°C and salinities between 1-35%0 (Cameron etal., 
1988). Vibriosis has a global distribution with epizootics on all continents and in a 
wide range of fish species. 
3.1.4 Pathogenicity mechanisms: 
V. anguillarum constitutes part of the normal microflora of the aquatic 
environment and may constitute part of the natural microflora of marine fish (West 
and Lee, 1982; Muroga et al., 1986). There are uncertainties as to how the organism 
transforms from an apparent commensal to a pathogen. Infection through adhesion of 
the organism to the skin, colonisation, growth and penetration of skin then 
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subcutaneous tissue followed by spreading all over the body, seems to be one possible 
mode of infection (Funahashi et a/. 1974). Penetration is probably accomplished by 
the bacteria using their lytic enzymes or by inducing the host to phagocytosis them 
(Evelyn, 1984). 
Ransom (1978) postulated that infection probably begins with colonisation of 
the posterior gastro-intestinal tract and rectum. This has been demonstrated 
experimentally with mortalities occurring when an inoculum was introduced via the 
anus to avoid exposing the pathogen to the secretions of the stomach (Chart and 
Munn, 1980). However, under natural conditions it is an unlikely route of entry. 
Evelyn (1984) concluded that the gill is a likely tissue for the entry of pathogenic 
bacteria into fish. It provides the fish with only a single layer of fragile cells as a 
barrier between the circulatory system and the external environment. Indeed, large 
particles, including killed V. anguillartun cells, appear to gain entry into fish via gills, 
even without obvious traumatisation of the site (Smith, 1982; Tatner and Horne, 
1983). 
Two main factors are associated with outbreaks of vibriosis due to V. 
anguilarum. The first and most important one is stress, such as acclimatisation to 
seawater and overcrowding (Snieszko, 1974). The other important factor is water 
temperature when it rises over 10°C. Rapid changes in water temperature, poor water 
quality; high amounts of organic material (faeces, etc.), low oxygen level and high 
suspended solids may provide an opportunity for this bacterium to build-up and may 
be involved in the occurrence of the disease. Skin lesions due to trauma or poor water 
quality may also provide a suitable portal of entry for the bacteria (Snieszko, 1974). 
A detailed study of the pathogenesis of vibriosis in young coho salmon was 
undertaken by Harbell etal. (1979) who induced acute vibriosis by bath exposure to V. 
anguillarum and noted anaemia and leucopenia. They also obtained evidence for 
widespread cell and tissue destruction and loss of osmotic control. However, injection 
of fish with V. anguillarum endotoxin, culture supernatant and cell lysates, singly or 
in combination did not reproduce these clinical signs. 
The question of how V. anguillarum manages to proliferate in the host and the 
nature of the virulence mechanism has been largely answered by the work of Crosa, 
(1980); (Crosa and Hodges, 1981). Virulent strains of V. anguillarum have an efficient 
iron-sequestering system (siderophores) that permits growth under conditions of iron 
limitation found in the host. In some strains of V. anguillarum, the iron-sequestering 
system is chromosome-determined (Toranzo et al., 1983). However, a correlation 
between the presence of a 50 megadalton plasmid and the virulence of V. anguillarum 
was found (Crosa et al., 1977). Subsequent experiments by Crosa (1980) and Crosa 
and Hodges (1981) demonstrated that the plasmid enhanced virulence by coding for 
iron chelation, which allowed V. anguillarum to successfully compete with the 
available iron in the fish tissues (Crosa, 1980). 
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Trust et al. (1981) proposed that the virulence of fish pathogenic vibrios may 
also be related to bacterial adhesion to target cells on host gill and gut epithelia. They 
found that neither adhesive nor haemagglutination functions were plasmid-coded. In 
vitro work has shown that V. anguillarum cells preferentially adhere to excised 
sections of mid and upper fish gut in preference to lower gut regions (Home and 
Baxendale, 1983). Munn (1978, 1980) demonstrated haemolysin as a further virulence 
factor. 
More recently, proteases of 36 kDa have been implicated with virulence 
(Inamura et al., 1984; Kodama et al., 1984). Finally, a zinc metalloprotease has been 
associated with invasive processes (Norquist et al., 1990). 
3.1.5 Clinical signs and pathology: 
Vibriosis can occur in forms ranging from peracute to chronic. Peracute vibriosis 
is indicated by no defined clinical signs except occasional periorbital or abdominal 
oedema (Inglis et al., 1993). In the acute stage fish have no clinical signs (Baudin 
Laurencin and Egidius, 1985), or dark skin swellings which ulcerate to release 
necrotic tissue containing very large numbers of bacteria (Inglis et al, 1993). Clinical 
signs include inappetence, lethargic behaviour and melanisation (Carson,- 1990) and 
the presence of large haemorrhagic lesions (Munday, 1988). As the disease progresses, 
fish may develop hyperaemic prolapsed vents, visible congestion at the base of the 
fins and in chronic cases swollen haemorrhagic lesions are usually located deep in the 
muscle layers on the flanks of the fish (Carson, 1990). 
Internally, there may be splenomegaly in acute cases (Baudin-Laurencin and 
Egidius, 1985) and more often skin lesions, fin erosion, haemorrhages in skin, 
muscles, and in all internal organs, splenic enlargement and liquefaction. The gut and 
rectum may be distended and filled with clear viscous fluid (Austin and Austin, 1993). 
Chronically infected fish generally have large granulating lesions deep in the muscle, 
pale gills and fibrinous adhesions between viscera and parietal peritoneum (Inglis et 
al., 1993). 
Histological findings in peracute cases include cardiac myopathy, renal and 
splenic necrosis associated particularly with the erythroid haemopoietic tissue and 
periorbital oedema (Inglis et al., 1993). The bacterial cells appear to be uniformly 
distributed throughout the affected tissues, although the greatest concentration is in the 
blood (Tajima et al., 1981). None of these lesions are specific for vibriosis and the 
diagnosis must be established by bacteriological techniques (Baudin Laurencin and 
Egidius, 1985). 
3.1.6. Isolation of the pathogen: 
Vibrio species are curved to straight, motile by one or more polar flagella, Gram 
negative oxidase positive rod-shaped bacteria (Carson, 1990). The pathogen may be 
isolated from the infected organs by using tryptic soy agar (Traxler and Li, 1972), 
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thiosulphate-citrate-bile sucrose agar (Bolinches et a/., 1988), nutrient agar (Muroga 
et al, 1976 a, b) and brain heart infusion agar (Tajima et a/., 1981), usually more 
profusely in the presence of sodium chloride at 0.5 to 3.5% (w v -1 ) or seawater (35%o) 
with incubation at 15-25° C for periods of up to 7 days. 
Identification can be made by biochemical tests, partial 16 S rRNA sequences, a 
specific 16 S rRNA oligonucleotide probe (Rehnstatrt et al., 1989). The detection of a 
thermolabile 0-antigen termed the k-1 antigen by slide agglutination (Tajima et al., 
1987) is an other diagnostic test. 
3.1.7 Treatment: 
Vibrio anguillarum may cause a primary disease in fish or it may be a secondary 
invader. In either case, treatment with antibacterial drugs is common and frequently 
contributes to resolution of the problem. Antibiotics are administered to fish either 
orally via medicated food, by bath or by injection. 
In any antibacterial treatment protocol, drug residues in tissues, particularly 
muscle, should be considered. Also antibiotic resistance and incomplete therapy are 
frequent problems in fish medicine. In Japan, Aoki et al. (1974) found 65 of 68 
random bacterial isolates from fish carried transferable drug resistant factors (R 
plasmid). In a further study, Aoki etal. (1981) identified such transferable R plasmids 
in 165 of 250 strains when they used combinations of six commonly used antibiotics. 
Antibiotic resistance problems from fish pathogens have also been investigated by 
Aoki (1988), Hole et al., (1992), Hjeltnes etal., (1987) and Inglis etal., (1991). 
Doses of oxytetracycline at 75 mg/kg body weight/day for 10 days requires a 
withholding period of 60 days at >10°C (Salata and Liest01, 1983). McCracken et al. 
(1976) established that trimethoprim remained in rainbow trout muscle for 77 days 
after administration. 
Appendix VII lists active doses of the most commonly antibiotics for treatment 
of vibriosis in aquaculture. 
Anti-microbial agents were used as bath treatments or as food additives but drug 
resistance restricted their use. Every effort must be made to reduce stress on the fish 
such as: overcrowding, and warm water. Fish which are still feeding can be treated 
with antibiotics/ antibacterials in the food. 
Medical treatment is expensive as well as hazardous to the ecosystem and, 
therefore, efforts have been made to find other means of protection against fish 
diseases, such as change in management, isolation and vaccination program (Harrell et 
al., 1975; Antipa, 1976; Gould et al., 1979). As well as changes in management, it 
might also be possible to improve resistance against vibriosis through selective 
breeding (Gjedrem and Aulstad, 1974). 
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3.1.8 Disease control and prevention: 
Vibriosis control programs in salmonids frequently incorporate vaccination 
(Evelyn, 1984). Therefore, many attempts have been made to develop commercial 
vaccines for control of the disease. Vaccines against vibriosis are the most successful 
of any of the available vaccines against major diseases of fish (Smith, 1988). 
3.1.8.1 Immunisation 
Active immunisation is based upon the immune response (both antibody 
mediated immunity and cell mediated immunity) of the animal to the foreign 
molecules (antigens). Bacterial vaccines are preparations of antigens derived from 
pathogenic organisms. The first commercial product licence for a vaccine for fish was 
granted in the USA in 1976 for use against enteric redmouth (ERM) (Ellis, 1988a). 
Since then product licences have been granted for Vibrio vaccines in many parts of the 
world and vaccines against several fish diseases such as furunculosis, cold water 
vibriosis, and vibriosis have proved to be of great commercial value (Ellis, 1988a). 
Commercial vibriosis vaccines in the northern and southern hemispheres contain 
mixtures of the most commonly encountered local species, generally V. anguillarum 
and V. ordalii. Most of these vaccines consist of simple inactivated whole cells and 
extracellular products. Also in a few cases the bacteria have been lysed either 
physically or chemically. The immunogenicity of V. anguillarum in these vaccines 
appears to be dominated by heat-stable (to 100-121°C) lipopolysaccharides in the cell 
wall. These high molecular-weight compounds, 100 kDa (Evelyn and Ketcheson, 
1980), are considered to confer protection to the recipient host. The 
lipopolysaccharides present in the cell walls of the fish pathogenic vibrios account not 
only for their serotypic specificity but apparently also for most or all of their 
immunogenicity (Johnsen, 1977; Aoki etal., 1981). Sonicated heat-killed vaccines in 
adjuvant, also stimulate elevated levels of antibody in the skin and mucus (Harrel et 
al., 1976; Evelyn, 1984). The protective antigen in Vibrio vaccines appears to be the 
lipopolysaccharide which is a T-independent antigen (Bly et al., 1986a). 
Chart and Trust (1984) isolated two minor proteins with molecular weights of 
49-51 IcDa from the outer membrane of V. anguillarum and these were potent 
antigens. A weakly antigenic protein, with a molecular weight of approximately 40 
kDa was also present. Perhaps these antigens are heat-labile, protective, and explain 
the reasons for the greater protection achieved with formalin-inactivated vaccines 
compared to heat-killed products (Kusuda et al., 1978; Itami and Kusuda, 1980). 
However, Gould et al. (1978) reported both forms of the vaccine to be equally 
protective. 
The production of live attenuated vaccines is under investigation. The use of 
avirulent strains of V. anguillarum as live attenuated vaccines was tested by Norquist 
etal. (1989). Three avirulent mutants were able to induce protective immunity against 
the homologous as well as a heterologous strain of V. anguillarum. Also, these 
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attenuated strains were capable of inducing cross-reactive protective immunity against 
A. salmonicida. However, more needs to be known about the stability of these strains 
before they can be recommended for commercial use Norquist et a/. (1989). 
The feasibility of constructing live attenuated strains of V. anguillarum that 
might be useful in future vaccines has been anticipated (Singer et al., 1991). However, 
Smith (1988) concluded that it is unlikely that Vibrio vaccines will become more 
sophisticated than the present simple formulations. Improvement in formulation of 
currently used vaccines by addition of water-soluble adjuvants to in order to improve 
potency and duration of protection of immersion-applied vaccines was seen as a need 
by Smith (1988). 
For a Vibrio vaccine to be effective, it must contain the serotypes of the 
pathogen indigenous to the locality in which it is to be used. Since there is only one 
known V. anguillarum responsible for vibriosis in Tasmanian salmonids, a successful 
vaccine "Anguillvac-C" a formalin killed vaccine has been introduced to Tasmanian 
fish farmers. It is currently produced by the Fish Health Unit, Department of Primary 
Industry of Tasmania, under the supervision of Dr. Jeremy Carson. This vaccine has 
been successful and there is great demand for it (Carson, pers. comm.). 
Cumulative percentage mortalities among experimental groups of fish 
vaccinated against vibriosis in experiments conducted by several researchers are given 
in Table 3.1. 
\ 
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Table 3.1: Cumulative percentage mortalities among experimental groups of fish vaccinated against vibriosis in experiments conducted 
by several researchers 
Reported 	Fish 	Vaccine 	Days post- 	 % Mortality 
by 	 species 	preparation Immunisation 	  
(number of 	Unvaccinated 	Oral 	Immersion 	Injected 	Spray 
bacteria used controls 	vaccinated 	vaccinated 	vaccinated 	vaccinate 
in challenge) 
Baudin-Laurencin 	Groups 	Formalin- 	???(not stated) 	33.8 	31.7 	2.1 	1.4 	not done(ND) 
& Tangtrongpiros of fish killed 
(1980) 
Amend & 	Salmonids 	 30(1.6x107 ) 	52 	27 	4 	0 	 1 
Johnson(1981) 
Hastein & 	Rainbow Commercial 75(ND) 	68.7 	ND 	7 	3 	 ND 
Refsti(1986) trout 	formalin killed 
Home et al., 	 56(2x107 ) 	100 	36 	ND 	0 	 ND 
(1982) 	 U 	85 " 100 78 53 7 ND 
330 " 	78 	ND 	56 	ND 
Johnson & 	Chinook 
	
ft 
	 ?? 
	
97 	35% 	ND 	ND 	ND 
Amend(1983) salmon Oral intubation(69% with gelatin) 
Dec et a/(1990) 	Turbot Commercial vaccine 	 65.4 	19.2 	ND 	ND 
	ND 
Sea bass (Rhone-Merieux) 49.1 11.3 
Antipa(1976) 	Chinook Formalized 	1-150(Natural) 	85.4 	ND 	ND 	37.8 
	ND 
salmon Heat-killed 	1-150(injection) 22.3 
3.2 Experiment I Passive immunisation (vibriosis): 
(determination of the rate of clearance of AVA from fish sera) 
3.2.1 Introduction and Aims: 
Passive immunisation of fish against vibriosis has been tried to prevent vibriosis 
(section 1.1 and Table 1.1.1). However, a detailed study to elucidate aspects of passive 
immunity at different intervals and monitoring the rate of clearance of Ig from fish 
sera by ELISA has not been conducted. 
The aim of this study was to measure the rate of loss of transferred immune sera 
(anti-Vibrio anguillarum antibodies) from fish sera. Fish in two replicates were 
injected i.p. with one of three types of immune antisera (sheep, rabbit or fish). 
3.2.2 Materials and Methods 
Immune sera: 
Anti-Vibrio anguillarum antisera of sheep, rabbit and fish were used in which 
the level of anti-Vibrio antibodies had been determined by ELISA (sections 2.4, 
2.6.1). 
Fish: 
Rainbow trout: In this experiment 92 rainbow trout [(126± 9.5 g (mean ± S.D. of 
weight)] were randomly allocated to different groups. Fish were tagged and injected 
i.p. with 0.1 ml 100 g -1 of fish body weight of three types of immune sera (either 
sheep, rabbit or fish). Twenty fish were allocated as controls and were bled at each 
interval (Table 3.2.1). The control fish were all tagged with plastic T-bar anchor tags 
(placed in the flesh just below the base of the dorsal fin for individual identification) 
and maintained in 4000 L tanks at 15°C. 
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Table 3.2.1: Experimental design for monitoring the rate of clearance of passively 
transferred anti-V. anguillarum antibodies (AVA) from rainbow trout sera 
Treatment 	Route of 
administration 
of 
AVA 
No. 
of 
fish 
Number of fish sampled at each time 
2h, 4h, 6h, 24h 3w 5w 8w lOw 
Sheep AVA i.p. 24 6 6 6 6 12 12 12 12 
(ELISA 0.D; 2.503)* 
Rabbit AVA i.p. 24 6 6 6 6 12 12 12 12 
(ELISA 0.D; 1.486)* 
Fish AVA i.p. 24 6 6 6 6 12 12 12 12 
(ELISA 0.D; 1.204)* 
Control 20 - - 10 10 10 10 
(Untreated) 
(ELISA 0.D; 0.134)* 	 (Total No. fish in 2 replicates= 92) 
h= Hours post-immunisation (p.i.) m= month 
II w= Weeks " 	 *= Optical density at 405 nm 
Six fish from each group were bled at each interval (2 h, 4 h, 6 h, 24 h) in such a 
way that by 24 h all immunised fish were bled. Twelve fish in each group were bled at 
week 3, 5, 8, or 10. 
Atlantic salmon: In order to measure the rate of clearance of immunoglobulins of 
sheep, rabbit and fish in Atlantic salmon sera a similar experimental design was used, 
80 fish (mean weight 96± 10.2g)were used. Fish were divided in four groups; control, 
sheep AVA injected, rabbit AVA injected and fish (rainbow trout) AVA injected. 
Control fish were only tagged but other groups received 0.1 ml 100 g-1 body weight of 
immunised sera intraperitoneally. Atlantic salmon were sampled only at week 1 and 4 
post-immunisation. 
ELISA: 
Sheep, rabbit and fish ELISAs were conducted to measure the antibody level of 
the antisera transferred to fish as described in section 2.6. For the sheep and rabbit 
AVA ELISAs soluble antigen was used to coat ELISA plates. Whole cell antigen was 
used to coat the plate in the ELISA for measuring the level of fish AVA. 
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3.2.3 Results: 
Rainbow trout: 
Administration of sheep anti-Vibrio antibodies was followed by a significant 
elevation of these antibodies in fish sera 2 h post-immunisation. Sheep A V A antibody 
levels declined slightly at 4 and 6 h and before nearing a plateau between 6 h and 5 
weeks post-immunisation (Figure 3.2.1). These antibodies declined to the mean 
ELISA O.D of 0.300 at week 8, and O.D of 0.252 at week 10 (Table 3.2.2). There 
was no significant difference between the sheep A V A antibody level at 6h, week 3 and 
week 5 (P< 0.05), however these antibodies reduced significantly in fish sera 5 weeks 
post-immunisation. The ratio of O.D of immunised fish with sheep A V A to O.D of 
non-immunised fish changed little up to week 5 (Table 3.2.3). 
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Figure 3.2.1: Rate of clearance of 3 types of anti-V. anguillarum antibodies from 
rainbow trout sera, 2 hours up to 10 weeks post-immunisation 
Fish given rabbit anti-Vibrio antibodies showed a significant elevation in serum 
antibody level 2 h post- immunisation. Antibody level continued to increase 6 h after 
immunisation and then declined. At week 10 the mean ELISA O.D was 0.201 which 
was still significantly higher than that of control fish (Table 3.2.2). The ratio of O.D 
of fish immunised with rabbit A VA to non-immunised fish was 4.651 up to 3 weeks 
post-immunisation (Table 3.2.3). 
Fish passively immunised with fish anti-Vibrio antibodies had increasing levels 
of AVA antibodies 6 h post-immunisation (O.D= 0.359). These antibodies then 
declined significantly and mean ELISA O.D at week 10 was the same as O.D of 
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control fish (Figure 3.2.1). The highest ratio of 0. D of immunised fish to those of 
control fish was at 6 h post-immunisation. This ratio then declined (Table 3.2.3). 
Table 3.2.2: The summary of figure 3.2.1; rate of clearance of AVA from fish 
serum (shown by 0.D= antibody level) 
Time post-passive 	6h 
Immunisation 
Week 3 	week 5 week 8 week 10 
ELISA 0.D readings (mean ± 1 S.E.)* 
Control 0.087a±0.048 0.089a±0.067 	0.093a±0.026 0.078a±0.04 0.083a±0.040 
Sheep AVA 0.574bc±0.132 0.612b±0.043 0.501bd±0.051 0.300c±0.044 0.252c±0.042 
Rabbit AVA 0.682b±0.100 0.414d±.0.058 0.267c±0.044 0.219C±0.045 0.201c±0 .024 
Fish AVA 0.359c±0.087 0.180a±0.047 0.144a±0.022 0.112a±0.042 0.099a±0.036 
*Values with the same superscript were not significantly different (P< 0.05). 
Table 3.2.3: The ratio of 0. D of immunised fish relative to 0. D of non-immunised 
fish (control) at various intervals post-immunisation 
Time post-passive 6h 
	
Week 3 	week 5 	week 8 	week 10 
Immunisation 
Sheep AVA 6.597 6.786 5.387 3.846 3.036 
Rabbit AVA 7.839 4.651 2.870 2.807 2.421 
Fish AVA 4.126 2.022 1.548 1.435 1.192 
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Atlantic salmon: 
The results of the passive immunisation of Atlantic salmon are shown in Figure 
3.2.2. Sheep AVA was detected at high levels after one week post-immunisation and 
after 4 weeks it showed an 0.D of 0.621 suggested the remarkable level of this 
antiserum in Atlantic salmon sera. 
Weeks post - immunisation 
Figure 3.2.2: Rate of clearance of 3 types of anti-Vibrio antibodies from Atlantic 
salmon sera 
Rabbit AVA in Atlantic salmon sera appeared with an 0. D of 0.712 after 1 
week and still significant level at week 4. Atlantic salmon sera showed significant 
rainbow trout AVA only at one week post-immunisation. 
3.2.4 Discussion: 
In this experiment, sheep anti-Vibrio antibodies reached peak levels in fish serum 
by 2 h whereas rabbit and fish AVA peaked at 6 h. A dip in the level of sheep AVA at 
6 h post-immunisation could be due to the fact that different fish were bled at each 
time (up to 24 h post-immunisation). 
The persistence of sheep AVA after administration was higher as compared with 
rabbit AVA. This is presumably due to the higher antibody level of the sheep AVA 
inoculum (Table 3.2.1). Sheep and rabbit antibodies transferred into fish consist 
mainly of IgG and have different catabolic rate from fish antibodies. IgG, which under 
normal conditions is found in the highest concentration of the five classes in normal 
individuals (human), generally shows the longest half-life (Table 3.2.4 ) (Waldmann et 
al., 1976). Therefore, the longevity of sheep AVA in fish sera could be due to such 
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long half life of IgG. Lower metabolism of Ig in a poikilothermic condition of fish 
could be another reason for such a longevity. 
Table 3.2.4: Metabolic properties of human irnmunoglobulins (norinal individual), 
adapted from Waldmann et a/. (1976) 
Immuno- 
globulin 
serum 
concentration 
(mg m1 1 ) 
Distribution 
(% Intra-vascular 
of total body pool 
Total circulating 
pool 
(mg kg-1 ) 
FCR* Half-life 
(days) 
Synthtic 
rate 
mg kg- liday 
IgE 0.0001 41 0.004 94.3 2.7 0.0038 
IgD 0.023 75 1.1 37.0 2.8 0.4 
IgM 0.93 76 37.0 18.0 5.1 6.7 
IgA 2.6 42 95.0 25.0 5.8 24.0 
IgG 12.1 45 494.0 6.7 23.0 33.0 
*FCR= % of the intravascular pool catabolised per day. 
Fish injected with fish AVA had an antibody peak at 6 h which declined 
afterwards. This is consistent with Groberg et al. (1979) who found that absorption of 
radiolabelled coho salmon Ig protein from the peritoneal cavity is relatively fast and is 
complete in 8 h at 12°C and the efficiency and kinetics of intraperitoneal absorption of 
Ig is temperature dependent. Immunised fish with fish AVA showed significantly 
lower amounts of antibodies post-immunisation than fish given sheep or rabbit AVA. 
This could also be due to the lower level of fish antibodies transferred to fish. 
Moreover, catabolic rate studies showed that normal tetrameric Ig of coho salmon has 
a relatively short half-life of — 49 h at 12°C (Voss et al., 1980). 
Another explanation for the differential results with sheep, rabbit and fish AVA 
include more rapid metabolism of rabbit and fish Ig compare with sheep Ig, or a more 
vigorous immune response against the former antigens (AVA as antigen for fish). 
Atlantic salmon immunised by the same amount of the three types of antisera 
showed slightly higher level of antibody level in their sera 1 week and 4 weeks post-
immunisation in comparison with rainbow trout. It is possible that differences in 
weight of rainbow trout (126 g) and Atlantic salmon (96 g) could account for higher 
ELISA O.D. However, these differences were not significant (P< 0.05). 
Study of catabolic rate of mammalian antibodies and fish antibodies in fish sera 
using radioiodination of Ig, might clarify the observations made in this experiment. 
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3.3 Experiment II Adaptive humoral response of fish to sheep and rabbit AVA 
3.3.1 Introduction and Aims: 
In passive immunisation, heterologous proteins are transferred to fish. It was 
assumed that the fish immune system would recognise these antigens and produce 
antibodies. This experiment was set up to study the fish humoral response to sheep 
and rabbit sera containing IgG, serum proteins and other components. Therefore, sera 
collected at different intervals from fish immunised with sheep and rabbit AVA were 
tested by ELISA to monitor the level of antibody production against the mammalian 
sera. 
3.3.2 Materials and Methods: 
Sera: 
The sera collected from rainbow trout in experiment I (section 3.2) were used. 
These sera were collected from 2 h up to 10 weeks after passive immunisation. Since 
the collected sera were mainly used for ELISA (in duplicate wells and repeating the 
test because of high coefficient of variation), some of these sera were pooled to allow 
the required volume in the ELISA in this experiment. Thus, the number of sera 
examined in this experiment (shown in Table 3.3.1 and 3.3.2) decreased over the time. 
ELISA: 
An ELISA was set up to determine the fish Ig against sheep and rabbit AVA 
components as described in section 2.6.3.2. 
Fish given multiple doses of mammalian AVA: 
Forty rainbow trout (mean weight 105 g) in two groups were injected with three 
doses of 0.1 ml either sheep (20 fish) or rabbit (20 fish) at intervals of two weeks. This 
was to observe if any death due to hypersensitivity could be demonstrated. 
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3.3.3 Results: 
Fish response to sheep AVA:  
The number of fish that responded to sheep AVA at different times are shown in 
table 3.3.1. A relatively small number of fish responded to sheep AVA. None of the 
control fish showed positive 0.D measured by ELISA. 
Table 3.3.1: Number and percentage of rainbow trout responded to heterologous 
sheep anti-V. anguillarum serum 
Time post-passive 
Immunisation 
Week 3 	Week 5 	Week 8 
Number of fish and per cent 
Week 10 
Number of fish n(%) 	n(%) 	n(%) n(%) 
+ fish anti- 
sheep 
0 (0) 3 (12.5) 2 (12.5) 2 (16.6) 
- fish anti- 
sheep 
32 21 14 10 
Total number of fish 32 24 16 12 
Fish antibodies to sheep serum (with positive ELISA 0.D) peaked at week 8 
and declined after 8 weeks of immunisation (Figure 3.3.1). Control tests confirmed the 
binding attachment of sheep AVA and rabbit AVA to tnicrotitre plates. 
Wk. 3 
	
Wk. 5 
	
Wk. 8 
	
Wk. 10 
Weeks post - immunisation 
Figure 3.3.1: Rainbow trout humoral response to the heterologous sheep AVA 
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The number of fish which responded to the heterologous rabbit Ig are shown in 
table 3.3.2. A higher percentage of fish showed anti-rabbit antibodies when compared 
with fish injected by sheep AVA (Table 3.3.2). 
Table 3.3.2: Number and percentage of rainbow trout responded against heterologous 
rabbit anti-V. anguillarum serum 
Time post-passive 
Immunisation 
Week 3 	week 5 	week 8 
Number of fish and per cent 
week 10 
Number of fish n(%) 	n(%) 	n(%) n(%) 
+ fish anti- 
rabbit 
9(27.3) 9(34.7) 8(33.3) 4(30.8) 
- fish anti- 
rabbit 
24 17 16 9 
Total number of fish 33 26 24 13 
The antibody response of fish to the rabbit Ig is plotted in figure 3.3.2. The 
rabbit AVA decreased as the fish anti-rabbit Ig increased. Fish anti-rabbit Igs peaked 
at week 8 (ELISA 0.D= 0.576) and gradually declined. Fish responded to the rabbit 
antiserum from week 3 and the reaction continued to rise up to week 8. 
Weeks post - immunisation 
Figure 3.3.2: Rainbow trout humoral response to the heterologous rabbit AVA 
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Table 3.3.3: Summary of figures 3.3.1 and 3.3.2 showing ELISA 0.Ds ±S.E. 
Weeks 
post-immunisation Control fish 
Fish injected i.p. with 
Sheep AVA 	Rabbit AVA 
Wk. 3 0.158±0.041 0.264a±0.035 0.352a±0.140 
Wk. 5 0.094±.038 0.323a±0.089 0.55 1 b±0.098 
Wk. 8 0.124±.044 0.418c±0.042 0.576b±0.042 
Wk. 10 0.143±0.045 0.345a±0.021 0.473b0.+_0. .087 
Values with the same superscript are not significantly different (P<0.05). 
Fish given multiple doses of mammalian AVA  
Non of the forty fish injected intraperitoneally with either sheep or rabbit AVA 
died or exhibited apparent anaphylaxis after 3 injections in two weeks intervals. 
3.3.4 Discussion: 
In this experiment, fish adaptive immune responses to rabbit AVA were 
significantly higher than those against sheep AVA (P< 0.05) (Table 3.3.3). It is 
possible that at the molecular level rabbit proteins were more antigenic than sheep 
AVA. Although, rabbit AVA declined more steeply than sheep AVA possibly due to 
rapid metabolism in fish liver or spleen (section 3.2.3), fish adaptive immune 
responses was higher to these antibodies. It is probable that such a response from fish 
to rabbit AVA induces the clearance of these antibodies as it was seen from the results 
of rate of decay (Figure 3.2.1). 
Fish might respond to other serum proteins as well as the antibodies. These 
hypothesis could be clarified if affinity purified Igs was used. In that case one could 
see if the fish responses were against heterologous Igs or other sera components. 
Further studies are required to clarify if this response is a significant modulator of the 
persistence of mammalian immunoglobulins in fish. 
None of the fish injected with multiple doses of hyperimmune sera of sheep and 
rabbit AVA died as a result of hypersensitivity. It can be concluded that these 
antibodies are safe at therapeutic and prophylactic doses to fish, even in multiple 
injections. 
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3.4 Experiment III: Active immunisation (vibriosis) 
3.4.1 Introduction and Aims: 
As it was discussed in section 3.1.8, bacterins work ideally in control of vibriosis 
worldwide. This experiment aimed to compare production of active antibodies with 
the persistence of passive antibodies. The humoral responses of fish to a complex 
particulate bacterial antigen, and an adjuvanted vaccine were investigated. This 
experiment evaluated the antibody responses of rainbow trout actively immunised 
concurrently with fish in passive immunisation experiment (section 3.2) to compare 
the persistence of fish antibodies itself and sheep and rabbit Ig transferred to fish. 
In order to compare the antibody responses of Atlantic salmon, 20 Atlantic 
salmon were also immunised with the same vaccines as rainbow trout. 
3.4.2 Materials and Methods: 
Bacterial antigen: 
Bacterins for active immunisation of fish were prepared as described in section 
2.2. The inoculum for intraperitoneal injection of fish in this experiment contained 1 
mg (dry weight) bacterin. 
as.h: 
Rainbow trout: Experimental fish (126± 11.0 g) were allocated randomly in two 
replicates in two tanks. Fish were anaesthetised, injected intraperitoneally either with 
0.1 ml of V. anguillarum ,V. anguillarum in FCA or immersed into V. anguillarum 
immersion solution at week 0 (Table 3.4.1). Fish immunised by immersion were 
placed in a 30 L fish bin containing a 1:10 dilution of vaccine containing lx 1010  cells 
of formalin-killed V. anguillarum whilst netted for 30 seconds. They were then held 
in another fish bin with freshwater for 30 seconds then anaesthetised, tagged (placed 
through the base of the dorsal fin in the flesh until it penetrates between the interneural 
spines) and returned to the main tank. All fish were individually tagged 
simultaneously (wk 0) at the time of immunisation. Fish in the control group did not 
receive any injection or immersion vaccination. 
Fish were kept in 4000 L circulating, temperature controlled tanks at 15°C. 
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Table 3.4.1: Experimental design for active immunisation of rainbow trout 
Groups 	Number of fish 	Immunogen given 	Route 
at week 0 	 of administration 
Control 	28 
V. anguillarum 	14 	 Formalin killed cells 	i.p. 
V/FCA 	 14 	 Formalin killed cells in FCA 	i.p. 
V. anguillarum 	14 	 Formalin killed cells 	Immersion 
At week 3, 5, and 8 fish were bled and sera were collected as described 
previously. 
Atlantic salmon: Twenty Atlantic salmon (110± 7.4 g) were used to study the humoral 
response of these fish. Fish were immunised at week 0 and bled 4 and 6 weeks post-
immunisation. 
ELISA: 
The ELISA protocol used to determine fish antibody responses was as described 
in section 2.6.3.1. 
3.4.3 Results: 
Rainbow trout: Significant elevation in antibody level was present at week 3 in 
all groups that had been immunised with V. anguillarum vaccines at week 0, but the 
greatest response was present where the antigen had been administered with the 
adjuvant. Antibody levels continued to increase in following weeks in all group except 
of the immersion immunised group. Thus, the persistence of antibody appeared to be 
related to the method of immunisation, being least with immersion immunisation and 
greatest with i.p. immunisation with the adjuvanted vaccine. 
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Figure 3.4.1: Rainbow trout humoral response to different antigens with or without 
adjuvant at different times post-immunisation 
Serological responses (a summary of ELISA 0.D of Figure 3.4.1) of rainbow 
trout to different immunogens are shown in Table 3.4.2. 
Table 3.4.2: Summary of Table 3.4.1, humoral responses of fish to different 
immunogens 
(ELISA 0.D readings± S.E. mean) 
Time (p.i.) Week 0 Week 3 week 5 week 8 
Control 0.145a±0.017 0.152a±0.016 0.160a±0.019 0.143a±0.014 
V. angu (i.p.) 0.452b±0.066 0.342b±0.096 0409b+0 119 
V. anguRCA (LP.) – 0.747c±0.111 0.890d-±0.71 0.959d±0.101 
V. angu (Immersion) _ 0.363b±0.028 0.108a±0.015 0.127a±0.020 
Values with the same superscript are not significantly different (P< 0.05). 
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In comparing the result of passive immunisation (section 3.2.3) and this result, it 
is obvious that at week 5 the humoral response of fish to V.anguillarum /FCA 
increased while the amount of sheep AVA reduced (Figure 3.4.2). There were no 
statistical differences (P< 0.05) between antibody , level of fish injected with Vibrio 
bacterin/FCA and fish injected with sheep AVA at week 3 post-immunisation. Also, 
there was no significant difference between 1) sheep AVA level and fish AVA (due to 
injection of Vibrio cells) in fish sera up to 8 weeks post-immunisation, 2) rabbit AVA 
level in fish sera with those antibodies that fish actively produced after 5 weeks post-
vaccination with Vibrio cells. 
The persistence of passive antibodies and production of active antibody levels 
(This is a compilation of data already presented to aid interpretation) is shown in 
figure 3.4.2. 
—0--- Control 
	• 	 Sheep AVA From 
Rabbit AVA Fig. 
Fish AVA 3.2.1 
Vibrio/FCA 
(i.P.) 
Vibrio cells 
(LP.) 
Immersion 
(bath) 
Time post - immunisation 
Figure 3.4.2: Comparison of the persistence of AVA in passively and actively 
immunised rainbow trout 
Thus, antibodies due to i.p. immunisation of fish were elevated from 3 weeks 
while they declined from 3 weeks in those fish immunised by immersion. Generally 
passively transferred antibodies declined from 5 weeks post-immunisation onward. 
Atlantic salmon: Results of the humoral responses of twenty Atlantic salmon 
immunised with V. anguillarum cells/FCA showed a significant elevation of fish 
antibodies from one week up to 6 weeks post-immunisation (Figure 3.4.3). 
86 
M
ea
n  E
LI
SA
 0
.D
 (4
05
  n
m
)±
  S
. E
.  
1 .5 
Sheep AVA From Fig. 3.2.2 
Rabbit AVA From Fig. 3.2.2 
Fish AVA From Fig. 3.2.2 
0.5 - 
	 Vibrio cells/ FCA (i.p.) 
-r 
Elk -13—  Control fish 
' • *0.0. 
or 
-r 
0 
wk 1 	 wk 4 	 wk 6 
Weeks post - immunisation 
Figure 3.4.3: Atlantic salmon humoral response to V. anguillarum cells compared 
with the rate of clearance of sheep, rabbit or rainbow trout AVA from Atlantic salmon 
sera 
3.4.4 Discussion: 
When comparing active and passive immunisation, it is apparent that passive 
immunisation gives an immediate antibody level. This appears 2h post-immunisation 
and may last for 10 weeks or more (Figure 3.2.1). Active immunisation, in contrast, 
does not seem to appear in less than 3 weeks. For example, Atlantic salmon sampled 
after one week of immunisation showed an antibody level (mean 0.D of 0.223) 
(Table 3.4.3) which was significantly different when compared to controls (P< 0.05). 
Also the pattern of elevation of antibodies in fish following immunisation with FCA 
containing and non-adjuvanted vaccines showed less antibody level at early weeks 
after immunisation. Therefore, it can be concluded that one week is the minimum 
required for development of immunity even though the level of antibodies produced 
may not sufficient to combat the pathogen. 
Fish immersed in Vibrio cells, had elevated antibody level (0.D= 0.363) at three 
weeks post-immunisation. At week 5 and later no anti-V. anguillarism antibodies 
could be detected. However, this is in agreement with Whittington et al. (1994) who 
reported a significant elevation in antibody level 3 weeks after bath vaccination with 
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V. anguillarum but levels decreased thereafter. Immersion vaccination provides 
protective immunity for up to one year (Alexander, 1990). Despite low or no 
detectable antibody production after one month, the immunity seems presumably to 
be the resultant of enhanced cell mediated defense mechanism in fish, or immune 
memory with rapid humoral responses after contact with the pathogen. 
When comparing ELISAs 0.D, it is worth considering the endogenous antibody 
levels (fish response) after active immunisation and rabbit/ sheep AVA transferred to 
fish and the problem in making a conclusion because the ELBA may not have equal 
signal for each mole of antibody. However, protective immunity conferred with i.p. of 
sheep, rabbit or fish AVA (section 3.6) answers the problem to some extent. 
Atlantic salmon responded in a similar manner to rainbow trout. The 
monoclonal antibody used for detection AVA in Atlantic salmon was anti-rainbow 
trout IgM, however the Atlantic salmon responses were detected indicating a useful 
cross reaction that can be expected in future studies. 
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3.5 Experiment VI Comparison of the efficacy of delivery of antiserum at two 
different sites of intraperitoneal injection 
3.5.1 Introduction and Aims: 
Intraperitoneal injection has been used in fish for decades to deliver 
chemotherapeutics for disease treatment and vaccines for immunisation programs. It 
has been used in the Pacific north-west of the USA to vaccinate Pacific salmon against 
vibriosis since the early 1970s and, more recently, the method has become common 
practice in Scandinavia for furunculosis prophylaxis, since injection vaccination 
proved to be the most effective(Smith, 1988; Erdal and Reitan, 1992). Intraperitoneal 
injection is relatively safe and simple even in very small fish. It has been described as 
the most effective way of immunising fish, though the method usually requires 
anaesthetisation before handling. The use of adjuvants which enhance the magnitude 
of the immune response is also possible with this method (Ellis, 1988a). 
Despite the importance of this route of delivery of drugs and vaccines there is 
little published information on the exact site of injection to be used. It has been 
suggested for ornamental fish that midway between the pelvic fin and anus is the 
appropriate site for intraperitoneal medication (Stoskopf, 1988). Similarly, Ashburner 
(1978) and Reddacliff (1985) described a site just anterior to the vent. Others 
(Whittington and Cullis, 1988; Nilsen et al, 1992; Turgeon and Elazhary, 1992) have 
used a site immediately anterior to the pelvic fins. However, none of these workers 
appear to have critically evaluated the appropriateness of the various sites of injection. 
During studies involving rainbow trout, when fish were injected 
intraperitoneally using the site midway between pelvic fin and anus , it was observed 
that some inocula had been injected into the rectum. Consequently, it was decided to 
investigate the efficacy of injecting material at two different sites. 
3.5.2 Materials and Methods: 
Fish: 
In the experiment reported below, Seventy two rainbow trout (880± 22.2 g) in 
two groups were passively immunised with 0.4 ml sheep anti-V. anguillarum 
antiserum. Thirty six fish in group 1 were injected at site 1 (midway between the 
pelvic fin and anus on the midline), and 36 fish in group 2 were injected with the 
same amount of antiserum at site 2 (1- 1.5 cm anterior to pelvic fin, on the midline) 
(Plate 3.5). Fish were injected with 19 mm length and 25 gauge needles. 
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Site 2 	Site 1 
Plate 3.5: Two different sites of intraperitoneal injection 
Fish were individually tagged and maintained in a temperature-controlled 
tank(17°C) and fed with commercial trout pellets. All injections were made by one, 
experienced person. 
ELISA: 
Fish were bled one week and four weeks after injection by caudal vein. The rates 
of loss of sheep anti-Vibrio antibodies from the serum in two groups of fish were 
monitored by sheep ELISA (section 2.6.1). The test was undertaken in duplicate wells 
for each sample and also it was conducted at two different laboratories (Mt. Pleasant 
Laboratories and EMAI immunology Laboratory, where the ELISA's were 
performed). 
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3.5.3 Results: 
Figure 3.5 shows the results of the ELISAs. There were no significant 
differences (P< 0.05) in the amount of AVA antibodies comparing the two sites of 
injection over time. Also no significant differences were observed comparing the 
results between the laboratories (P< 0.05). 
M
ea
n  E
LI
SA
 0.
D 
(4
05
  n
m
)  ±
  S
.E
.  
1.5 	 
  
  
 
1 - 
0.5 - 
 
 
 
 
    
o 
    
    
  
I 	 I 
wk 1 wk 4 
 
—0— Control fish Control fish —0— 
• 	 Sheep AVA (site 1) . 4> 	 Sheep AVA site 1 
--O .-- Sheep AVA (site 2) ----0--- Sheep AVA (site 2) 
Laboratory 1 	 Laboratory 2 
Figure 3.5: Levels of sheep AVA in rainbow trout sera measured by ELISA in two 
different laboratories 
3.5.4 Discussion: 
This experiment shows that i.p. injection of fish at both sites 1 and site 2 gave 
similar efficacy. Also regarding similar results obtained by ELISA between the two 
laboratories, both used the same method for ELISA assay and as pointed out earlier in 
section 2.6 for optimisation of ELISA, transferring the method from one laboratory to 
another was successful. It can be concluded that once an experienced practitioner 
understands the basic anatomy of fish either of these sites is appropriate for i.p. 
injection. Though site 1 has the disadvantage of potentially injecting into the rectum, it 
minimises the chance of injuring the liver, spleen or kidney. Site 2, however could 
cause damage to the pyloric caeca, liver or spleen. 
The following protocol is recommended: Position the fish on it's back inside a 
sponge slit lined with plastic, to minimise stress. Use a gauge of needle as small as 
possible and appropriate to the solution to be injected. With a controlled insertion 
penetrate through the skin and muscle to a depth slightly greater than the thickness of 
wall of the abdomen. Rub the injection site after every injection to disperse the 
injected solution and minimise the chance of losing the drug or vaccine after the 
needle is removed. 
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3.6 Experiment V Evaluation of protection (vibriosis) 
3.6.1 Introduction and aims: 
Levels of protection in passively immunised fish (Table 1.1.1, section 1.1) and 
actively immunised fish determined by other researchers were discussed previously 
(Table 3.1, section 3.1.8). This experiment was carried out in order to evaluate the 
protective efficacy of anti-Vibrio anguillarum antibodies one, two and three months 
post-immunisation. An experiment (different from experiment I) was conducted 
specifically to evaluate protection in the knowledge that passive antibody levels could 
be high at 1 month and declined during the time (experiment I). In this experiment, 
fish were immunised passively with three different antisera at the time 0 and 
challenged with virulent V. anguillarum (LD70). One extra groups of fish were 
immunised actively to compare results of passive and active immunisation. 
Little work has been done regarding protective value of passive immunity 
against vibriosis. This new approach can provide passive transfer of antibodies and 
can possibly be applied against other infectious diseases of fish. The main aim of this 
experiment was to compare passive and active protective immunity concurrently at a 
high challenge level (LD70) and evaluate the protective immunity conferred to fish by 
passive immunisation. 
3.6.2 Materials and methods: 
Fish: 
Rainbow trout (average weight of 70± 5.3 g) were acclimatised to temperature 
controlled 4000 L tanks at the trout room before immunisation. Fish were starved for 
12h prior to immunisation. Fish were allocated randomly to 5 groups in two replicates 
(Table 3.6.1). 
Antisera for passive immunisation: 
Anti-Vibrio anguillarum antibodies (AVA) for passive immunisation of fish 
were prepared for use in this experiment as described in section 2.4. Each fish while 
lightly anaesthetised received 0.1 ml 100 g -1 fish body weight i.p. of sheep, rabbit, or 
fish AVA. The antibody levels (ELISA 0.Ds) of sheep and rabbit (at dilution of 1: 
200) or fish AVA (at dilution of 1: 100) used for passive immunisation of fish were 
2.503, 1.486, 1.2 respectively. 
Bacterin for active immunisation: 
Formalin killed V. anguillarum for immersion vaccination of fish was prepared 
as described in section 2.2.2. Undiluted vaccine contained lx 10 10 cells. Fish were 
held in a 1: 10 dilution of vaccine (contained 5.5 x 10 9 m1-1) whilst netted for 30 
seconds in a aerated 20 L fish box (18 L freshwater + 2 L undiluted vaccine). 
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Virulent V. anguillarum with LD  70_for challenge:  
Fish were challenged with the virulent bacteria as described in section 2.10.1. In 
this experimental challenge, fish were inoculated with 6.8x10 6 cfu 0.1 m1 -1 (LD75), 
8x106 cfu 0.1 m14 (LINO) 6.2x106 cfu 0.1 m14 (LD73) of live V. anguillarum cells at 
one month, two months and three months challenges respectively. 
Table 3.6.1: Experimental design for challenge of passively and actively immunised 
fish in an experimental infection of V. anguillarum 
Treatment* 	Route of 
administration 
Number of fish challenged(in two replicates) 
lm 2m 3m 
Sheep AVA i.p. 20 20 30 
Rabbit AVA i.p. 20 20 30 
Fish AVA i.p. 20 20 30 
Immersion 
(bath) 
20 20 30 
Control 
(tagged, untreated) 
- 40 20 20 
Total No. of fish= 360 
* each fish was injected with 0.1 ml 100g -1 body weight 
AVA= Anti-V anguillarum antisera 	 m= months post-immunisation 
Challenge: 
Immunised fish (both passively and actively) in two replicates were challenged 
with V. anguillarum (experimental design, Table 3.6.1). Control fish (in two 
replicates) that had not received any treatment and were only tagged at the time of 
immunisation, were included in the challenge. Twenty of the control fish (out of 40 
fish) were injected with sterile saline at the time of one-month challenge in order to 
ascertain if any deaths were due to i.p. injection procedure. These fish were kept in the 
trout room. 
Before challenge, the required number of fish for each challenge were taken to 
an isolated (disease) unit and kept in freshwater tanks at 15°C, acclimatised for 2 days 
and then challenged. 
Fish were challenged with 0.1 ml i.p. V .anguillarum. The temperature was 
maintained at 15°C. Fish were observed twice daily for 14 days after challenge. 
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Freshly dead and moribund fish from each group were collected and their kidneys 
inoculated aseptically on to blood agar for the isolation of V. anguilarum. The 
isolated bacteria were recultured if it was required and confirmed both 
morphologically and serologically with rabbit AVA as V. anguillarum. 
Mortalities began after approximately 48 h and ceased 5 days later. Activity, 
response to feeding, development of lesions and mortalities were recorded. 
3.6.3 Results: 
, One-month challenge:  
Results of challenge of immunised fish allocated for one month were reported as 
number of mortalities and relative per cent of survival (RPS, mean of two replicates' 
RPSs± S.E.) (Table 3.6.2). 
Table 3.6.2: Mortality and RPS after challenge(with virulent V. anguillarum, LD75) 
of rainbow trout immunised passively (sheep, rabbit, and fish AVA) and actively 
(immersion) at one month post-immunisation (p.i) as compared to controls 
Number of mortality caused by V. anguillarum* 
Treatment 
RPS ± S.E. Replicate 1 Replicate 2 Combined Replicate 
Sheep AVA 1/10 0/10 1/20 93.3 ± 6.67 
Rabbit AVA 1/10 1/10 2/20 86.6 ± 0.0 
Fish AVA 4/10 5/10 9/20 40.0 ± 6.66 
Active 
Immunisation 
(immersion) 
1/10 1/10 2/20 86.6 ± 0.0 
Controls 
Challenged 
non-immune 
8/10 7/10 15/20 0.0 ± 6.66 
Non-challenged 
non-immune 
0/10 0/10 0/20 100 ± 0.0 
* Experimental challenge LD75=1.2x10 7 cfu 0.1 ml -1 by i.p. injection. 
Control groups, which were non-immunised fish, suffered a 75% mortality. In 
contrast, fish immunised with immune sera showed consistent and significant 
protection (chi-square; P= 0.005). Those immunised with fish serum, however, were 
only weakly protected (RPS of 40.0%) compared with fish immunised with sheep and 
rabbit AVA serum (RPS of 93.3 and 86.6% respectively). 
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Both passive and active (immersion) immunisation provided protection in 
comparison with control group but the highest RPS (93.3%) was observed in those 
fish immunised by sheep AVA. 
The result of bacteriological examination of mortalities due to challenge showed 
100% positive isolation of V. anguillarum. No V. anguillarum was isolated from the 
kidney of survivor fish 14 days post-challenge. None of the controls injected with PBS 
died post-injection. 
Two-month challenge:  
Results of the second challenge after two months of immunised fish allocated for 
this challenge are shown in table 3.6.3. 
Table 3.6.3: : Mortality and RPS after challenge(with virulent V. anguillarum, LINO) 
of rainbow trout immunised passively (sheep, rabbit, and fish AVA) and actively 
(immersion) at two months p.i. as compared to controls 
Number of mortalities caused by V. anguillarum* 
Treatment 
Replicate 1 Replicate 2 Combined Replicate RPS± S.E. 
Sheep AVA 5/10 7/10 12/20 25.0± 12.0 
Rabbit AVA 5/10 8/10 13/20 18.7 ± 18.75 
Fish AVA 8/10 6/10 14/20 12.5± 12.50 
Active 
Immunisation 
(immersion) 
1/10 0/10 1/20 93.0± 6.25 
Controls 
Challenged 
non-immune 
8/10 8/10 16/20 0.0 ± 0.0 
* Experimental challenge LD80= 8x10 6 cfu 0.1 m14 by i.p. injection 
Protection in this trial ranged from RPS of minimum 25% (sheep AVA) to 
18.7% (rabbit AVA) and 12.5% (fish AVA). RPS of immersion vaccination fish was 
93% the highest of all for this challenge. 
Comparing the results of first challenge after one month and the second 
challenge after 2 months post-immunisation, it is obvious that protection rate of 
immune sera declined markedly. However, immersion vaccinated fish provided fish a 
high protection (RPS= 93.0%) after two months post-immunisation. 
No bacterial fish pathogens were detected in surviving fish ( samples from 
kidney and brain ). 
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Three-month challenge:  
Results of the three months challenge are shown in table 3.6.4. In this challenge 
there were three replicates. 
Table 3.6.4: : Mortality and RPS after challenge(with virulent V. anguillarum,LD73) 
of rainbow trout immunised passively (sheep, rabbit, and fish AVA) and actively 
(immersion) at three months p.i. as compared to controls 
Number of mortalities caused by V. anguillarum* 
Treatment 
RPS± S.E. Rep. 1 Rep. 2 Rep. 3 Combined Replicates 
Sheep AVA 7/10 5/10 7/10 19/30 13.3 ± 9.13 
Rabbit AVA 8/10 7/10 6/10 21/30 4.1 ± 7.90 
Fish AVA 7/10 6/10 7/10 20/30 9.0 ± 4.56 
active 2/10 1/10 1/10 4/30 81.8 ± 4.54 
Immunisation 
(immersion) 
Controls 
Challenged 
non-immune 
9/10 5/10 8/10 22/30 0.0 ± 16.45 
* Experimental challenge LD73= 6.2x106 cfu 0.11 ml by i.p. injection. 
The results indicated that immersion vaccination provided almost complete 
protection while protection obtained by intraperitoneal administration of immune sera 
after three months post-immunisation was only marginally effective. 
Sheep AVA apparently marginally protected fish 3 months post-immunisation, 
RPS= 13.3%, which was not significantly different from control fish (chi-square; P< 
0.05). No bacterial fish pathogens were detected in survivors of the groups of fish 
sampled at 14 days post-challenge. 
Relative per cent survival of passively and actively immunised fish challenged 
with the virulent V. anguillarum 1, 2, 3 months post-immunisation is shown in Figure 
3.6. 
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Figure 3.6: Relative per cent survival of passively and actively immunised fish 
challenged with the virulent V. anguillarum 1, 2, 3 months post-immunisation 
3.8.4 Discussion: 
Sheep AVA conferred high protection to fish which was not significantly 
different from that of immersion vaccination. It seems that the level and activity of 
immunoglobulins in 0.1 ml of antisera 100 g -1 body weight of fish was high enough to 
protect fish for at least one month after immunisation. These Ig are presumably 
distributed and stored in various organs following immunisation of fish. 
The reason for the higher protection rate following administration of sheep AVA 
than those conferred by rabbit and fish AVA may be due to; 1) higher ELISA 0.D 
(higher antibody level). 2) higher antibody functional activity against Vibrio 
anguillarum. 3) lower response by fish to sheep AVA resulting in greater persistence. 
The lower RPS obtained from rabbit AVA is possibly due to the fish response to 
rabbit AVA (section 3.3.3). Nevertheless, both antisera significantly protected fish 
after one month post-immunisation (P< 0.05). 
Fish AVA provided an RPS of 40% for rainbow trout challenged one month 
post-immunisation in this experiment (Table 3.6.2). This is in contrast with the 
findings of Harrell et al. (1975) who reported 90-95% protection 62 days post-
immunisation following the injection of juvenile rainbow with 0.5 ml of rainbow trout 
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AVA in a challenge with 2.5x 10 5 V. anguillarum. However, 0.5 ml of the antisera 
was used in that study but 0.1 ml AVA 100g-1 fish body weight was only used in this 
experiment. Fish AVA did not protect rainbow trout significantly in challenges two 
and three months post-immunisation (Table 3.6.3 and 3.6.4). 
These findings suggest that protective immunity was mainly due to specific Igs. 
However the collaboration of non-specific immunity was postulated as an essential 
factor to eliminate the infection. Investigations regarding the possibility of 
involvement of non-specific immunity in passive immunisation of fish is discussed 
later in this thesis (experiment VII). 
The protection rate achieved with a single immersion vaccination was the same 
as protection conferred by i.p injection of sheep AVA. However, this protection was 
presumably conferred by cell mediated responses since no humoral antibody could be 
detected after one month post-vaccination. Also, immune memory may have played a 
role. 
The mechanism of protection provided by sheep and rabbit antisera to V. 
anguillarum antigens presumably is simply in neutralising the biological effects of 
toxins and opsonising the bacteria. Furthermore, the level of protection and its 
duration in passively immunised fish will depend upon the rate at which the rabbit 
antibodies are complexed by the bacterial antigens present in the fish. Mammalian Ig 
would be mainly IgG, however, fish Ig are IgM possibly a more effective agglutinin. 
Two month after immunisation, fish immunised passively with sheep, rabbit and 
fish AVA showed a moderate protection. This could be due to the high challenge rate 
(80% mortality) but was more likely due to the rate of clearance of these specific 
antibody to low levels after two months (section 3.2.3). 
After three months of immunisation, the strongest protection occurred in fish 
actively immunised by immersion (Figure 3.6). This is consistent with the work of 
other researchers (Table 3.1, section 3.1.8) who reported a long protection following 
such a vaccination. At the time, those fish immunised passively with antisera were 
only marginally protected, if at all. This is consistent with the results of the rate of 
clearance of these antisera in the immunised fish after 70 days (section 3.2.3). 
In all challenges, it was intended to keep the mortality rate at approximately 
70% by using LD70 of live virulent bacteria as inocula. Nonetheless, slight variation 
due to time to time preparation of inocula affected the mortality pattern. 
With respect to the horizontal transmission (section 2.11.1) during the 
challenges, it well reflects the more natural route of transmission of the disease for fish 
that are exposed and it express the protectiveness required by fish in order to escape 
natural infection. Only fish with a degree of immunity combat the disease. Thus, even 
a relatively low RPS from passive immunisation might be useful in the field where a 
mortality rate of 20% can easily occur by natural transmission. 
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3.7 Experiment VI Evaluation of protection against vibriosis using equivalent 
amounts of sheep, rabbit and fish anti -Vibrio anguillarum antibodies 
3.7.1 Introduction and Aims: 
This experiment was conducted in order to evaluate the protective value of the 
anti-Vibrio antibodies produced in sheep, rabbit and fish when they were given 
intraperitoneally in equivalent amount into fish. The aim was to evaluate how much 
sheep AVA is equivalent quantitatively to rabbit and fish AVA when given i.p. into 
fish fifteen and thirty days before experimental challenge. Equivalent binding activity 
in ELISA was initially used to standardise the dose of Ig. 
3.7.2 Materials and Methods: 
Antisera: 
Anti-Vibrio antibodies (AVA) were produced as described in section 2.4. Fish were 
injected i.p. with 0.1 ml 100 g -1 their body weight of the antisera. 
Fish: 
Rainbow trout average weight 65± 8.22 g were held in two 4000 L temperature 
controlled tanks (15°C). After immunisation, fish were kept in the tanks until the time 
of challenge. The required number of fish from each group were taken and transferred 
to the isolation unit for experimental challenge at 15 days and the rest of fish left for 
30 days post-immunisation (Table 3.7.1). 
ELISA: 
For the purposes of this experiment the ELISA reactivity of the different sera 
was used as the quantitative standard. Several ELISA were run to measure the activity 
of sheep, rabbit and fish AVA. Once the dilution at which the various ELISA gave the 
same reading were determined, the three kinds of antisera were diluted and the assay 
was run again to verify the procedure. The antisera for the immunisation trial were 
diluted just before intraperitoneal injection as follows: 
First trial: 
Sheep AVA: dilution of antisera to achieve 0.D= 1.0. 
5 .t.1 Whole sheep AVA + 100 cc PBS (20,000 times dilution) 
4.7 gl Ammonium sulphate purified (Amm. sul. pur.) sheep AVA + 100 ml PBS 
(21,000 times dilution). 
100 1.1.1 Protein G purified sheep AVA +70 ml PBS (700 times dilution). 
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Rabbit AVA: dilution of antisera to achieve 0.D= 1.0. 
100 p.1 Whole rabbit AVA + 20 ml PBS (200 times dilution) 
100 p.1 Amm. sul. purified rabbit AVA + 20 ml PBS (200 times dilution). 
100 p.1 Protein A purified rabbit AVA +30 ml PBS (300 times dilution). 
Fish AVA: dilution of antisera to achieve 0.D= 1.0. 
Whole fish AVA (0.D= 1 measured by ELISA). 
4 ml concentrated Arrun. sul. pur.AVA + 16 ml PBS.(0.D= 1). 
Concentrated amm. sul. pur.AVA (ELISA 0.13= 1.4). This was not equivalent but 
was chosen to compare the higher degree of Ig content at this 0.D at challenge. 
Fish were injected with 0.1 ml 100 g body weight -1 of antisera, each with an 
ELISA 0.D= 1. 
Immunised fish were challenged 15 and 30 days post-immunisation (Table 
3.7.1). 
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Table 3.7.1: Experimental design for challenge of passively immunised fish with 
equivalent amounts of antisera 
Treatment 	Route of 
administration 
of antisera 
Number of fish challenged (two replicates) 
15 days 	30 days 
Whole sheep 
serum 
i.p. 20 20 
Ammonium sulphate 
purified 
sheep serum 
i.p. 20 20 
Protein G 
purified 
sheep AVA 
i.p. 20 20 
Whole rabbit 
serum 
i.p. 20 20 
Ammonium sulphate 
purified 
rabbit serum 
i.p. 20 20 
Protein A 
purified 
rabbit AVA 
i.p. 20 20 
Whole fish 
serum 
i.p. 20 20 
Ammonium 
sulphate precipitated 
fish serum 
i.p. 20 20 
1:4 diluted 
ammonium sulphate 
precipitated 
fish AVA 
i.p. 20 20 
Control 
Challenged 
non-immune 
20 20 
Total No. of fish= 400 
AVA= Anti-V. anguillarum antisera 
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Dry weight of antisera: 
In order to have an estimation of dry weight of the amount of anti-Vibrio 
antibodies in the immune sera, 1 ml of different non-immune and immune sera were 
freeze dried. 
Quantitative precipitin test of sheep. rabbit and fish AVA: 
In an attempt to measure the antibody levels in three different sera 
quantitatively, different concentrations of lipopolysaccharide (LPS) antigen were 
added to a constant amount of each antibody in series of tubes and the antibody 
content was measured as described by Heidelberger and Kendall (cited by Hudson and 
Hay, 1989). Immunodiffusion was also conducted to evaluate the quantitative level of 
antibodies. 
LPS was prepared by phenol extraction method described by Westphal and Jann 
(1965). Briefly, V. anguillarum cells, after cultivation in vibrio broth for 24 h, were 
centrifuged, and the sediment was washed with PBS. The bacteria were then 
lyophilised and twenty gram (dry weight) of bacteria were suspended in 350 ml of 
distilled water at 68°C (on a water bath); 350 ml of 90% phenol, preheated to 68°C, 
was then added with vigorous stirring and the mixture was kept at 68°C for 15 min . 
After cooling to about 10°C by placing the vessel in an ice bath, the emulsion was 
centrifuged at 3000 r.p.m for 45 min, which resulted in the formation of three layers. 
The water phase was collected and dialysed for 3 days against distilled water to 
remove phenol and small amounts of low-molecular-weight bacterial substances. The 
resulting product contained 40-50% of lipopolysaccharide and 50-67% of bacterial 
ribonucleic acid. To eliminate the bacterial ribonucleic acid, the extract was 
centrifuged for 8 h at 80,000 x g. The sediment was then suspended in distilled water 
and the suspension was recentrifuged 3 times at 105,000 x g for 3 h. The final 
sediment was taken up in a minimum amount of water and freeze-dried. The yield of 
bacterial lipopolysaccharide was 420 mg. 
Radial immunodiffusion: 
This test was performed to measure the antibody level of sheep, rabbit and fish 
AVA. Briefly, sheep, rabbit or fish AVA was incorporated into three flasks of agar (1 
ml of AVA into 100 ml 45-50°C agar). Plates were left to solidify and then 25 IA of 
antigen [LPS (5 mg m1-1 )] was placed in several wells into agar. Plates were incubated 
overnight in a moist chamber at room temperature. After 24-48 h the area of 
precipitation ring was measured and compared with different sera in different plates. 
This test was repeated 5 times with 0.1, 0.2, 0.4, 0.6 and 0.8 ml of the AVA 
incorporated into agar against concentrations of 20, 15, 10, 5 and 2 Ill of the LPS 
respectively. 
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Complement fixation test: 
Complement fixation test (CFT) utilising LPS was also performed to evaluate 
the antibody activity in sheep, rabbit and fish AVA. Briefly, the antigen (5 mg m1 -1 ) 
and the antiserum (dilution 1: 40) under test (deprived of its complement by heating at 
56°C for sheep and rabbit and 44°C for fish) were incubated in the presence of 
guinea-pig serum, which provided a source of complement. After allowing the 
antigen-antibody-complement mixture to react for 20 min at 37°C, antibody-coated 
sheep red blood cells (RBC) was added. Microplate was incubated for 20 min at 37°C 
and centrifuged. Lysis of the RBC was a negative result indicated that the complement 
was not fixed. Absence of lysis of RBC [(no lysis (4+) to 50% lysis (1+) dependent 
upon the amount of complement unbound)] was a positive result indicated that the 
antigen reacted with the specific antibody and then complement bound to the immune 
complex. Before performing the CFT, all reagents including complement, sheep RBC, 
antibody against RBC (haemolysin), antigen and test sera were optimised 
Virulent V. anguillarum for challenge: 
Challenge was conducted at 15 days after immunisation on half of the 
immunised fish. Fish were challenged with virulent bacteria as described in section 
2.10.1. In this experimental challenge, fish were inoculated with 2.2x 10 7 cfu 0.1 m1 -1 
(L131 84.21), and 2.1x 107 cfu 0.1 m1 -1 (L1385) of live V. anguillarum cells for 15 days, 
30 days challenges respectively. 
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3.7.3 Results: 
Table 3.7.2 shows the mortality and RPS after challenge of the passively 
immunised fish with equivalent amounts of antisera (ELISA 0.D= 1) fifteen days 
post-immunisation. 
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Table 3.7.2: Mortality and RPS after challenge (with virulent V. anguillarum, 
LD8,421) of rainbow trout passively immunised with equivalent (measured by ELISA 
0.D= 1.0) sheep, rabbit and fish AVA at 15 days p.i. as compared to controls 
Number of mortality caused by V. anguillarum* 
Treatment 
RPS± S.E. Replicate 1 Replicate 2 Combined Replicates 
Whole 
sheep serum@ 
8/10 7/10 15/20 11.7 ±5.88 
Amm. sul 
precipitated 
7/10 8/10 15/20 11.7 ± 5.88 
Sheep serum@ 
Protein G 4/10 4/10 8/20 53.0 ±0.0 
Purified 
sheep serum@ 
Whole Rabbit 
serum@ 
5/10 7/10 12/20 29.4 ± 11.76 
Amm. sul 
precipitated 
rabbit serum@ 
7/10 7/10 14/20 17.6 ± 0.0 
Protein-A 
purified 
rabbit serum@ 
7/10 6/10 13/20 23.5 ±5.88 
Whole 
fish AVA 
1/10 1/10 2/20 88.2 ± 0.0 
Amm. sul. 
precipitated 
fish AVA 
1/10 0/10 1/20 94.1 ± 5.88 
1:4 diluted 2/10 3/10 5/20 70.6± 5.88 
Amin. sul. 
precipitated 
fish AVA 
Control 
Challenged 
non-immune 
8/10 9/10 17/20 0.0 ± 5.88 
AVA (Anti - Vibrio anguillarum) Amm. sul. = Ammonium sulphate 
* Experimental challenge LD85= 2.2x107 cfu 0.1 -1 ml by i.p injection. 
@ Anti-V. anguillarum antisera adjusted to ELISA 0.D of fish AVA (0.D= 1.0) 
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Despite the equal ELISA activity of the injected AVA (ELISA 0.D. 1.0), there 
was not a significant difference (P< 0.05) between groups of fish immunised with 
equivalent sheep and rabbit compared to control fish. The protection obtained was 
irrelevant to ELISA activity of these sera. Protein-G purified sheep AVA protected 
fish with a higher survival rate (RPS of 53.0%), although the ELISA activity of these 
sera was 0.D= 1.0. None of the rabbit AVA (0.D= 1.0) could protect fish against 
vibriosis. 
Whole fish AVA and ammonium precipitated fish AVA equally protected fish in 
the challenge at 15 days post-immunisation. Protections obtained from immunisation 
of fish with whole fish serum (RPS of 88.2%) and ammonium sulphate precipitated 
fish serum (RPS of 94.1%) were not significantly different from each other (P< 0.05). 
Protections obtained in the challenge after 15 days post-immunisation in the fish 
immunised with equivalent amounts of antisera (0.D= 1.0) are also shown in Figure 
3.7.1. 
1 El Control 
(Mortality 85%) 
2 Ea Sheep AVA 
Sheep AVA 
(Ammonium sulphate purified) 
Sheep AVA 
(Protein G Purified) 
Rabbit AVA 
Rabbit AVA 
(Ammonium sulphae purified) 
Rabbit AVA 
(Protein A Purified) 
8 	Fish AVA 
9 El Fish AVA 
(Ammonium sulphate purified) 
oEl Fish AVA 
(Ammonium sulphate purified) 
1:4 diluted 
3 
4 SI 
5 EI 
6 
7 4 
3 4 5 6 7 8 9 10 
15 days post-immunisation 
Figure 3.7.1: Protection rate of equivalent amounts (ELISA 0.D= 1.0) of sheep, 
rabbit and fish AVA 
Trial 2 (modifying the experimental design): 
Since no protection was observed after 15 days of immunisation on half of the 
immunised fish in groups of fish immunised with equivalent sheep and rabbit diluted 
and adjusted to an equivalent 0.D to that of fish (measured by ELISA) in trial 1, the 
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remaining fish except those immunised with fish AVA antisera (kept for a 30 days 
challenge, results in Table 3.7.5) were divided in two 6 groups (6 groups for sheep 
AVA and 6 groups for rabbit AVA injection, each group consisted of 10 fish) in such 
a way that partially immunised fish receive the highest amount of AVA (low dilution 
of AVA) and injected with different dilutions of sheep and rabbit AVA as follows. 
Dilution of sera: 
Sheep AVA injected fish: 
1: 5 dilution; 1 ml whole sheep AVA +4 ml PBS (5 times dilution) 
1: 50 dilution; 0.1 ml whole sheep AVA + 4.9 ml PBS (50 times dilution). 
1: 250 dilution; 20 ill whole sheep AVA + 4.98 ml PBS (250 times dilution). 
1: 750 dilution; 10 pl whole sheep AVA + 7.49 ml PBS (750 times dilution). 
1: 2500 dilution; 2 ill whole sheep AVA + 4.99 ml PBS (2500 times dilution). 
1: 5500 dilution; 2 Ill whole sheep AVA + 10.98 ml PBS (5500 times dilution). 
Rabbit AVA injected fish: 
1: 2 dilution; 2.5 ml rabbit AVA + 2.5 ml PBS (2 times dilution) 
1: 4 dilution; 1 ml rabbit AVA +4 ml PBS (5 times dilution) 
1: 8 dilution; 1 ml rabbit AVA + 7 ml PBS (8 times dilution) 
1: 20 dilution; 250 gl rabbit AVA + 4.75 ml PBS (20 times dilution) 
1: 30 dilution; 200 i.t1 rabbit AVA + 5.8 ml PBS (30 times dilution) 
1: 60 dilution; 100 Ill rabbit AVA + 5.9 ml PBS (60 times dilution) 
Each group consisted of only one replicate since previous results showed a 
relatively small variation between replicates. Furthermore, there was not enough fish 
available with the same size of the experimental fish for setting up a replicate. The 
results of challenge of immunised rainbow trout with diluted sheep AVA and diluted 
rabbit AVA are shown in Table 3.7.3 and Table 3.7.4 respectively. 
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Table 3.7.3: Mortality and RPS after challenge (with virulent V. anguillarum,LD85) 
of rainbow trout passively immunised with different quantities of sheep AVA at 
15 days p.i. as compared to controls 	 
Number of mortality caused by V. anguillarum* 
Treatment 
RPS± S.E. Replicate 1 Replicate 2 Combined Replicates. 
Sheep AVA 
(1:5 dilution) 
Sheep AVA 
(1:50 dilution) 
Sheep AVA 
(1:250 dilution) 
Sheep AVA 
(1:750 dilution) 
Sheep AVA 
(1:2500 dilution) 
Sheep AVA 
(1:5500 dilution) 
Control 
0/10 
2/10 
8/9 
8/10 
9/10 
9/9 
8/10 
- 
9/10 
- 
17/20 
100 
76.4 
0 
5.88 
0 
0 
0.0 ±5.88 Challenged 
non-immune 
* Experimental challenge LD85= 2.1x107 cfu 0.1 -1 ml by i.p. injection. 
Table 3.7.4: Mortality and RPS after challenge (with virulent V. anguillarum,LD85) 
of rainbow trout passively immunised with different quantities of rabbit AVA at 15 
days p.i. as compared to controls  
Number of mortality caused by V. anguillarum* 
Treatment 
Replicate 1 Replicate 2 Combined Replicates RPS± S.E. 
Rabbit AVA 1/10 - 88.2 
(1: 2 dilution) 
Rabbit AVA 1/10 - 88.2 
(1: 4 dilution) 
Rabbit AVA 2/9 73.8 
(1: 8 dilution) 
Rabbit AVA 4/10 52.9 
(1: 20 dilution) 
Rabbit AVA 3/10 - 64.7 
(1: 30 dilution) 
Rabbit AVA 5/10 41.1 
(1: 60 dilution) 
Control 
Challenged 
non-immune 
8/10 9/10 17/20 0.0 ±5.88 
* Experimental challenge LD85= 2.1x107 cfu 0.1 m1-1 i.p injection. 
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It can be seen from the results that the equivalent quantity of three different 
antiserum which can confer immunity to fish against experimental infection is as 
follows: 
1:50 dilution of sheep AVA 1:8 dilution rabbit AVA — Whole fish AVA 
Table 3.7.5 shows the mortality and relative per cent survival of rainbow trout 
immunised with fish AVA (ELISA 0.D= 1.0) and challenged 30 days post-
immunisation. 
Table 3.7.5: Mortality and RPS after challenge (with virulent V. anguillarum, LD85) 
of rainbow trout passively immunised with different quantities of fish AVA at 30 
days p.i. as compared to controls 
Number of mortality caused by V.anguillarum* 
Treatment 
RPS± S.E. Replicate 1 Replicate 2 Combined Replicates. 
Whole 
fish AVA 
7/10 7/10 14/20 17.6 ± 0.0 
Amm.sul. 
precipitated 
fish AVA 
6/10 5/10 11/20 35.2 ± 5.88 
1:4 diluted 
amm. sul. 
precipitated 
7/10 8/10 15/20 11.7 ± 5.89 
Fish AVA 
Control 
Challenged 
non-immune 
8/10 9/10 17/19 0.0 ± 5.88 
* Experimental challenge LD85=2.1x107 cfu/ 0.1 ml i.p injection. 
Obviously the fish ammonium sulphate precipitated antiserum provided fish 
with more AVA antibodies. Therefore, the fish resisted the infection with higher RPS 
(RPS= 35.29%). However, RPS dropped when this serum was diluted 1:4 (RPS= 
11.7%). 
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Dry weight of antisera: 
Table 3.7.6 shows the dry weight of 1 ml of different immune AVA and non-
immune sheep, rabbit and fish sera. 
Table 3.7.6: Dry weight mg m1-1 of whole non-immune and immune anti-V. 
anguillarum antiserum of fish, rabbit and sheep measured after freeze drying 
Serum 
of 
Non- immune sera Immune sera 
Whole 
serum 
Amm.sul. 
precipitated 
Protein A / G 
purified 
Whole 
serum 
Amm.sul. 
precipitated 
Protein A / G 
purified 
Fish 23 10 40 25 
Rabbit 29 25 10 48 36 14 
Sheep 50 16 5 148 86 9 
Amm.sul.= Ammonium sulphate 
Quantitative precipitation using V. anguillarum LPS:  
Results of quantitative precipitation using V. anguillarum LPS test showed 
more precipitation with rabbit AVA than sheep and fish AVA. Rabbit antiserum had 
4.12 mg m1-1 and sheep AVA had 3.98 mg m14 precipitin antibody content. However, 
fish AVA did not precipitate with LPS (Figure 3.7.2). 
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Figure 3.7.2: Optical density of precipitate of sheep, rabbit and fish AVA vs 
different concentrations of V. anguillarum LPS (pg) 
Radial immunodiffusion: 
The results of radial immunodiffusion measuring the antibody level of sheep, 
rabbit and fish against V. anguillarum using sonicated V. anguillarum and the 
prepared LPS as antigen, showed that rabbit AVA have more precipitin activity than 
sheep AVA while fish AVA did not appear to show any precipitin activity. 
Rabbit 	 Sheep 	 Fish 
Plate 3.7: Radial immunodiffusion of rabbit, sheep and fish AVA against V. 
anguillarum LPS 
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Complement fixation test: 
Complement fixation test results utilising LPS as antigen with whole sheep, 
rabbit and fish AVA showed that rabbit antibodies fixed the complement more 
strongly (4+) than sheep antibodies (2+) whereas fish antibodies (-) did not show any 
complement fixing reactivity. 
3.7.4 Discussion: 
The equivalence activity of antisera in vitro measured by ELISA was not the 
same as in vivo when they were used in protection trials. The activity of each 
antiserum i.e sheep AVA was measured by sheep ELISA system where the type, 
affinity and avidity of immunoglobulins as well as the type of conjugate as a 
secondary antibody were all different from the rabbit ELISA system. Also, in the fish 
ELISA system a monoclonal antibody and an extra anti-secondary antibody was used. 
Therefore, the variation between the ELISA and protection results was predictable. 
Protein-G purified sheep conferred significantly higher protection (P<0.05) than 
whole and ammonium sulphate precipitated sheep AVA (with the same ELISA 0.D) 
(Table 3.7.2). It is obvious that the level of antibodies in the purified sera was greater 
than the whole sera even though the ELISA 0.D of these sera were the same. It is 
difficult to make a conclusion while the ELISA 0.Ds of these three sera were the 
same, the rate of protection they conferred to fish was different. 
Regarding the results of trial 2, a dilution of 1: 50 of sheep AVA was equivalent 
to the dilution of 1: 8 of rabbit and both of sheep and rabbit AVA in these dilutions 
provided fish with the same protection resulted from injection of immunised fish AVA 
into non-immune fish in the challenge 15 days after immunisation. It can be concluded 
that sheep anti-Vibrio immunoglobulins are 50 times and rabbit anti - Vibrio 
immunoglobulins are 8 times either quantitatively or qualitatively more potent than 
fish immunoglobulins in protecting fish from the infection in spite of the fact that their 
dry weight measured by freeze drying (Table 3.7.6) were not much far quantitatively. 
However, if the quantity is considered, rabbit AVA showed more precipitin 
antibodies. Therefore, the difference might be due to quantity of antigen-antibody of 
rabbit AVA and lack of other properties in neutralising bacterial antigens when 
compare with sheep AVA. 
By subtracting non-immune dry weights from immune dry weights of sheep and 
rabbit sera (Table 3.7.6), the differences are presumably due to anti -Vibrio antibodies 
produced as a result of immunisation (Table 3.7.7). When this difference is divided by 
the serum dilution factor required for equivalent protection of fish (1: 50 for fish sera, 
1; 8 for rabbit sera), the result can be considered to represent units of antibody activity. 
For sheep and rabbit the weights of Ig required for equivalent protection were similar 
(Table 3.7.7). 
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Table 3.7.7: Correlation of dry weight (mg m1 -1 ) with the protection efficacy of rabbit 
and fish AVA 
Sera 	Immune, non-immune 	Immune, non-immune 
of (whole serum) 	 (amm.sul. precipitated) 
Rabbit 	19 mg 	 11 mg 
19/ 8*= 2.38 mg 	 11/ 8*= 1.37 mg 
Sheep 	98 mg 	 70 mg 
98/ 50*= 1.95 mg 	 70/ 50*= 1.4 mg 
Fish 	17 mg 	 15 mg 
17/ 1*= 17 mg 	 15/ 1*= 15 mg 
* Ratios were obtained from the protection experiment (trial 2) 
This does not work similarly with fish presumably due to the fact that fish Ig are 
IgM like with a high molecular weight and those of mammalian are mainly IgG with 
lower molecular weight. It is also possible that other proteins rather than Ig are 
precipitated and constitute some weights. Therefore, further work is required to 
elucidate this. 
Rabbit AVA showed higher precipitating antibody than sheep with an 
equivalent antigen (LPS) amount (Figure 3.7.2). This is probably due to higher 
precipitin activity of rabbit Ig. It is in contrast with what obtained in vivo where sheep 
AVA was superior to rabbit AVA. Fish on the other hand did not show precipitin in 
either of the tests suggesting presumable lack of precipitin activity. Fish IgM does not 
possibly diffuse in gels and even when incorporated in gel as sheep and rabbit IgG do. 
Therefore, precipitin evaluation is probably useful for comparing within species but 
not inter- species. Moreover, the method used for equivalence of antigen- antibody is 
well defined for soluble antigen such as human serum albumin and antibodies such as 
anti-human albumin, but not for bacterial soluble antigen and the corresponding 
antibody response. Agglutinating antibodies also was not appropriate in comparing 
antibody equivalence of three different species (section 2.8). Normal fish serum was 
not used in complement fixation test for fish because the aim was to compare sheep, 
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rabbit and fish sera activity in this test. Therefore, it is possible that immune 
complexes in fish CFI, could not fix guinea pig complement. 
Thus, according to the results obtained from protection trial in this experiment, 
in order to obtain an equivalent protection, fish, rabbit and sheep antisera required to 
be diluted 1: 8 and 1: 50 respectively. However, these dilution levels were not 
coincident with those required to give equivalent ELISA 0.D readings which were 1: 
200 and 1: 20,000 for rabbit and sheep sera respectively. Consequently, while ELISA 
titres provided valuable information on the relative potencies of antisera, the in vitro 
systems used in these observations did not permit direct biological comparisons. 
Regarding multiple injections of fish in the second challenge and the possibility 
of any conferred protection, it is clearly shown (in the non-specific trial, section 3.8) 
that injection itself or with a non-immune serum could not confer protection. 
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3.8 Experiment VII Evaluation of non-specific protective factors associated with 
passive immunisation 
3.8.1 Introduction and Aims: 
Fish depend more on their non-specific defense mechanisms than the specific 
immune response for protection against diseases (Anderson, 1992). It has been shown 
from different protection trials that fish may respond non-specifically when injected 
with a variety of products even, non-immune serum. Examples of this are as follows: 
Intraperitoneal injection of either sterile or formalin-inactivated Aeromonas 
salmonicida caused an increase in serum lysozyme in rainbow trout. It was suggested 
that a number of antibacterial factors increased in concentration following 
immunisation and that these probably played a role in protection against microbial 
disease (Rainger and Rowley, 1993). 
Murai et al. (1990) showed that a C-reactive protein (CRP) in the serum of 
rainbow trout increased in concentration following immunisation with V. anguillarum 
and it was suggested that this glycoprotein was important in defense against bacterial 
infection. 
Ellis et al. (1988) reported that control rabbit serum (rabbit injected with 
Freund's complete adjuvant alone) injected into fish resulted in some degree of 
protection compared with saline-injected fish; the reason for this was unknown. 
Control rabbit serum possessed no detectable antibodies to A. salmonicida antigens in 
any of the assays used. The protective effect was, therefore, probably due to non-
specific effects possibly relating to toxin neutralisation or macrophage activation via, 
for example, interleukins (Ellis et al., 1988). Also, there were fewer mortalities in 
groups of Atlantic salmon injected with control serum (non-immune rainbow trout 
serum) than in the non-injected control when Atlantic salmon were challenged with 
virulent A. salmonicida (Cipriano, 1982). 
The aim of this study was to determine if serum complement components in 
non-immune and immune whole serum from sheep, rabbit and fish contained 
substances capable of providing non-specific protection or stimulating non-specific 
responses of fish. 
3.8.2 Materials and Methods: 
Antisera: Antisera were the same as described in section 2.4. For complement 
inactivation of fish serum a heat treatment at 44°C for 20 min was used (Sakai, 
1981a). For rabbit and sheep sera 56°C heat for 30 min was used (Sakai, 1981b). 
Complement inactivation of sera was carried out immediately before their use. 
Fish: Rainbow trout average weight 120± 11 g kept in temperature controlled tanks 
(15°C). Twenty fish were used for each treatment in two replicates (Table 3.8.1). Fish 
were injected with 0.1 ml 100 g - lof the antisera. 
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Virulent V. anguillarum with LD  70_for challenge:  
Half of fish were allocated for challenge at 15 days and the other half for 30 
days challenge. Fish were challenged with the virulent bacteria as described in section 
2.10.1. In this experimental challenge, fish were inoculated with 1.2x 10 7 cfu 0.1 m14 
(LD84.21), and 7.2x 107 cfu 0.1 m14 (LD90) of live V. anguillarum cells at 15 and 30 
days challenges respectively. 
Table 3.8.1: Experimental design for challenge of fish received non-immune and 
immune sera to assess the effect of complement 
Treatment Route of 
administration 
of antisera 
Number of fish challenged(in two replicates) 
15 days 	30 days 
Non-immune 
sheep serum 
i.p. 20 20 
Heated++ 
non-immune 
sheep serum 
i.p. 20 20 
Heated++ 
immune sheep 
i.p. 20 20 
AVA 
Non-immune 
rabbit serum 
i.p. 20 20 
Heated++ 
non-immune 
rabbit serum 
i.p. 20 20 
Heated++ 
immune rabbit 
i.p. 20 20 
AVA 
Non-immune 
fish serum 
i.p. 20 20 
Heated-H- 
non-immune 
fish serum 
i.p. 20 20 
Heated++ 
immune fish 
i.p. 20 20 
AVA 
Control 
Challenged 
non-immune 
20 20 
Total No. of fish= 400 
AVA= Anti Vibrio anguillarum antisera 
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3.8.3 Results: 
Fifteen-day challenge: 
Protection obtained from i.p. injected fish by immune and non-immune, with 
complement or without complement in a challenge (L1384.21) after 15 days post-
immunisation is shown in Table 3.8.2. Only the immune sera provided protection 
fifteen days after immunisation. 
Table 3.8.2: Mortality and RPS after challenge (with virulent V. anguillarum, 
L1384.21) of rainbow trout passively immunised with non-immune, heated AVA and 
non-immune heated sheep, rabbit, and fish at 15 days p.i. as compared to controls 
Number of mortalities caused by V. anguillarum* 
Treatment 
Replicate 1 Replicate 2 Combined Replicates RPS± S.E. 
Non-immune 
sheep serum 
9/10 8/10 17/20 0.0 ± 5.93 
Heated++ 
immune sheep 
0/10 0/10 0/20 100 ± 0.0 
AVA 
Heated-H- 
non-immune 
sheep serum 
8/10 9/10 17/20 0.0 ± 5.93 
Non-immune 
rabbit serum 
7/10 8/10 15/20 1.1 ± 4.44 
Heated++ 
immune rabbit 
0/10 0/10 0/20 100 ± 0.0 
AVA 
Heated++ 
non-immune 
rabbit serum 
9/10 9/10 18/20 0.0 ± 0.0 
Non-immune 
fish serum 
8/10 9/10 17/20 0.0 ± 5.93 
Heated++ 
immune fish 
0/10 1/10 1/20 94.1 ± 5.94 
AVA 
Heated++ 
non-immune 
fish serum 
7/10 9/10 16/20 5.0 ± 11.87 
Control 
Challenged 
non-immune 
8/10 8/9 16/19 0.0 ± 5.26 
* Experimental challenge LD84.21=  1.2x107 cfu 0.1 m1 -1 by i.p. injection. 
A complete protection was observed following the injection of 0.1 ml 100 g -1 
fish body weight of the complement inactivated sheep and rabbit and fish AVA. 
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Protection conferred by fish AVA markedly protected fish after 15 days post-
immunisation (RPS= 94.1%) and this was not significantly different (P< 0.05) from 
the protection conferred by sheep and rabbit AVA. 
Thirty-day challenge: 
After 30 days post immunisation, complete protection was observed following 
the injection of 0.1 ml 100 g-1 fish body weight of complement inactivated sheep 
AVA. A RPS of 83.3% was obtained for rabbit AVA that was not significantly 
different (P< 0.05) from the protection conferred by sheep AVA (RPS of 100%). Fish 
AVA marginally protected fish (RPS= 16.66%) after 30 day of passive immunisation 
which was not significantly different from control fish (P< 0.05). No protection was 
observed following the injection of non-immune sera (Table 3.8.3). 
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Table 3.8.3: Mortality and RPS after challenge (with virulent V. anguillarum , LD90) 
of rainbow trout passively immunised with non-immune, heated AVA and non- 
immune heated sheep, rabbit, and fish at 30 days p.i. as compared to controls 
Number of mortalities caused by V. anguillarum* 
Treatment 
RPS± S.E. Replicate 1 Replicate 2 Combined Replicates 
Non-immune 
sheep serum 
8/10 9/10 17/20 5.5 ± 5.55 
Heated++ 
immune sheep 
0/10 0/10 0/20 100 ± 0.0 
AVA 
Heated++ 
non-immune 
sheep serum 
9/10 9/10 18/20 0.0 ± 0.0 
Non-immune 
rabbit serum 
9/10 10/10 19/20 0.0 ± 5.55 
Heated-H- 
immune rabbit 
1/10 2/10 3/20 83.3 ±5.55 
AVA 
Heated++ 9/10 9/10 18/20 0.0 ± 0.0 
Non-immune 
rabbit serum 
Non-immune 
fish serum 
10/10 9/10 19/20 0.0 ± 5.55 
Heated++ 
immune fish 
8/10 7/10 15/20 16.6 ± 5.56 
AVA 
Heated++ 
non-immune 
fish serum 
10/10 10/10 20/20 0.0 ± 0.0 
Control 
Challenged 
non-immune 
10/10 8/10 18/20 0.0 ± 11.10 
* Experimental challenge LD90-= 7.2x107 cfu 0.1 m1-1 by i.p. injection 
The results of relative per cent survival obtained following challenge of 
immunised fish with immune and non-immune, complement inactivated or normal 
sera are also shown in figure 3.8. 
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Figure 3.8: Protection obtained from complement inactivated and normal immune 
(AVA) and non-immune sera 
3.8.4 Discussion: 
The results showed that the protection was not related to complement and was 
therefore almost certainly due to antibodies in the serum. Complement inactivated sera 
and sera with complement protected fish equally. It is probable that by heating the sera 
in the certain temperatures used, some components of complement were not 
inactivated. Thus, the similarity of complement-inactivated sera and sera with 
complement might be due to the existence of some complement components. Further 
research is required to elucidate this. 
The non-immune sera used in this experiment were the sera of non-immune 
animals that did not confer protection against vibriosis to fish. However, Ellis et al. 
(1988) found that control rabbit serum (rabbit injected with Freund's complete 
adjuvant alone) resulted in some degree of protection against furunculosis compared 
with saline-injected fish. It is well known that mycobacterial antigens can stimulate a 
range of non-specific immune factors. Therefore, the rabbit serum could have 
conferred some degree of protection to fish. Also, it is not understood why the trial 
challenge using non-immune rainbow trout serum against A. salmonicida gave 
marginal protection to brook trout (Cipriano, 1982). It is possible, however, that the 
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pattern of non-specific responses of fish to furunculosis may also be different from 
that of vibriosis. 
The complement inactivated sheep, rabbit or fish AVA were as protective (in 
this experiment) as the unheated sera (experiment V). This is in agreement with 
Olivier et a/. (1985) who found complement inactivated rabbit anti-A eromonas 
salmonicida (RAS) was as protective as unheated RAS. 
RPS of 5 and 5.5% obtained due to injection of fish with non-immune sera is 
probably due to individual differences between fish, however, they were not 
significantly different from control (P< 0.05). 
The differences observed between the rate of protection of rabbit AVA and fish 
AVA after 15 days and one month post-immunisation in this trial compared with 
previous trials (section 3.2) are presumably due to the different nutrition and condition 
variation of individual fish used. 
The other component of serum such as lysozyme did not appear to confer any 
protection against vibriosis since they were included in the inoculum (non-immune 
serum). However, the lysozyme content of non-immune sera was not determined 
before their use. 
These observations suggest that protective immunity was mainly due to the 
activity of specific Ig. Protection appears to be associated with specific antibodies and 
not complement at least in the case of immune rabbit serum against A. salmonicida 
(Olivier et al., 1985). However the collaboration of non-specific immunity probably 
has been an essential factor to eliminate the infection. Further work is required to 
elucidate the role of non-specific immunity in fish. 
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3.9 Experiment VIII Passive immunisation by the oral route using the carriers, 
Quil-A, Iscar and LTB . 
3.9.1 Introduction: 
Oral delivery of vaccines has long been regarded as an ideal method for fish 
farmers to control diseases. Nonetheless, it has been difficult for scientist to make it 
applicable as an effective route for the aquaculture industry. Although immersion and 
intraperitoneal vaccination methods have proved beneficial in the industry, oral 
immunisation is still very restricted in its use (Hart et al., 1988; Lillehaug, 1989). 
Georgopoulou et a/. (1985, 1986) showed that the epithelial cells of the 
posterior intestine in both young and adult trout are structurally and functionally 
comparable to those of the ileum of the suckling rat that play a basic nutritional role 
and proteins which do not undergo hydrolysis in the lumen or protein fragments, pass 
into the large vacuolar system characteristic of these cells, where they are digested. 
The intestinal tract of teleost fish is regionally differentiated, the anterior intestine are 
associated with lipid absorption and the posterior intestine can carry out 
macromolecule endocytosis (Georgopoulou et al., 1988). 
Evidence has shown that proteins were detected in fish blood plasma and 
various tissues when they were administered orally to the fish, for example, plasma 
and tissue accumulation of HRP (McLean and Ash, 1987) and HRP with the 
antiprotease, soybean trypsin inhibitor and a synthetic detergent following oral 
delivery to rainbow trout (McLean and Ash, 1990). Orally administered HRP crossed 
the intestinal epithelium into the circulation and there was a direct correlation between 
the quantity ingested and the quantity transferred to the plasma within the 
experimental limits chosen (Georgopoulou et al., 1988). Transport of orally 
administered rabbit Ig into blood circulation of goldfish (Carassius auratus) has also 
been shown (Nakamura et al., 1990). 
Tests on plasma from coho salmon vaccinated orally with V. ordalii 
lipopolysaccharide revealed antibodies against V. ordalii LPS and passive transfer of 
this plasma to naive coho also resulted in measurable protection of the recipient coho 
against V. ordalii (Velji et al., 1993). 
Several novel delivery systems have been employed to carry antigens through 
fish gut e.g. the saponin adjuvant Quil-A as a direct adjuvant had a direct effect on the 
intestine of the tilapia in regard to the level of absorption of human gamma globulin 
and subsequent cellular localisation (Jenkins etal., 1991). 
Aizpurua and Russell-Jones (1988) showed that oral administration of LTB (the 
GM-1-binding subunit of Escherichia coli heat-labile toxin) to mice elicited 
significant antibody titres. It was proposed from this work that LTB is able to bind to 
glycolipids and glycoproteins on the intestinal mucosa and stimulate these cells to 
transport the protein into the systemic circulation, thereby eliciting a systemic immune 
response. 
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Immunisation of rabbit and mice injected with bovine serum albumin coupled to 
TraT (immuno-stimulatory carriers, an internal membrane of E. coil) resulted in the 
production of high titres of antibody without need for oil-based adjuvants (Croft et al., 
1991). TraT has been shown as a T-cell immunopotentiating agent (Bell Stephen et 
a/., 1993). 
These results indicate the need for further research to evaluate oral delivery of 
proteins either as immunoglobulins for passive immunisation or microbial extracts for 
active immunisation purposes. 
The main aim of this experiment was to evaluate the protective value of purified 
sheep anti-Vibrio antibodies (AVA) when they were conjugated to some known 
protein carriers like Quil-A, TraT and LTB and fed to rainbow trout. 
3.9.2 Materials and Methods: 
Purified anti-Vibrio anguillarum (AVM: 
Purification of sheep antisera (sheep AVA) using protein-G was carried out as 
described in section 2.3. Briefly fractions of 5 ml were collected and immediately 
neutralised by appropriate 11.1 of 2M Tris, pooled and extensively dialysed against 
multiple changes of Tris saline for 24 h at 4°C, pooled, concentrated against Aquacide 
aliquoted and stored at -20°C. The yield of affinity purified Igs from pools were 9.4 
mg/ml after dialysis against, and concentrated using, Aquacide II. ELISA activity of 
the purified AVA was 1.8 (0.D= 405 nm) at a dilution of 1: 200. 
Carriers: 
Quil-A (Superfos Biosector a/s, Denmark) 0.03% solution, TraT and LTB 
(Biotech Australia); TraT 50 11.g/fish and LTB 100 p.g/fish were used as protein 
carriers. 
Preparation of Quil-A and AVA as a micellar package: 
The method used for micelle formation of Quil-A and anti-V. anguillarum 
antibodies was adapted from Jenkins et al. (1991). Briefly; micelles were prepared by 
prolonged vortexing of 10 mg m1-1 of purified sheep AVA with 0.03% solution of 
Quil-A and 0.5 ml of this solution was subsequently administered to fish by mouth. 
Preparation of conjugated TraT and LTB with sheep AVA: 
The method used for conjugation of anti-V. anguilarum antibodies and both 
TraT and LTB was adapted from Kitagawa et al. (1982) as recommended by Biotech 
Australia with slight modification. A three-step synthesis was used as follows: 
1- 1.4 ml of TraT solution (3.6 mg m1 -1 ) dissolved in 4 ml of PBS were incubated 
with 3.14 mg N-(m-maleimidobenzoyloxy) succinimide (MBS; Pierce, USA) as a 
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cross-linker dissolved in 0.5 ml of tetrahydrofuran at 30°C for 30 min with occasional 
stirring. Tetrahydrofuran was removed by flushing with nitrogen, then excess MBS 
was extracted from the reaction mixture three times with 5 ml portions of methylene 
chloride. The aqueous layer was used for step 3. 
2- Sodium borohydride reduction of disulfide bonds in AVA antibodies: 
A total of 25 mg of NaBH4 and 2 ml of n-butanol were alternatively added 
portionwise to the solution of AVA (10 mg m1 -1 protein). The mixture was incubated 
at 30°C for 30 min and then excess NaBH4 was decomposed by adding 5 ml of 0.1 M 
sodium phosphate (monobasic) and 2 ml of acetone. 
3-Conjugation of MBS to the reduced AVA: 
The solution of reduced AVA solution was incubated at 25°C for 2 h with the 
aqueous layer of step 1 solution and the mixture was chromatographed on a Sephadex 
G-100 column (2.5x57 cm) with 6 M urea as an eluent and concentrated against 
Aquacide II to yield desirable volume. A 0.5 ml of the chromatographed solution was 
subsequently administered to each fish by stomach tube. 
The same procedure as described above was used for conjugation of sheep AVA 
to LTB using 10 mg LTB. 
ELISA: 
An ELISA was set up to determine the activity of immunoglobulins after 
conjugation in another conjugation trial before the experiment. The reaction was the 
same as the sheep AVA before conjugation. 
Agglutination, precipitation and CFT: 
Also agglutination test, precipitation test, complement fixation test (as described 
in section 3.7.2) were undertaken on the conjugated sheep AVA to assess the activity 
of Ig. All test proved that conjugation procedure did not affect sheep Ig serological 
activities. 
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Fish: 
Rainbow trout average weight 135±14.5 g were used for this experiment. For 
dosing fish of this size a 1 ml hypodermic syringe was found to be appropriate and 
used as stomach tube for placing the inoculum into the stomachs of the fish. Some 
extra rainbow trout were dosed with malachite green and watched for several hours to 
ascertain there was no regurgitation. All fish were starved for 24 hours before oral 
immunisation. Fish were all tagged individually in two replicates into two 4000 L 
temperature controlled (15°C) tanks. Fish were immunised either i.p. with 0.1 ml 100 
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g-1 fish body weight or orally (by stomach tube) with 0.5 ml 100 g -1 fish body weight 
of sheep AVA (Table 3.9.1). 
Table 3.9.1: Experimental design for oral immunisation using different 
carriers 
Treatment 	Route of 	Number of fish(in two replicates)  
administration 	Blood sample* Challenge@ 
of antisera 	24 h* lw* 15 d@ 	lm*@ 2m* 3m* 
Purified(Prot.G) 	i.p. 	12 	12 	20 	32 	12 12 
sheep AVA 
Purified(Prot.G) Stomach 	12 	12 	20 	32 	12 12 
sheep AVA 	tube 
Purified(Prot.G) Stomach 	12 	12 	20 	32 	12 12 
sheep AVA 	tube 
+Quil-A 
Purifietl(Prot.G) Stomach 	12 	12 	20 	32 	12 12 
sheep AVA 	tube 
+TraT 
Purified(Prot.G) Stomach 	12 	12 	20 	32 	12 12 
sheep AVA 	tube 
+LTB 
Control 
	
20 
	20 	20 
(Untreated tagged) 
Total No. fish= 560 
h= Hours post-immunisation 	Prot.G= Affinity chromatography 
w= Weeks " 	 by Protein G 
AVA= Anti Vibrio anguillarum Antisera * Fish allocated for blood sampling. 
@ Fish allocated for challenge. *@ 12 fish for blood sampling and 20 fish for 
challenge 
At each interval the required number of immunised fish (from those fish 
dedicated for serological tests) were taken out for blood sampling. Blood samples 
were collected via the caudal vessels and fish were euthanised after each blood 
collection. 
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Fish sera collected at 24 h, 1 m, 2 m and 3 m (Table 3.9.1) were examined by a 
specific ELISA using carriers Quil-A, TraT and LTB as antigen for coating ELISA 
plates for any response against Quil-A, LTB and TraT. Since they are 
immunostimulants it was postulated that fish could produce antibody against them. 
Also ELISAs were run to determine if fish responded to sheep Ig conjugated to 
the three carriers, using sheep Ig as antigen for coating ELISA plates. Since carriers 
used for transporting these antibodies were reported to have all have 
immunostimulatory properties and it was presumed that sheep AVA to have been 
transferred into fish through the intestine. So it was possible that fish responded 
significantly to sheep AVA. 
Trial 2: 
In order to evaluate the immunostimulatory effect of Quil-A, TraT and LTB 
themselves on fish, groups of fish were dosed by these carriers with the same amount 
used for conjugation with sheep AVA (Table 3.9.2). 
Table 3.9.2: Experimental design for oral dosing using different 
carriers only 
Treatment 	Route of 
	
Number of fish challenged(in two replicates) 
administration 
Replicate 1 	Replicate 2 
Saline 	Stomach 	 10 	 10 
tube 
Quil-A 	Stomach 	 10 	 10 
0.03% solution 	tube 
TraT 	Stomach 	 10 	 10 
5011g/fish 	tube 
LTB 	 Stomach 	 10 	 10 
100 jig/fish 	tube 
Virulent V. anguillarum with LD 7o_for challenge:  
Fish were challenged with the virulent bacteria as described in section 2.10.1. In 
this experimental challenge, fish were inoculated with 7.1x 10 7 cfu 0.1 m1 1 (LD80), 
7x 107 cfu 0.1 m1-1 (LD75) and 7.4x 107 cfu 0.1 m1-1 (LD85) of live V. anguillarum 
cells at 15 days, 30 days and 15 days (carriers only) challenges respectively. 
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3.10.3 Results: 
Trial 1: 
Fifteen-day challenge: 
With respect to the protection conferred by oral immunisation using three 
carriers, the highest protection was observed in fish fed AVA conjugated to LTB by 
stomach tube (RPS= 37.5%). Results of challenge after 15 days of immunisation for 
determination of RPS is shown in table 3.9.3. 
Table 3.9.3: Mortalities and RPS after challenge (with virulent V. anguillarum, LD80) 
of rainbow trout passively immunised [(orally and by injection using Protein G 
purified sheep AVA (SAVA)] at 15 days p.i. as compared to controls 
Mortalities caused by V. anguillarum* 
Treatment 
RPS± S.E. Replicate 1 Replicate 2 Combined Replicates 
SAVA(0.1 ml) 
by injection 
0/10 0/10 0/20 100±0.0 
SAVA(0.5 ml) 
by stomach 
tube 
7/10 9/10 16/20 0.0 ± 6.25 
SAVA+Quil-A 8/10 7/10 15/20 6.2 ± 6.25 
(0.5 ml) by 
stomach tube 
SAVA+TraT 6/10 7/10 13/20 18.7 ± 6.25 
(0.5 ml) by 
stomach tube 
SAVA+LTB 5/10 5/10 10/20 37.5 ± 0.0 
(0.5 ml) by 
stomach tube 
Control 
Non-injected 
tagged fish 
8/10 8/10 16/20 0.0 ± 0.0 
* Experimental challenge LD80=7.1x10 7 cfu 0.1 -1 ml by i.p. injection. 
Groups of fish fed AVA conjugated to TraT or in micellar form with Quil-A 
showed RPS of 18.7% and 6.2% respectively. However, protections obtained by oral 
immunisation were not significantly different from control (P< 0.05). This is while the 
protection in fish injected with the purified sheep AVA had a RPS of 100%. No 
protection was conferred following oral dosing of fish with sheep Ig. 
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Thirty-day challenge: 
Results of challenge immunised fish after 30 days by oral route is shown in table 
3.9.4. 
Table 3.9.4: Mortalities and RPS after challenge (with virulent V. anguillarum, LD75) 
of rainbow trout passively immunised [(orally and by injection using Protein G 
purified sheep AVA(SAVA)] at 30 days p.i. as compared to controls 
Mortalities caused by V. anguillarum* 
Treatment 
Replicate 1 Replicate 2 Combined Replicates RPS± S.E. 
SAVA (0.1 ml) 
by injection 
1/10 0/10 1/20 93.3 ±6.67 
SAVA (0.5 ml) 
by stomach 
tube 
8/10 8/10 16/20 0.0 ± 0.0 
SAVA+ Quil-A 8/10 9/10 17/20 0.0 ± 0.0 
(0.5 ml) by 
stomach tube 
SAVA+ TraT 7/10 6/10 13/20 13.3 ± 6.67 
(0.5 ml) by 
stomach tube 
SAVA+ LTB 6/10 5/10 11/20 27.0± 7.0 
(0.5 ml) by 
stomach tube 
Control 
Non-injected 
tagged fish 
7/10 8/10 15/20 0.0 ± 6.67 
* Experimental challenge LD75=7x107 cfu/ 0.1 ml i.p. injection 
The highest protection after 30 days post-immunisation was observed in fish fed 
AVA conjugated to LTB by stomach tube (RPS = 27%). This was not significantly 
different from the RPSs of AVA conjugated Quil-A, TraT and control fish (P< 0.05). 
Groups of fish fed AVA conjugated to TraT or in micellar form with Quil-A showed 
RPS of 13.33% and no relative protection respectively. 
Challenge of fish 15 days after dosing carriers only: 
Results of challenge on fish dosed with only carriers without immune sera is 
shown in table 3.9.5. 
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Table 3.9.5: Mortalities and RPS after challenge (with virulent V. anguillarum, LD80) 
of orally dosed rainbow trout using different carriers only at 15 days p.i. as compared 
to controls 
Mortalities caused by V. anguillarum* 
Treatment 
RPS Replicate 1 Replicate 2 Combined Replicates 
Quil-A0.03% 
solution 
by stomach 
tube 
9/10 9/10 18/20 0 
TraT (TraT) 8/10 9/10 17/20 0 
5014/fish 
(0.5 ml) by 
stomach tube 
LTB 9/10 9/10 18/20 0 
10012g/fish by 
stomach tube 
Control 
Non-injected 
tagged fish 
8/10 9/10 17/20 0 
Saline 
by injection 
8/10 9/10 17/20 0 
* Experimental challenge LD85=7.4x107 cfu 0.1 ml -1 by i.p. injection 
No protection was observed following the oral dosing of the different carriers 
(Quil-A, TraT and LTB) alone. 
ELISA: 
The ELISA for monitoring the AVA levels transferred orally into the fish after 
different intervals (24 h, 1 week, 15 days, 1 month, two months) post-immunisation 
were all negative (0.Ds ranged from 0.092- 0.135). Nonetheless, serum samples of 
fish injected intraperitoneally with sheep AVA showed significant antibody titre at 24 
h after immunisation and to a lesser extent later. The rate of clearance of purified 
AVA injected to the fish was similar to the rate of clearance of the whole AVA 
(without any purification) that was measured earlier (section 3.2.3). 
The ELISA for monitoring fish anti-sheep Ig antibodies against protein-G 
purified antibodies was carried out, however, all ELISA results showed negative 
values (0.Ds in a range of 0.085- 0.128) indicated low uptake by fish and/or low 
immunogenicity for fish. Figure 3.9 shows the relative survival of fish orally dosed 
with AVA conjugated to carriers after 15 and 30 days post-immunisation. 
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Figure 3.9: Protection conferred by conjugated sheep AVA dosed orally to fish 
3.10.4 Discussion: 
In groups of fish orally immunised by AVA conjugated to different carriers, the 
highest protection was seen in fish fed AVA conjugated to LTB by stomach tube 
(RPS= 37.5% at 15 days after dosing) suggesting a moderate to marginal protection 
following conjugating AVA with this carrier. Groups of fish fed AVA conjugated to 
TraT and micellar form of Quil-A only showed RPS of 18.7 and 6.25% respectively. 
The highest protection at 30 days post-immunisation was observed in fish fed 
AVA conjugated to LTB by stomach tube (RPS = 27%) that marginally protected fish. 
These results demonstrate that oral vaccination may be a feasible approach for the 
prevention of fish diseases. This presumably suggests that the specific antibodies 
transferred to fish bound to receptors at key sites such as the spleen, liver and kidney. 
Groups of fish fed AVA conjugated to TraT or in micellar form with Quil-A showed 
RPS of 13.33% and no protection respectively (Figure 3.9). A possible explanation for 
low level or no protection obtained in this experiment might be the method of 
conjugation. Further research is required to elucidate this. 
Feeding of different carriers themselves did not confer any protection to the fish 
as a result of their immunostimulatory activities. A possible explanation is that the 
carriers had a low uptake in the dosage used for fish in this experiment. 
In group of fish immunised passively by intraperitoneal injection, complete 
protection (RPS = 100%) was found in the group of fish immunised with purified 
5E3 Sheep AVA/TraT 
(0.5 ml, s.t.) 
6 IN Sheep AVA/LTB 
(0.5 ml, s.t.) 
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sheep AVA 15 days and significant protection (RPS = 93.33%) one month post-
immunisation. This is consistent with the results of Maquis and Lallier (1989) who 
found that purified rabbit immunoglobulins specific to virulent A. salmonicida were as 
protective as the initial rabbit hyperimmune serum in protecting brook trout against 
furunculosis. 
In challenge of immunised fish, a single i.p. dose of V. anguilarum was used. It 
was shown earlier that the virulent bacteria appears in the circulating water soon after 
the challenge and a permanent exposure of fish to the organism continues. The rate of 
mortality of control fish cohabited (horizontal infection) with immunised challenged 
fish due to this exposure was 20%. Therefore, fish must have a certain degree of 
immunity to resist the infection regardless of the route of exposure. For example 
immunised fish with a certain specific antibody level, memory cells or non-specific 
immunity can only survive. 
The rate of elimination of purified sheep AVA injected to the fish was similar to 
the rate of decay of the whole AVA (without purification). This explains the longevity 
of protection provided by the specific immunoglobulins in both whole and purified 
sera. 
No protection was observed following the feeding of different carriers(Quil-A, 
TraT and LTB) by stomach tube. These show that protection obtained by oral 
immunisation of AVA conjugated to these carriers was due to specific anti-Vibrio 
anguillarum antibodies conferred to the fish. Secondly, these results indicate that the 
protection provided by these carriers was not due to their immunostimulants activity, 
at least when they are used against vibriosis. 
Radiolabelled AVA might be considered as a sensitive indicator of AVA in fish 
serum and tissues in order to elucidate the sites of activity of orally-administered 
AVA. Also, dosing fish with higher amount of carriers may enhance greater 
gastrointestinal absorption of TraT and LTB. 
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CHAPTER 4.0 
STREPTOCOCCOSIS, PASSIVE AND ACTIVE IMMUNISATION AND 
EVALUATION OF PROTECTION 
4.1 Introduction/Literature review: 
Streptococcosis has been reported in a number of species, but the specific 
disease has only been definitely identified in Japan among yellowtails (Seriola 
quinqueradiata) (Kusuda et al., 1976; Kitao et al., 1979), in Japanese eels (Kusuda et 
al., 1978b), ayu and tilapia (Kitao et al, 1981); the populations of rainbow trout in 
South Africa (Boomker et al., 1979), Australia (Carson and Munday, 1990) and Italy 
(Ceschia et al., 1992). The disease may also have occurred sporadically in Great 
Britain and Norway (Austin and Austin, 1993). Nevertheless, there is good evidence 
that streptococcosis is problematical in both farmed and wild fish stocks (Austin and 
Austin, 1993). 
While the taxonomy of the organism has not been defined, it is presently 
classified as an Enterococcus sp., probably Enterococcus seriolicida (Kusuda et al., 
1991). 
Streptococci are gram-positive and spherical (approximately 0.5 to 1.0 1.t in 
diameter), usually non-motile and non-spore forming bacteria. They usually grow in 
pairs or characteristically form chains. Most of them grow on common laboratory 
media at temperatures between 20° and 37°C, but addition of blood or tissue extracts 
enhances their growth. 
Many of the pathogenic streptococci may be divided on the basis of serological 
differences, based on the composition of antigens located in their cell walls and a 
combination of features: colony growth characteristics, haemolysis patterns on blood 
agar (a-haemolysis, B-haemolysis) and biochemical reactions. For example, the 
ability to attack blood has been highlighted since pathogenic strains show different 
patterns on blood agar; i.e, a-haemolytic (Kusuda et al., 1976), 13-haemolytic 
(Robinson and Meyer, 1966; Minami et al., 1979; Kitao et al., 1981), non-haemolytic 
(Plumb et W., 1974; Cook and Lofton, 1975; Iida et al., 1986). Although, some well-
established taxa, e.g. Streptococcus agalactiae contain both a and B-haemolytic 
strains (Cowan, 1974). 
At various times, the fish pathogenic streptococci have been linked with 
Streptococcus agalactiae, S. dysagalactiae, S. equi, S. equisimilis, S. faecium, S. 
pyogenes and S. zooepidermicus. South African isolates have been described as 
comprising unidentified Lancefield Group D Streptococcus (Bootnker et al., 1979); 
Japanese isolates have been linked with, but are not identical to S. faecalis and S. 
faecium; whereas American strains approximate to the description of S. agalactiae 
(Kusuda and Komatsu, 1978). 
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Kitao et al. (1981) reported a new serotype in Japan which did not react with 
specific antisera to Lancefield groups. This conclusion was also reached by Kitao 
(1982b) and Kusuda and Kimura (1982). 
A significant number of works describe the isolation and some characteristics of 
streptococci isolated from diseased fishes. Many characteristics are shared by the 
majority of fish pathogenic streptococci. However, there is some variance in 
description reported by workers. For example, biochemical reactions and growth 
temperatures of South African and Japanese strains. Such differences may reflect the 
lack of standardisation in the tests and heterogenecity in the species composition of 
the pathogens isolated from the fish (Austin and Austin, 1993). 
Properties of 12 strains of pathogenic streptococci from yellowtails and eels in 
Japan and 4 strains from saltwater fishes and white bass in America were compared by 
Kusuda and Komatsu (1978). Japanese isolates have been linked with, but are not 
identical to S. faecalis and S. faecium; whereas American strains approximate to the 
description of S. agalactiae. 
Kusuda et al. (1991) described E. seriolicida sp. nov., isolated from diseased 
specimens of cultured yellowtail and eels as a result of detailed biochemical and 
DNA/DNA hybridisation studies. The bacterium was gram-positive, short-chain-
forming, catalase-negative, a facultatively anaerobic coccus, grew at 10 and 45°C in 
6.5% NaC1 (pH 9.6) with 40% bile and 0.1% methylene blue-milk were positive. It 
could be distinguished from other species of the genus Enterococcus by several 
biochemical characteristics and by Lancefield's group antigen. The researchers 
indicated that the isolates belonged to the genus Enterococcus and that they could be 
differentiated from Streptococcus sp. and Lactococcus spp. by positive growth at both 
10 and 45°C, in 6.5% NaC1, and at pH 9.6, which are important characteristics of 
Enterococcus sp. (Schleifer and Kilpper-Balz, 1987). Therefore, "enterococcal 
infection" is proposed instead of "streptococcal infection" or "streptococcosis" for the 
disease caused by this ethiological agent (Kusuda et al., 1991). 
4.1.1 The streptococcal fish pathogen used in this study: 
In a recent study, Australian and South African strains collected from outbreak 
of streptococcal disease from farmed rainbow trout, appeared to have attributes of the 
genus Enterococcus. Although no Lancefield group D antigen could be detected, all 
strains grew at 10°C but not at 45°C, grew in 6.5 % NaC1, were bile-aesculin positive 
and hydrolysed L-pyrrolidonyl-B-naphthylamide and had similar phenetic 
characteristics and whole cell protein profiles (Carson et al., 1993). Streptococcus sp. 
biovar. I, has been reported the etiological agent of streptococcosis in Australia 
(Carson, 1990). All workers recommended more work to resolve the exact status of 
fish pathogenic enterococci/ streptococci. The epithet Streptococcus sp. (biovar 1) is 
used in the present study. This isolate is a-haemolytic on sheep RBC, Voges-
Proskauer reaction positive, hydrolyses aesculin and grows in 0-6.5% NaCl. 
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4.1.2 Epidemiology: 
Streptococcal infection has been described as a serious disease of cultured fish. 
The disease transmitted horizontally within 5 days by cohabiting an infected golden 
shiner with healthy specimens of the same species (Robinson and Meyer, 1966). Food-
borne infection was highlighted by Taniguchi (1983). 
Streptococcal infection may cause serious problems in both fresh water and 
marine environments. For instance, in Japan, streptococcal infections occur among 
many different species of fish especially yellowtail (Seriola quinqueradiata) (Kusuda 
et al., 1976; Minami eral., 1979) and eels (Anguilla japonicus) (Kusuda et al., 1978b). 
It has been shown that the bacteria remain in sea water and mud around fish farms 
throughout the year, but during the summer months somewhat higher numbers of 
organisms are detected in sea water than in mud (Inglis et al., 1993). In contrast, 
during autumn and winter, Kitao et al. (1979) found that the organisms were more 
easily isolated from mud. 
Streptococcosis has been associated with acute to chronic mortalities of several 
estuarine fishes (striped mullet, Atlantic menhaden, pinfish, Atlantic croaker, sea 
trout) in coastal Alabama and Florida (Plumb et al., 1974). 
In fresh water it has been reported in rainbow trout (Hoshina et al , 1958; 
Barham et al ., 1979; Miyazaki, 1982). Kitao et al. (1981) isolated streptococci from 
several species of tilapia. The Streptococcus sp. isolated from fish in Japan was 
haemolytic. 
In North America, non-haemolytic Group B streptococci were isolated from 
diseased golden shiners, (Notemignus crysoleucas) (Robinson and Meyer, 1966) in 
freshwater and several species of marine fishes from the gulf of Mexico (Plumb et al., 
1974). These two , isolates were serologically identical. 
Carson and Munday (1990) described streptococcosis as an emerging disease in 
aquaculture and pointed out the wide geographic distribution around the world. They 
also emphasised the fact that many varieties of fish are at the risk of the disease. In 
water temperature in excess of 18°C, more mortality was observed (up to 60%). 
4.1.3 Pathogenicity mechanisms: 
Experimental infections have been achieved by injection of 10 4 to 105 cells 
(Cook and Lofton, 1975), and by exposure (immersion) of fish for 10 min to 10 6 
bacteria (Robinson and Meyer, 1966). The pathogenicity of a-haemolytic 
Streptococcus species towards yellowtail is enhanced by in vivo passage through 
yellowtail (Kusuda and Kimura, 1978). After percutaneous challenge with bacteria of 
high virulence, the kidneys retained the bacteria with the relatively high count of 10 7 
cells per gram of tissue while in other organs 10 5-106 cells were detected in 10 min, 
this was followed by a progressive decrease up to 24 h post-inoculation with a 
subsequent rapid increase during the later stages of the disease progress. The highest 
rate of growth was obtained in the intestine, where 107 cells were detected at 72 h 
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after inoculation. After oral challenge, the bacteria were detected at high levels from 
organs and blood within 10 min but they were completely removed from all organs 
except the intestine within 24 h (Kusuda and Kimura, 1978). 
Kimura and Kusuda (1979) isolated Streptococcus sp. from blood and various 
internal organs of cultured yellowtails shortly after challenge irrespective of the 
virulence of bacteria or route of infection. The pathogenicity of streptococci in 
yellowtail has been attributed to an exotoxin (Watson, 1960). 
The toxicity of the ECP and it's relation to the virulence factors of 
Streptococcus sp. was tested (Sakai et al., 1991b). However, they could not determine 
the main virulence factor. Only 20% of rainbow trout injected with 10-30 mg of ECP 
died. Nevertheless, in all injected fish, haemorrhages and inflammation of the injected 
sites were observed. 
Pathogenicity of a non-haemolytic group B Streptococcus sp. in gulf killifish 
(Fundulus grandis) has been studied by Rasheed and Plumb (1984). Fish were 
infected when they were injured prior to dipping in to the bacterial suspension. Oral 
administration of the bacteria, crowding of fish and low oxygen concentration after 
dipping into the bacterial suspension did not precipitate infection. No death was 
reported by dipping alone in the bacterial suspension nor when the fish were exposed 
to a 50 parts per thousand hyperosmotic solution prior to dipping. 
Regarding antigenic variation, Kitao (1982b) stated that there were two 
antigenic types; the KG+ type agglutinates and KG- type strain possessed a specific 
envelope-like substance which inhibits agglutination with antiserum of the 
Streptococcus KG7409. 
Streptococcosis has been reported in a number of fish species including bait 
minnow (golden shiners) in the United States, rainbow trout in Japan, South Africa 
and Australia, yellowtail, red sea bream, ayu, eel, and true sardine (Sardinopus 
melanosticta) (Japan), while some tilapia species (Sarotherodon mossambicus and 
Tilapia sparrmanii), carp and largemouth bass (Micropterus salmoides) were not 
affected (Boomker et al., 1979). Comparative studies indicated that, rainbow trout 
were much more susceptible to streptococcosis than either Atlantic salmon or brown 
trout (Munday et al., 1993). Mortality in rainbow trout was closely related to water 
temperatures in excess of 18°C (Munday et al., 1993). 
4.1.4 Clinical signs and pathology: 
Fish with streptococcal septicemia may become lethargic. Erythema around the 
anus, inflammation along the dorsal surfaces especially in the vicinity of the caudal 
peduncle are frequently observed. Haemorrhages in the intestine and the existence of 
pink mucus which fills the intestine, swollen kidney , congested liver with dark colour 
and inflammation in the muscular tissues are other gross lesions due to the disease. 
Streptococcal infection produces a typical septicemia, pronounced 
exophthalmos (popeye) often leading to complete degeneration of the eye and 
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asymptomatic carriers. In acute cases fish become dark, swim sluggishly and cease 
feeding. Chronically infected fish may develop a scoliosis (twisting of the spine) 
(Jack, 1990). No Streptococcus sp. has been isolated from either culture of the egg 
surface or the interior of the egg. Thus it appears that the disease is not vertically 
transmitted (Jack, 1990). 
Variation in disease symptoms include exophthalmos and distended abdomen 
(also common features of bacterial kidney disease), haemorrhaging in the eye (enteric 
red mouth feature), haemorrhages in the opercula, at the base of the fins, and 
haemorrhages on the surface (similar to vibriosis). Darkening of the skin and erratic 
swimming of the fish are other characteristics of the disease. 
Postmortem findings in yellowtail were damage to the liver, kidney, spleen and 
intestine. Also, abdominal cavity filled with ascitic fluid, enteritis, pale livers and 
blood in the peritoneal cavity were seen. Kidneys were unaffected (Plumb et al., 
1974). 
4.1.5 Isolation of the pathogen: 
Recovery of the streptococcosis is straightforward, involving use of bovine 
blood tryptose agar (Boomker et al., 1979), Todd-Hewitt broth, nutrient agar 
supplemented with rabbit blood (Kitao et al., 1981) or brain heart infusion agar 
(Minami et al., 1979). 
Inoculated media (incubated at 22-37°C for up to 48 h) develop dull grey 
colonies approximately 1-2 mm in diameter. Confirmation of the presumptive 
identification with different biochemical and serological tests is necessary 
The growth of this organism at an incubation temperature of 37°C is in excess of 
the preferred temperatures of many fish species, particularly salmonids. This may 
indicate that Streptococcus sp. have been derived from warm-blooded animals, and 
may therefore constitute a public health risk. This aspect is presently under 
investigation (Hawkesford, pers. comm.). 
Isolation and identification of the bacterium is necessary for definitive 
diagnosis. The use of special media with different amount of sodium chloride, bile 
salts and other substances such as various carbohydrates leads to the definite 
recognition of the organism. Bragg et al. (1989) described a selective media for the 
field isolation of pathogenic Streptococcus sp. of rainbow trout. 
4.1.6 Treatment: 
Apart from good management, including the prompt removal and destruction 
of diseased fish and the adoption of improved hygienic practices around fish farms, 
use of antimicrobial compounds have met with considerable success. Effective 
antimicrobial compounds for the treatment of streptococcosis in fish are listed in Table 
4.1. 
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Table 4.1: Antimicrobial compounds for streptococcosis treatment 
Antimicrobial compound Dose 	 Reference 
Erythromycin 
Josamycin 
Doxycycline 	 20 mg/kg body weight of fish/day 
25 mg/kg body weight 
of fish/day for 4-7 days 
75-125mg/kg body weight /day 
for 10-21 days 
30 mg/kg body weight 
of fish for 3 days (or at 
20 mg/kg body weight of 
fish/day for 5 days) 
(Kitao, 1982a) 
(Munday, 1993) 
(Nakamura, 1982) 
(Kusuda and 
Takemaru, 1987; 
Takemaru 
and Kusuda 1988) 
Sodium nifurstyrenate 	50mg/kg body weight of fish 	(Austin and 
per day for 3 to 5 days Austin, 1993) 
Oxytetracycline 
Tetracycline 
50-75 mg/kg of body weight/day 	 It 
for 10 days 
75-100 mg/kg of body weight/day for 10-14 days " 
4.1.7 Disease control: 
The development of vaccine against streptococcosis of cultured yellowtail has 
been investigated. Kusuda and Takagi (1983) determined antibody production against 
Streptococcus sp. in naturally infected yellowtail by agglutination and passive 
hemagglutination of endotoxin and exotoxin of the bacteria. It was implied in this 
work that the toxoid vaccine was better than the bacterin because the antibody 
production against endotoxin was greater than that which was produced against the 
cellular antigen in yellowtail. Therefore, it was necessary to examine the toxicity and 
detoxication of the endotoxin to yellowtail in order to develop the vaccine for 
streptococcosis. This is despite the fact that it is generally believed that gram positive 
bacteria do not possess endotoxin. Production of agglutinating antibody in intestinal 
mucus suggests that the intestine is an important place for fish to develop this 
infection first (Kusuda and Takagi, 1983). However, attempts to introduce a 
commercial vaccine against the disease have not yet been successful (Carson and 
Munday, 1990). 
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4.1.7.1 Immunisation: 
Vaccination as a control measure has been recommended (Iida et al., 1981). 
Sakai et a/. (1987) vaccinated rainbow trout against B-haemolytic streptococcal 
disease. They used formalin killed cells with and without Freund's complete adjuvant, 
both intraperitoneally and by immersion. Their results showed that following 
challenge with live bacteria 70% or greater protection was achieved. Nevertheless, 
anti-Streptococcus sp. agglutinating antibody titres were low in intraperitoneally 
immunised fish and no detectable agglutinating antibody was demonstrated following 
the immersion route. 
The opsonic effect of antibody and complement on phagocytosis of 
Streptococcus sp. by macrophage-like cells of yellowtail has been investigated. 
Specific antibody increased the phagocytic activity and phagocytic index significantly, 
However, after addition of complement neither phagocytic activity nor the phagocytic 
index changed significantly. In the presence of specific antibody and complement, 
phagocytic activity and phagocytic index were significantly higher than in the 
controls. It was concluded that activation of the classical pathway of yellowtail 
complement by antigen-antibody reaction is an important function in opsonisation of 
particulate antigen (Kusuda and Tanaka, 1988). 
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4.2 Experiment I: Passive immunisation (streptococcosis): 
(determination of the rate of clearance of ASA from fish sera) 
4.2.1 Introduction and Aims: 
Passive immunisation of fish against furunculosis, vibriosis, edwardsiellosis etc. 
have been tried to some extent (Table 1.1.1 section 1.1). However, a study to research 
aspects of passive immunisation against streptococcosis particularly collecting 
immunised fish sera at different intervals and monitoring the rate of clearance of them 
from fish sera by ELISAs has not been reported in the literature. The effectiveness of 
active immunisation against streptococcosis has yet to be established. Therefore, 
passive immunisation might be an alternative method. 
The aim of this study was to measure the rate of elimination of transferred anti-
Streptococcus sp. antibodies from fish sera. In this experiment fish in two replicates 
were injected intraperitoneally with three types of immune antisera (sheep, rabbit and 
fish anti-Streptococcus antibodies). 
4.2.2 Materials and Methods: 
Antisera:  
Sheep, rabbit and fish anti-Streptococcus sp. (ASA) were prepared as described 
in section 2.3. The ELISA antibody levels of sheep and rabbit ASA were 2.10 and 
0.637 respectively at dilution of 1:128 and that of fish (ASA) was 0.301 at dilution of 
1: 64. Fish were immunised with 0.1 ml 100 g -1 of their body weight. 
ash: 
Rainbow trout (mean weight 57± 6.6 g) were tagged and treated according to the 
experimental design (Table 4.2.1). Eighty fish were allocated randomly for sheep, 
rabbit and fish ASA injection groups. Fish were lightly anaesthetised and immunised 
at the start and kept in two large fish bins (400 L with a constant temperature of 15°C) 
(each fish bin for one replicate). After 2, 4, 6 and 24 h intervals, 20 fish were bled 
and returned to main tanks in such a way that at 24 h after immunisation all the fish 
had been bled and placed in two temperature-controlled tanks (15°C). After 1 week, 1, 
2, 3 m, each time 24 fish of each group were taken from the main tanks, bled and 
returned to the tank. In addition 20 fish were bled from stock at the start of the 
experiment and their sera were used as negative control in ELISA. 
ELISA  
ELISA was run according to the ELISA protocol established and described in 
section 2.6.4. Sera collected from passively immunised fish at different intervals were 
tested by the specific ELISA against sheep and rabbit antisera already described in 
section 2.6.3.1 in order to measure the heterogenicity of these antisera for fish. 
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Table 4.2.1: Experimental design for monitoring the rate of clearance of anti- 
Streptococcus sp. antibodies (ASA) from fish sera 
Treatment Route of 
administration 
Number of fish (in two replicates) bled 
at 
2, 4, 6, 24 h 1w lm 2m 3m 
Sheep ASA i.p. 20 20 20 20 24 24 24 24 
Rabbit ASA i.p. 20 20 20 20 24 24 24 24 
Fish ASA i.p. 20 20 20 20 24 24 24 24 
Control 20 
Total No. fish= 260 
h= Hours post-immunisation 	w= Weeks post-immunisation 	m= month 
4.2.3 Results: 
Administration of sheep anti-Streptococcus sp. antibodies (ASA) was followed 
by a significant elevation of the immune antibodies in fish sera at 2, 4, 6 h post-
immunisation. The peak ELISA value (0.D= 0.921) for these antibodies was 24 h 
after immunisation. Sheep antibody levels declined slightly at one week (mean 0.D= 
0.901) and more after one month (mean 0.D= 0.392) post- immunisation. Sheep ASA 
showed an elevated ELISA activity (0.D= 0.244) after 2 months and then appeared to 
be nearing a low level (0.D= 0.187) at three months post-immunisation which was not 
significantly different from that of control fish (P< 0.05) (Figure 4.2.1). 
139 
M
ea
n  
EL
IS
A
 0.
D 
(4
05
  n
m
)  ±
  S
.E
.  
1.4 	 
1.2 - 
1 - 
0.8 - 
0.6 - 
0.4 - 
0.2 - 
o 
T 
T 
........ 	....... 
I 	\ 
0** 
o..__.  
11 ..... .......  
-r 
—13— Control 
	 Sheep ASA 
' Rabbit ASA 
Fish ASA 
2h 	4h 	6h 	24 h 1 wk 1m 	2m 	3m 
Figure 4.2.1: Rate of clearance of three types of anti-Streptococcus sp. antibodies 
from fish sera 
Fish given rabbit anti-Streptococcus sp. antibodies showed a significant elevation 
in serum antibody level measured by ELISA 2 h post- immunisation (0.D= 0.511). 
The antibody level continued to rise up to 24 h (mean ELISA 0.D= 0.680) after 
immunisation and declined gradually by week 1 (mean ELISA 0.D= 0.341). At one 
month post-immunisation, the antibodies level had declined markedly and the mean 
ELISA 0.D was 0.199 (significant differences are shown in Table 4.2.2). From this 
point onward the ELISA antibody levels were similar to those of control fish (Figure 
4.2.1). 
Fish passively immunised by fish ASA antibodies showed the highest amount of 
antibodies at 2 h post-immunisation (0.D= 0.221). These antibodies declined rapidly 
up to 24 h when no positive 0.D could be detected. ELISA 0.Ds were the same as 
control samples from 24 h onwards. Summary of the Figure 4.2.1 and the significant 
values are shown in Table 4.2.2. 
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Table 4.2.2: The summary of figure 4.2.1; rate of clearance of ASA from fish 
serum 
Time post-passive 	24h 
immunisation 
1 week 	1 month 2 months 3 months 
ELIS A 0.D readings (mean ± S.E.)* 
Control 0.121a±0.025 	0.119a±0.034 	0.091a±0.046 0.094a±0.023 0.109a±0.042 
Sheep ASA 0.921b±0.125 0.901b±0.063 0.392c±0.031 0.244c-±-0.44 0.1 87±O.032 
Rabbit ASA 0.680d±0.126 0.341c±0.048 0.199ac-±0.044 0.184ac±0.035 0.163a±.032 
Fish ASA 0.165a±0.027 0.141a±0.027 0.124a±0.032 0.111a±0.020 0.101a±0.024 
*Values with the same superscript were not significantly different (P<0.05). 
The highest ratio of antibody level of immunised fish with sheep ASA to non-
immunised fish was 7.6 times at 24 h and 7.5 times at 1 week post-immunisation. This 
ratio was 5.6 and 1.6 times after 24 h for fish immunised with rabbit ASA and fish 
ASA respectively (Table 4.2.3). 
Table 4.2.3: The ratio of 0. D of immunised fish relative to 0. D of non-immunised 
fish (control fish) at each observation 
Time post-passive 24h 	1 Week 
	
1 month 	2 months 3 months 
Immunisation 
Sheep ASA 7.611 7.571 4.296 2.595 1.715 
Rabbit ASA 5.619 3.376 2.186 1.968 1.495 
Fish ASA 1.633 1.396 1.362 1.191 0.926 
Fish antibody responses to sheep and rabbit ASA are shown in Figure 4.2.2. The 
highest response was 2 months after immunisation of fish with sheep and rabbit sera. 
There was no significant difference between fish response to rabbit sera and sheep 
sera at each interval (P< 0.05). 
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Figure 4.2.2: Fish humoral response to sheep and rabbit anti-Streptococcus sp. 
antibodies 
4.2.4 Discussion: 
In this experiment, sheep ASA antibodies reached the highest amount in fish sera 
after i.p. administration with the peak occurring at 24 h post-immunisation. The 
antibody peak for rabbit ASA and fish ASA post-immunisation occurred at 24 h and 2 
h respectively. The persistence of antibody appeared to be highest after administration 
of sheep antibodies. There were significant differences in the level of ASA in fish 
injected with sheep and rabbit ASA at different intervals post immunisation (Table 
4.2.1) which shows the persistence of sheep ASA. 
The patterns of appearance of sheep and rabbit antibodies from 2 to 24 h could 
well be explained by the gradual appearance of these antibodies in fish blood. 
Nonetheless, fish ASA shows the highest amount only two hours post-immunisation. 
This is probably due to the low amount of these antibodies in fish immune sera. Fish 
injected with fish ASA showed comparatively lower amounts of these antibodies post-
immunisation which was significantly different from groups of fish injected with 
sheep and rabbit ASA (P<0.05). It seems that rabbit ASA was metabolised rapidly 
whereas sheep ASA persisted much longer. This might be due to the fish responses to 
the heterogenous rabbit Ig. 
It is possible that because sheep and rabbit responded greater than fish to 
Streptococcus sp., their immunised sera could confer a higher level of immunity which 
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is more prolonged. In general the sheep ASA shows a high persistency followed by 
rabbit ASA in fish blood. 
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4.3 Experiment II Active immunisation (streptococcosis): 
4.3.1 Introduction and Aims: 
Active immunisation of fish was already discussed in section 4.1.9. Since there 
is no bacterin available for the control of streptococcosis and also the fish responses to 
bacterins have not been clearly elucidated, the intension was to study the use of 
bacterin by i.p. and immersion method and demonstrate the fish response to the 
Australian Streptococcus sp. isolated from rainbow trout in Tasmania. 
4.3.2 Materials and Methods: 
Bacterins: 
The method used in preparation of Streptococcus sp. bacterins was as described 
in section 2.2. One group of fish with a replicate was injected i.p. with 0.1 ml of 
bacterin containing 1 mg washed formalin killed bacteria (dry weight) using a 1 ml 
hypodermic syringe. The other group of fish with a replicate was immersed for 30 
seconds in bacterin as described in section 2.2.2. The immersion vaccination method 
consisted of placing the netted fish in a aerated 20 L fish box containing 10% diluted 
bacterin (18 L freshwater + 2L bacterin). Each ml of vaccine solution contained 5.5 x 
109 formalin killed bacteria. The fish were placed in the vaccine for 30 sec then 
washed in a fish box containing aerated freshwater for 1 min and then returned to 
main tanks. Temperature of the vaccine solution was kept at the ambient water 
temperature. 
Fish: 
Sixty four rainbow trout (average weight of 57± 6.6 g) were used as shown in 
the experimental design (Table 4.3.1). Twenty four fish were immunised in each 
group and they were divided randomly in two replicates into two temperature 
controlled tanks. Fifteen fish were allocated for a control group to collect serum 
samples for negative ELISA controls. Fish were bled one month and again 2 months 
post-immunisation. 
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Table 4.3.1: Experimental design for active immunisation against Streptococcus sp. 
Treatment Route of 	Total 
administration 	number 
of fish 
Number of fish (in two replicates) 
Blood sample 
lm 	 2m 
Immersion 
vaccinated 
immersion 
(30 s) 
24 24 24 
Injected 
vaccinated(1 mg 
cells) 
i.p. 24 24 24 
Control 16 12 12 
Total No. fish= 65 
ELISA  
ELISA was run according to the protocol described in section 2.6.4. 
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4.3.3 Results: 
The results of active immunisation are summarised in Table 4.3.2. Immersion 
vaccinated fish did not show any antibody level 1 or two months post-immunisation. 
Fish injected with 1 mg formalin killed Streptococcus sp. cells showed an antibody 
level with an ELISA 0.D of 0.291 and 0.232 one and two months post-immunisation. 
Table 4.3.2: Humoral antibody level of fish injected and immersed with 
Streptococcus sp. formalin killed cells 
Fish 
status 
ELISA OD 
min max positive/negative 
__cut-off 
mean S.D. 
Immunised fish 
0.291a 0.044 0.212 0.416 0.193 lm (i.p.) 
lm (bath) 0.121c 0.035 0.087 0.162 0.175 
2m (i.p.) 0.232b 0.039 0.225 0.445 0.189 
2m (bath) 0.132c 0.029 0.090 0.151 0.169 
Control fish 
0.105c 0.104 0.067 0.165 lm 
2m 0.111c 0.035 0.082 0.172 
Values with the same superscript were not significantly different (P< 0.05). 
4.3.4 Discussion: 
Fish immersed in the streptococcal bacterin did not show any humoral antibody 
response to the antigen. It is probable that there is no antigen uptake following 
immersion of fish or even a low uptake can not elicit antibody production. This is 
consistent with the finding of Sakai et al. (1987) who did not find detectable 
agglutination antibody in rainbow trout following immersion in B-haemolytic 
Streptococcus sp. bacterin. 
Injection vaccination using 1 mg Streptococcus sp. cells showed moderate to 
marginal antibody production in fish. Sakai eral. (1987) also found low antibody titres 
after intraperitoneal injection of formalin-killed bacteria in rainbow trout. Low 
antigenicity of bacterin for fish is possibly one interpretation for the low antibody 
response. It is implied from the work of Kusuda and Takagi (1983) that toxoid vaccine 
is better than the bacterin. 
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4.4 Experiment III Evaluation of protection (streptococcosis) 
4.4.1 Introduction and Aims: 
A few studies have been carried out to evaluate the protectiveness of active 
immunisation against streptococcosis as described in section 4.1.9. The use of passive 
immunisation against streptococcosis has not yet been attempted. In this experiment, 
the aims were to immunise fish passively and actively and then challenge them at 
different intervals in order to evaluate the protectiveness of these vaccination methods. 
4.4.2 Materials and Methods: 
Anti sera: 
Anti-Streptococcus sp. antisera (ASA) were produced as is described in section 2.4. 
The ELISA antibody levels of sheep and rabbit were equal to 0.D of 2.10 and 0.637 
respectively at dilution of 1:128 and that of fish (ASA) was 0.301 at dilution of 1: 64. 
Fish were immunised with 0.1 ml 100 g-1 body weight. 
Bacterin for active immunisation  
Formalin killed Streptococcus sp. for injection and immersion vaccination of 
fish was prepared as described in section 2.2. Fish were immunised with the bacterins 
as described in section 4.3.2. 
Fish: 
Rainbow trout average weight 57 ± 6.6 g at the time of immunisation were kept 
in 4000 L freshwater temperature controlled tanks (at 15°C) in the trout room. Lightly 
anaesthetised fish were tagged individually and treated by i.p. injection of 0.1 ml 100 - 
1 sheep, rabbit, fish ASA or 1 mg (dry weight) of bacterin (active immunisation) and 
maintained in two 4000 L temperature controlled tanks (15°C ) (Table 4.4.1). Control 
fish did not receive any treatment but were only tagged at the time of immunisation. 
Virulent Streptococcus sp. with LD  70for challenge:  
Fish were challenged with the virulent bacteria as described in section 2.10.2. In 
this experimental challenge fish were inoculated with 32-43 cfu 0.1 m1 4 (LD75), 55- 
65 cfu 0.1 m1 -1  (-D85) and 4-7 cfu 0.1 ml -1 (LD62.5)  of live Streptococcus sp. cells at 
one month, two months and three months challenges respectively. 
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Table 4.4.1: Experimental design for challenge of passively and actively immunised 
fish with experimental infection of Streptococcus sp. 
Treatment Route of 
administration 
of antisera 
Number of fish challenged(in two replicates) 
lm 2m 3m 
Sheep ASA i.p. 24 24 24 
Rabbit ASA i.p. 24 _ 	24 24 
Fish ASA i.p. 24 24 24 
Immersion 
vaccinated 
immersion 24 24 24 
Injected 
vaccinated(1 mg) 
i.p. 24 24 24 
Control 24 24 24 
(Untreated tagged) 
Total No. of fish= 432 
ASA= anti-streptococcal antibodies 
Challenge:  
All immunised and control fish were challenged i.p. (in the ventral midline 
immediately anterior to the pelvic fins) with 0.1 ml of the virulent bacteria after 
anaesthetising with benzocaine. Protection levels in actively and passively immunised 
fish were expressed in terms of relative per cent survival (RPS). 
One, two or three months after passive immunisation, the allocated number of 
fish for each time were challenged intraperitoneally. The temperature was maintained 
at 20°C during the challenge. 
The mortality percent (mean) in all actively and passively immunised groups 
including challenged control were calculated. RPS which showed the immunity status 
of the fish was obtained from the mortalities in different groups and controls and then 
compared as described previously. 
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4.4.3 Results: 
One-month challenge: 
The challenge was conducted so that a minimum of 70% of the non-immune fish 
died. Results of protection level of immunised fish after one month of immunisation is 
shown in Table 4.4.2. 
Table 4.4.2: Mortality and RPS after challenge (with virulent Streptococcus sp., 
LD75) of rainbow trout immunised passively with sheep, rabbit and fish ASA and 
actively immunised ( by immersion and injection ) 
at one month p.i. as compared to controls 
Number of mortalities caused by Streptococcus sp.* 
Treatment 
RPS± S.E. Replicate 1 Replicate 2 Combined Replicates 
Sheep ASA 0/12 2/12 2/24 88.8± 11.10 
Rabbit ASA 4/12 5/12 9/24 50.0 ± 5.56 
Fish ASA 8/12 10/12 18/24 0.0± 11.10 
Active 
immunisation 
1/12 1/12 2/24 88.8 ± 0.0 
Active 
immunisation 
(bath) 7/12 9/12 16/24 11.1 ± 11.33 
Controls 
Challenged 
non-immune 
8/12 10/12 18/24 0.0 ± 11.11 
* Experimental challenge LD75= 32-42 cfu 0.1 -1 ml by i.p injection. 
Regarding protection obtained from passive immunisation, the highest RPS 
(88.8%) was observed in those fish immunised by sheep ASA one month post-
immunisation. It was 50% in the case of rabbit ASA (not significant from that of sheep 
ASA, P< 0.001) and 0% in the case fish ASA. 
With respect to the results of RPS obtained following injection and immersion 
immunisation ( 88.88% and 11.10% respectively) and their comparisons with that of 
sheep ASA, it is obvious that ,RPS conferred by sheep ASA is similar to that of the 
injection immunisation. 
No fish pathogens were detected from the survivors of the treated groups 
(kidney and brain were sampled and cultured on BHI and BA). One of the survivors 
from the control group was culture-positive 14 days post-challenge. The remaining 
survivors from the control group were negative in culture from kidney and brain. 
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Two-month challenge: 
The allocated fish for two-months challenge were challenged i.p. with 55-65 cfu 
live Streptococcus sp. (Table 4.4.3). 
Table 4.4.3: Mortality and RPS after challenge (with virulent Streptococcus sp., 
LD85) of rainbow trout immunised passively with sheep, rabbit and fish ASA and 
actively immunised (by immersion and injection ) 
at two months p.i. as compared to controls 
Number of mortalities caused by Streptococcus sp* 
Treatment 
RPS± S.E. Replicate 1 Replicate 2 Combined Replicates. 
Sheep ASA 8/12 6/12 14/24 33.3 ± 9.52 
Rabbit ASA 10/12 9/12 19/24 6.8 ±4.76 
Fish ASA 11/12 8/12 19/24 6.8 ± 14.27 
Active 
immunisation 
(LP-) 7/12 6/12 13/24 38.1 ± 4.76 
Active 
immunisation 
(bath) 9/12 11/12 20/24 4.7 ±9.51 
Control 
Challenged 
non-immune 
10/12 11/12 21/24 0.0 ± 4.89 
* Experimental challenge LIN5= 55-65 cfu 0.1 -1 ml by i.p injection. 
Protection level in this trial ranged from RPS 38.1% (active immunisation with 
i.p. injection of cells) to RPS of minimum 6.8% (related to rabbit and fish ASA). The 
highest rates obtained from injection immunised fish (RPS of 38.1%) and sheep ASA 
(RPS of 33.3%). There were no significant differences between the protection level of 
fish passively immunised with sheep ASA and fish immunised actively with formalin 
killed cells. However, protection rate for dip immunised group was very low (RPS= 
4.7%). None of the protection obtained from passive and active immunisation in this 
trial could protect fish significantly after two months post-immunisation when 
compared with control fish (P< 0.05). 
When comparing the protection level of fish at one and two months, the second 
challenge at 2 month post-vaccination showed that the protection declined markedly in 
passively immunised fish with sheep, rabbit and fish having RPS values declining 
from 88.8% to 33.3%, 50% to 6.8%, and 0 to 6.8% respectively. That of the actively 
i.p. immunised fish after 2 months also declined markedly. 
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Two fish from dip vaccination and one fish from sheep ASA injected survivors 
were culture-positive (kidney and brain were cultured on BHI and BA). The control 
groups which had not been immunised showed one positive fish in culture both from 
the kidney and the brain. The remaining survivors from different groups were culture 
negative 14 days post-challenge. 
Three-month challenge: 
Results of challenge of the immunised fish allocated for three months post-
immunisation challenge (challenged i.p. with 4-7 cfu Streptococcus sp.) are shown in 
Table 4.4.4. 
Table 4.4.4: Mortality and RPS after challenge (with virulent Streptococcus sp., 
LD62.5 ) of rainbow trout passively immunised with sheep, rabbit and fish ASA and 
actively immunised (by immersion and injection ) 
at three months p.i. as compared to controls 
Number of mortalities caused by Streptococcus sp* 
Treatment 
RPS± S.E. Replicate 1 Replicate 2 Combined Replicates. 
Sheep ASA 6/12 7/12 13/24 13.3 ± 6.66 
Rabbit ASA 6/12 9/11 15/23 0.0 ± 20.0 
Fish ASA 8/12 6/12 14/24 6.6 ± 13.32 
Active 
immunisation 
(LP.) 5/10 3/10 8/20 36.0 ± 16.0 
Active 
immunisation 
(bath) 7/12 8/11 15/23 0.0± 11.51 
Control 
Challenged 
non-immune 
6/12 9/12 15/24 0.0 ± 20.0 
* Experimental challenge LD62.5=4-7 cfu 0.1 m1 -1 by i.p. injection 
Results indicated that the protection conferred by i.p. administration of immune 
sera after three months, were marginally effective to almost ineffective (protection 
ranged from RPS of 13.34% to RPS of 0%). 
Protection rate was highest ( RPS) in the group injected with 1 mg (dry weight) 
of formalin killed Streptococcus sp but significantly higher than those of other groups. 
Nonetheless, it was only moderately protective (RPS= 36%). 
One fish from sheep ASA treated survivors was detected culture-positive 
(kidney and brain were sampled cultured on BHI and BA). The remaining survivors 
from different groups including control group, were culture negative up to 14 days 
post-challenge. 
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The relative per cent survival of fish immunised passively with ASA and 
actively with streptococcal bacterins after challenge are also shown in Figure 4.4. 
1E1 Control fish 
75% mortality at 1 month 
87.5% mortality at 2 months 
62.5% mortality at 3 months 
2g1 Sheep ASA 
3 	Rabbit ASA 
4 Co Fish ASA 
51S1 Injection Streptococcus sp. 
cells (i.p.) 
6ID Immersion Streptococcus sp. 
cells (bath) 
1 
	 2 	 3 
Months post-immunisation 
Figure 4.4: Survival rate of fish passively and actively immunised against 
Streptococcus sp. when challenge 
4.4.4 Discussion: 
The control fish showed 75, 85 and 62.5% mortality after one, two and three 
months respectively. In contrast, fish immunised with sheep and rabbit immune sera 
and injected bacterin showed appreciable protection (Figure 4.4). Strongest protection 
occurred in fish immunised with sheep ASA serum. Sheep ASA by injection conferred 
significantly higher protection than that of immersion. It seems that the level of 
immunoglobulins in 0.1 ml of sheep and rabbit antisera are high enough to give fish a 
good protection at one month or more after injection against the disease. These Ig are 
possibly distributed and stored in different organs following immunisation of fish. 
Interestingly, fish do not respond against them anaphylactically. Strong challenge 
(85% mortality) during trials decreased the protection rate (RPS) significantly. 
Nevertheless, higher protection might not have been obtained even if low number of 
bacteria were used. In this experiment, fish immunised with fish ASA, did not show 
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any protection. This is consistent with the results of ELISA (section 4.3.3) suggested 
low level of ASA in fish sera. 
The results of this study is in agreement with the findings of Sakai et al. (1987) 
who vaccinated rainbow trout against B-haemolytic streptococcal disease using 
formalin killed cells with and without Freund's complete adjuvants both 
intraperitoneally and by immersion. Their results showed 70% protection of fish 
following challenge with live bacteria. However, the results of immersion vaccination 
in this study contradict their report. This is probably because they used 3 min 
immersion and a 30 seconds immersion has been used in this study. It is possible 
however that strain variation between Japanese and Tasmanian isolates have their own 
uptake potential. In contrast with the findings of Sakai et al. (1987), the results 
reported here using immersion vaccination does not show such a high protection. 
In agreement with the finding of Iida et al. (1981) who reported that 
intraperitoneal injection, was effective in yellowtail vaccinated against alpha-
haemolytic Streptococcus sp., the results reported here indicate that Tasmanian 
-haemolytic Streptococcus sp. bacterin delivered by intraperitoneal injection to 
rainbow trout is effective immunogen against streptococcosis. 
Anti-Streptococcus sp. agglutinating antibody titres were low (measured by 
ELISA) in i.p. injected fish (section 2.8). This is consistent with the low agglutination 
antibody following immersion in the bacterin and oral immunisation described by Iida 
et al. (1981). These antigens are probably not detectably immunogenic in rainbow 
trout. It is probable that Streptococcus sp. antigens were more immunogenic in sheep 
and rabbits. 
With regard to the results of injection vaccination, it seems likely therefore that 
despite poor immunogenicity of the bacterin in the host, significant protection is 
achieved by actively immunising of fish which could be explained by inducing the 
humoral and cell-mediated responses and possibly non-specific responses of fish by 
the immunogen components of the cells even though we can not detect them by 
agglutination or ELISA. Nevertheless, it's proper mechanism needs clarification. 
Kusuda and Takagi (1983) investigated antibody production against a- haemolytic 
Streptococcus sp. in naturally infected yellowtail and found high titres were induced 
by the bacterium. Vaccination of fish using the more immunogenic antigen than 
simply whole cells is proposed (Sakai et al., 1987). A RPS of 88.8% post-vaccination 
for the injection group was found in this investigation which is being reporting for the 
first time. 
These observations suggest that protective immunity was mainly due to the 
action of specific Ig in strong challenges (i.p.) and concurrently exposure of fish to a 
40% natural transmission (section 2.11.2). However the collaboration of cell-mediated 
and non-specific immunities have probably been an essential factor to eliminate the 
infection. It needs further work to elucidate the role of these components. 
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The mechanism of protection provided by sheep and rabbit antisera to 
Streptococcus sp. antigens is presumably simply the neutralising of the biological 
effects of toxins, since mammalian antibodies are incapable of activating rainbow 
trout complement (Sakai, 1981b) so this can not kill bacteria or act as opsonins. 
Furthermore, the level of protection and its duration in passively immunised fish will 
depend upon the rate at which the rabbit antibodies are complexed by the bacterial 
antigens released in the fish. This may explain the pattern of the results reported in the 
work of Ellis et al. (1988) where the Ranti 048 antiserum (antiserum to MT048, a less 
virulent protease-proficient A.. salmonicida cells and ECP) produced a higher level of 
protection and slower mortality rate in fish challenged with A. salmonicida (strain 
MT028) since there would be relatively more antiprotease antibody available to 
neutralise the smaller quantities of protease released from the more virulent protease-
deficient MT028 as compared with the less virulent protease-proficient MT048. 
It is probable that some of the protection resulted from non-specific immunity 
conferred by the injection of antisera irrespective of specific antibody as such was the 
finding of Ellis et al. (1988) that the control rabbit serum (rabbit injected with 
Freund's complete adjuvants alone) resulted in some degree of protection compared 
with saline-injected fish. The control rabbit serum possessed no detectable antibodies 
to A. Salmonicida antigens in any of the assays used. The protective effect is, 
therefore, likely to be due to non-specific effects possibly relating to toxin 
neutralisation or macrophage activation via, for example, interleuldns. However, in an 
experiment reported earlier (experiment VII), it was shown that non-specific factors 
could not confer immunity to fish against vibriosis (the rabbit was not injected and 
immunised by any adjuvant or bacterin). Non-specific defense mechanisms such as 
phagocytosis and complement, lysozyme and transferrin activities have been reported 
in fish (Fletcher and White, 1976). 
Despite the low challenge level (LD62.5) after three months, marginal protection 
occurred in fish immunised with injection vaccination (RPS of 36%). The mechanism 
by which immersion vaccination confers protection appears to be associated with cell 
mediated and non-specific immunity. However, long term protection (after three 
months and more) and its relation with non-specific immune response and other 
mechanisms involved are still unclear and need to be elucidated. 
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CHAPTER 5.0 
PARAMOEBIASIS, PASSIVE AND ACTIVE IMMUNISATION AND 
EVALUATION OF PROTECTION 
5.1 Introduction/Literature review: 
Amoebic gill disease (AGD) was first diagnosed in sea farmed salmonids on the 
south east coast of Tasmania in the summer of 1984-1985 (Munday, 1985). During this 
period, mortalities of up to 10% per week occurred during the second wave of infection 
in Atlantic salmon and rainbow trout (Foster and Percival, 1988a). There can be up to 
three outbreaks of AGD infection during the months of elevated water temperature 
when there is an absence of freshwater flushing from river outlets. Present control 
measures rely on treatment with freshwater which is difficult and costly. Therefore, 
immunoprophylaxis is an attractive alternative. Observations have suggested that 
previously-exposed salmonids are relatively resistant to reinfection i.e. immunity 
develops. The possibility of an immune response to Paramoeba sp. (PA) in recovered 
fish is promising but requires verification. 
5.1.1 Paramoeba sp., the causative agent of amoebic gill disease (AGD): 
The amoebae are present in large numbers, loosely attached to the surface of gill 
filaments and floating free in fresh preparations of the gill arch. The amoeba has a 
diameter of 20-30 gm with up to 50 digitate processes (pseudopodia) extending from 
the surface. They are motile and produce wide, rounded to conoid, clear pseudopods if 
left undisturbed on a slide (Langdon, 1990). Out of water this form retracts to a rounded 
granular body of 20 gm diameter. A locomotive form attached to the slide shows wide 
diaphanous pseudopodia. 
The amoeba found associated with damaged fish gill tissue was classified as a 
Paramoeba species in 1987 (Foster and Percival 1988b) due to the presence of 
parasomes [(also known as NebenkOrper (Perkins and Castagna, 1971) and Nebenkem 
(Hollande, 1980)]. These intracellular inclusions of the Paramoeba are thought to be 
related to the presentation of a kinetoplastid flagellates (Hollande, 1980). Such 
parasomes contain DNA and can be demonstrated by Feulgen's, Heidenhain's iron 
haematoxylin and DAPI (fluorochrome 4',6-diamino-2-phenylindole) stains (Rogerson, 
1988). 
From pathogenicity trials conducted in 1993 it was noted that the cultured 
Paramoeba could not elicit the disease in fish (Howard et al., 1993b). 
Roubal et al. (1989) suggest that Paramoeba are primary pathogens capable at 
least of mechanically damaging gill epithelium. Their pseudopodia penetrate between 
epithelial cells and deform their surface. Abundant Paramoeba were invariably 
associated with extensive gill hyperplasia, and there was no evidence that the necrosis 
was caused by bacteria prior to the onset of Paramoeba infection. Initially, Paramoeba 
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sp. were found only on salmonids, but subsequently they were detected at an 
unpredictable frequency on a range of native marine fish (Munday et al., 1990). 
Plate 5.1.1: Fresh wet mount of the gills, showing Paramoeba sp.; 1000 X 
Paramoeba is cultured on a variety of laboratory media e.g. on a bacterial 'lawn' 
of Pseudomonas maltophilia grown on malt and yeast extract seawater agar. One of the 
major problems facing the culture of pathogenic amoeba is the possibility of loss of 
virulence of the organism with time removed from the host. For example, Vincent and 
Neal (1960) found a gradual decrease in virulence occurred from polyxenic culture, but 
pathogenicity could be restored by passaging the organism (Entamoeba histolytica) 
through host cells. 
5.1.2 Epidemiology 
In Tasmania, disease associated with Paramoeba usually occurs in the first 
summer of sea cage farming of salmonids following their transfer from the freshwater 
hatchery (Langdon, 1990). The amoebae become apparent in low numbers on the gills 
two months after the introduction of fish to the sea (Foster and Percival 1988a). 
Increased severity of the disease occurs with the stress of elevated water temperatures 
(greater than 15-17°C) and factors such as poor hygiene, crowding, and decreased water 
exchange through biofouling on nets (Langdon, 1990; Munday et aL, 1990). However, 
at low stocking density, fish may still succumb to the disease (Foster and Percival, 
1988b). 
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Elevated water temperatures probably act to decrease generation time and lead to a 
higher population size of amoebae (Kent et al., 1988). This is consistent with the 
optimum temperature for in vitro culture being —20°C (Howard and Carson 1991). 
Increasing water temperature leads to a decrease in levels of dissolved oxygen in the 
water. As a result fish oxygen demand increases through increased metabolic activity. 
Roubal et a/.(1989) also suggested that the temperature stress on the fish may favour the 
increase in the parasite population. 
There are still many unknowns relating to the sequence of events proceeding the 
outbreak of the disease. However, the cause of mortality in salmonids (which can be as 
high as 2% per day) appears to be respiratory and/ or osmoregulatory failure associated 
with a branchitis and respiratory stress (i.e. flared operculum and sluggish movement) 
(Munday et al., 1990). 
AGD occurs in both rainbow trout and Atlantic salmon in Tasmania (Munday et 
al., 1990) coho salmon in Washington State and California, USA (Kent et al., 1988) 
chinook salmon in New Zealand (C. Anderson, pers. comm.; Howard and Carson, 
1993a) and Atlantic salmon and rainbow and brown trout in France (B. L. Munday, 
pers. comm.) farmed in the marine environment. The disease appears to be more severe 
in fish up to 2 kg body weight (young fish in their first season in the sea) (Munday et 
al., 1990). 
5.1. 3 Clinical signs and pathology: 
The infected fish are sluggish and swim with open opercula (Munday et al., 
1990). They usually swim at the surface. Mortality is variable, reaching 2% per day and 
up to 50% total in untreated cages (Munday et al., 1990). Subclinically and clinically 
affected fish have elevated plasma sodium levels (Landon, 1990). 
The outstanding pathological change is the presence of excessive mucus on the 
gills. In rainbow trout, this mucoid branchitis is relatively diffuse, but with Atlantic 
salmon, the lesions tend to be patchy (Munday et al, 1990). Epithelial hyperplasia 
involving the secondary lamellae, numerous active secreting mucus cells (Munday et al., 
1990), slightly thicker tips of the primary lamellae, prominent chloride cells and fusion 
of lamellae (Howard and Carson, 1992) are histological features of the disease. 
Histopathological changes in visceral organs are not associated with amoebae infestation 
(Kent et al., 1988). 
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Plate 5.1.2: Signs of amoebic gill disease (AGD), showing typical white patches on 
gills 
5.1.4 Diagnosis 
The swimming behaviour of fish and the presence of white patches on the gills 
provide a tentative diagnosis. Fresh wet preparations of infected gills gently prepared in 
ambient seawater and observation of the Paramoeba, histo-pathological changes to gills 
(Munday et al., 1990) as well as immunofluorescent antibody test (Howard and Carson, 
1993a, 1994) are used to confirm the tentative diagnosis. 
5.1.5 Treatment 
The only effective treatment to date has been the use of freshwater baths (Munday 
et al., 1990). 
5.1.6 Immunity against AGD: 
Observations have suggested that previously-exposed salmonids are relatively 
resistant to reinfection i.e. immunity develops. However, in some instances, rainbow 
trout and Atlantic Salmon may show disease again a few months after treatment 
(Langdon, 1990). The possibility of an immune response to Paramoeba in recovered 
fish is promising, but requires verification. Fish immune response to Paramoeba was 
speculated since both epidemiological and histological features of the disease suggested 
that there is development of immunity ,"judicious use of freshwater baths can be 
employed to produce a degree of natural vaccination"(Munday et al., 1990). 
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5.2 Experiment I Passive and active immunisation against AGD 
5.2.1 Introduction and Aims: 
The following experiment was conducted to evaluate the longevity of passively 
transferred sheep anti -Paramoeba sp. antisera and to investigate humoral responses of 
fish to AGD antigens, . Aims were as follows: 
-To produce a large quantity of hyperimmune serum against Paramoeba sp. in sheep. 
-To develop a diagnostic assay to detect and compare fish antibody production to the 
causative agent of AGD. 
-To determine how long sheep antiserum persists after injection into fish. 
5.2.2 Materials and Methods. 
Paramoeba:  
Paramoeba sp. (PA-016) was obtained from the Fish Health Unit, Mt. Pleasant 
Laboratories, Department of Primary Industry and Fisheries, Launceston. It was 
maintained on a bacterial 'lawn' of Pseudomonas maltophilia grown on malt and yeast 
extract seawater agar as described in section 2.2.1. 
Paramoeba culture: 
Most amoebae grow well on a solid phase substrate such as agar, particularly with 
an overlay of liquid. Malt extract, yeast extract 75% seawater agar is commonly used 
and recommended as a substrate for amoebae culture ( Kalinina and Page, 1992; 
Howard etal., 1993b). Martin (1985) compared suspension culture to solid substrate 
culture and found that Paramoeba pemaquidensis did not increase in number in 
suspension culture. This is consistent with findings with the causative agent of AGD 
(Howard and Carson 1991). 
Paramoeba was cultured according to the method described by Howard and 
Carson (1993b). Briefly, a medium consisted of malt and yeast extract seawater agar, 
comprising of 750 ml 0.2 1.1.m filtered seawater, 250 ml distilled water, 0.1 g malt 
extract, 0.1g yeast extract and 30 g agar (Oxoid No. 1) was prepared (steam autoclaved 
at 121°C for 20 minutes). Whilst the agar was cooling, at a temperature approximating 
60°C, 1 ml of 1% pimaricin (Sigma) L-1 as antifungal agent was added. The agar was 
then placed in 23 cm2 bioassay dishes (Nunc, Denmark). 
Plates were left to solidify overnight at room temperature, and were seeded with 2 
ml of a P. maltophilia suspension (-1.5 x 108 cells m1-1 ) in 0.2 inn filtered autoclaved 
seawater. The plates were then inoculated with 5 ml of amoeba suspension (-800 
amoebae cells) extracted from a 2-6 week old established culture 24 hours after the 
addition of bacteria. 
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Amoebae culture plates were sealed with cellophane tape to prevent evaporation 
and maintained in an incubator at 20°C. Subculturing was conducted every 4-6 weeks. 
Finally a dense Paramoeba suspension was harvested from the plates. 
Pseudomonas culture: 
Pure cultures of P. maltophilia obtained from Mt. Pleasant Animal Health 
Laboratories were grown in Oxoid nutrient broth No. 2, at 37°C. P. maltophilia was 
extracted from the broth after 48 hours incubation by centrifugation. The cells were 
subsequently washed with PBS, aliquoted and stored at 4°C. Fresh cultures of this 
bacterium were maintained throughout the experimental period by regular subculturing 
on sheep blood agar plates. 
Preparation of amoebic antigen: 
In order to produce antisera in sheep and a rabbit against Paramoeba sp. the 
following protocol was established. 
-Live Paramoeba (PA) from 3 plates were harvested with 3 ml of 0.211m filtered 
seawater for each plate using bent pasteur pipettes 'hockey sticks'. A total of 8 ml 
was harvested. 
-The suspension was divided into 4 tubes and then washed (4-5 volumes) in sterile 
filtered seawater by 3 centrifugation steps of 10 minutes at 500 g. Each time the 
supernatant was discarded (it contained most of the bacteria) and the pellet was 
resuspended again in the sterile seawater by vortexing. 
-The efficiency of bacterial removal was tested by direct microscopic examination (wet 
smear; 400 dines phase contrast) and by Gram stain. Still quite a few bacteria 
surrounded the Paramoeba and some within the amoebae. However, in each field 4- 
5 live Paramoeba existed in the final suspension. 
- A dense solution of washed cells were then frozen and thawed several times and 
sonicated for 3 minutes. A 3 ml suspension was further inactivated (0.5% formalin), 
left at 4°C and finally 50% v v -1 FCA was added and the solution was homogenised. 
- Protein content of the sonicated antigen was determined using a Lancer Microprotein 
rapid stat diagnostic kit. This test kit utilised Coomassie Brilliant Blue to attain a 
quantitative colorimetric determination of total protein. 
Preparation of crude antigen (wild PA) from diseased fish:  
Mucus from the gills of 40 severely infected Atlantic salmon was collected by 
scraping the gills. Normal saline was added to the suspension and homogenised. The 
suspension was filtered through glass wool and inactivated with 0.5% v v -1 formalin 
overnight. This crude vaccine was tested for sterility by culturing on blood agar, 
homogenised with 50% v v -1 FCA and kept frozen (-20°C) until used. 
160 
Animals  
Sheep: 
Two sheep were injected subcutaneously in the cervical area with a total of 3 ml of 
antigen [1.5 ml PA solution (containing approximately 1 mg protein) and 1.5 ml FCA 
per dose per sheep] . Four weeks later, sheep were boosted with the same amount of 
antigen, but in 50% v v -1 Freund's incomplete adjuvant. At the end of six weeks a large 
volume of blood was collected and the antiserum was collected and frozen at -20°C until 
used as described in section 2.4. The sheep response to PA was tested by both ELISA 
and immunofluorescent antibody assays. 
Rabbit: 
Rabbit antiserum was prepared as described by Howard and Carson (1991) with 
slight modification. Briefly, sonicated antigen obtained from 300,000 to 3 million 
Paramoeba was injected into the marginal ear vein of a New Zealand white rabbit by 
several injections (total inoculum = 1 mg protein) at 3-day intervals for 3 weeks. 
Antiserum was collected 21 days post-inoculation by complete exsanguination of the 
rabbit. Rabbit antiserum was tested by immunofluorescent antibody test for its activity 
and stored at -20°C for later use. 
Fish: 
1- In order to study the effect of the sonicated antigen (prepared from cultured 
Paramoeba sp.) in FCA on the humoral response of rainbow trout, twenty five fish 
(mean weight 127 g) from the Aquaculture Key Centre (AKC) were immunised with 1 
mg (protein concentration) of the sonicated antigen. 
2- In order to study the effect of the crude antigen in FCA on the humoral responses of 
Atlantic salmon, fifteen fish (mean weight 62 g) from AKC were used. 
3- For determination of the rate of clearance of sheep APA from fish sera, 100 Atlantic 
salmon, 50 fish from AKC (mean weight 62± 8.2) and 50 fish (mean weight 57± 7.0) 
from Salmon Enterprises of Tasmania (SALTAS) were used according to the 
experimental design given in Table 5.2.1. 
Fish were maintained in two 4000 L freshwater temperature control tanks at 15°C 
in recirculating biofilter systems at the Aquaculture Key Centre and fed daily with 
commercial trout pellets twice daily. Fish maintenance was the same as described in 
section 2.9. 
4- Control fish: Twenty five fish each of SALTAS and AKC origin were bled from the 
caudal vessels prior to the commencement of the experiment. Sera were harvested as 
described in section 2.4 and used as controls in the ELISA. 
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Table 5.2.1: Experimental design for monitoring the rate of clearance of sheep APA 
from fish sera 
Groups No. of 
fish* 
Treatment 
i.p. injection 
Blood collection 
1 week 4 weeks 8 weeks 
Control 40 PBS 20 20 20 
Hyper- 
immune 
serum 
60 0.1 ml sheep 
antiserum 
40 40 40 
Total number of fish (in two replicates)= 100 
Intraperitoneal injections 
1- Control group: Forty fish (20 from SALTAS and 20 from the Key Centre) were 
tagged, injected with PBS and kept in the tanks. 
2- Passive immunisation with anti -Paramoeba sp. hyperimmune serum prepared in 
sheep. 
Thirty fish (15 from SALTAS and 15 from the Key Centre) for replicate 1 in one 
tank and 30 fish (15 from SALTAS and 15 from the Key Centre) for replicate 2 were 
allocated for this group. Sheep APA antiserum was used for intraperitoneal injection of 
fish. Fish were injected (1 ml syringes, 25 G x 19 mm needles) with the hyperimmune 
serum at a rate of 0.1 ml 100g-1 fish body weight. The rate of elimination of sheep anti-
Paramoeba antiserum in fish body was monitored at one week, 4 weeks and 8 weeks 
post-immunisation. 
Immunisation of fish with crude antigen:  
Fifteen Atlantic salmon were injected with 0.5 ml of the crude antigen in FCA 
(wild Paramoeba sp.) in order to monitor their humoral response to this antigen. Fish 
were kept in temperature controlled (15°C) tanks and bled 6 weeks post-immunisation 
Immunological assays for detection of anti-Paramoeba sp.: 
An indirect fluorescent antibody test and an specific ELISA were employed to 
determine the antibody response of rabbit and sheep to Paramoeba. 
Immunofluorescent antibody test (IFAT): 
The immunofluorescent antibody test was employed as described by Howard and 
Carson (1991) . Briefly, Paramoeba smears were prepared from a culture plate and 
allowed to air dry. Smears were then fixed with 70% ethanol and air dried. Rabbit or 
sheep anti-Paramoeba antiserum (primary antibody), diluted to the appropriate 
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concentration in PBS was added. Slides were incubated for 60 minutes at 37°C in a 
moist chamber. They were rinsed for 5 minutes in PBS (repeated 3 times) and wiped 
dry. The secondary antibody, goat anti-rabbit or rabbit anti-sheep antiserum fluorescein 
isothiocyanate conjugated antibody (FITC) diluted at an optimal concentration in PBS 
was then applied. Slides were left to incubate for 60 minutes in a moist chamber. Slides 
were washed again in PBS and mounted in glycerine bicarbonate buffer, pH 9. Slides 
were observed by fluorescent microscopy for the presence of surface fluorescence of the 
Paramoeba sp. (Plate 5.2). 
ELISA:  
The ELISA used for detecting of antibodies against Paramoeba sp. was a 
modification of the ELISA described by (Bryant et al., 1994). The ELISAs employed 
in the detection of both sheep APA (by sheep ELISA) and fish APA (by fish ELISA) 
were as described in section 2.6.5. 
5.2.3 Results 
Immunofluorescent antibody test: 
The results of the IFAT on sheep anti-Paramoeba sp. were positive. Dilutions of 
1: 50, 1: 100 and 1: 250 were used from which a dilution of 1: 100 was optimal. 
Plate 5.2: Fluorescent antibody test of sheep anti-Parampeba antibodies, showing an 
intense yellow colour Paramoeba sp. cells; 1000 X (photo provided by courtesy of Ms 
Teresa Howard) 
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ELISA: 
Active immunisation: The results of ELISA for immunised sheep (pooled sera of 
sheep), rabbit and fish (pooled sera of rainbow trout) are shown in Table 5.2.2. Sheep 
responded, well to the sonicated antigen/ FCA . Rabbit showed a lower anti-Paramoeba 
antibodies level with 0.D = 0.821 (sonicated antigen) and rainbow trout showed an 0.D 
of no more than 0.421 when they were injected with the same antigens (sonicated PA + 
FCA). The ELISA 0.Ds for control sera of sheep, rabbit and fish were previously 
shown in Figure 2.6.5. 
Table 5.2.2: Humoral response of sheep, rabbit and fish (rainbow trout) to 
Paramoeba s . vaccines 
o .f us et ii?an Sheep (pooled sera) Rabbit Fish (pooled sera) Non-imm. Imm. Non-imm. Imm. Non-imm. Imm. 
1:64 0.174 2.401 0.145 0.821 0.145 0.421 
1: 128 0.156 2.341 0.153 0.701 0.146 0.354 
1:256 0.151 2.000 0.134 0.683 0.123 0.387 
1:512 0.145 1.921 0.131 0.434 0.132 0.254 
1: 1024 0.133 1.653 0.099 0.241 0.111 0.183 
1: 2048 0.123 1.324 0.098 0.171 0.095 0.101 
1: 4096 0.121 1.245 0.074 0.149 0.119 0.098 
Non-imm.= Non- immune serum 	Imm.= Immune anti-Paramoeba serum 
Atlantic salmon: Atlantic salmon injected with formalin killed wild PA + FCA 
developed a significant antibody level at six weeks post-immunisation (mean ELISA 
0.D = 0.452). Only 40% of fish were seropositive and the rest of fish were 
seronegative (Table 5.2.3). 
Table 5.2.3: Humoral response of Atlantic salmon to crude Paramoeba vaccine at 6 
weeks post-immunisation 
Immunised 	No. 	Percentage of 	ELISA 0.D  
Atlantic salmon of fish 	seropositive mean ± S.E. Maximum 	minimum 
Wild 
PA/ FCA 	15 	40 	0.452a± 0.096 1.324 	0.075 
Control fish 	25 	 0.092b±.0.037 0.142 	0.078 
(AKC naive fish) 
Means with the same superscript are not significantly different (P<0.05). 
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Passive immunisation: The rate of clearance of sheep APA from Atlantic salmon sera 
(mean ELISA 0.D± S.E. of SALTAS and AKC fish) is shown in Figure 5.2.1. Sheep 
APA had a high level (0.D = 0.682± 0.053) at one week post-immunisation. These 
antibodies declined rapidly to 4 weeks then gradually to 8 weeks post-immunisation. 
Weeks post-immunisation 
Figure 5.2.1: Rate of clearance of sheep APA from Atlantic salmon sera for up 
to 8 weeks post-immunisation from fish sera 
5.5.4 Discussion: 
Sheep, rabbit and fish developed humoral antibody when they were immunised 
with Paramoeba sp. vaccines (Table 5.2.2). 
When sheep APA were injected intraperitoneally into Atlantic salmon to passively 
immunise fish, it was shown that these antibodies were long lasting (up to 8 weeks) 
(measured by sheep ELISA in fish sera). Therefore, the persistence of these antibodies 
can provide fish with passive immunity if the specific immunity proves to be protective. 
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5.3 Experiment II Evaluation of protection (paramoebiasis) 
5.3.1 Introduction and Aims: 
This experiment was conducted in order to evaluate the effectiveness of passive 
immunisation (passively transferred antisera into fish) and active immunisation against 
AGD. Aims were as follows: 
-To demonstrate protection against AGD as a result of injecting the anti-Paramoeba 
antisera into fish and challenge the fish by cohabitation with AGD infected fish. 
- To immunise fish actively with live and sonicated Paramoeba sp. and challenge them 
to investigate the effectiveness of this immunisation. 
- To evaluate the efficacy of a crude vaccine (wild Paramoeba sp.) against the disease. 
5.3.2 Materials and Methods 
Preparation of antigens: 
Antigens were prepared as described in section 5.2.2. 
Preparation of sheep and rabbit anti-Paramoeba sp. sera:  
Sheep and rabbit anti-Paramoeba sp. sera were prepared as described in section 
5.2.2. 
Preparation of crude (wild Paramoeba sp.) antigen from diseased fish: 
This antigen was prepared as described in section 5.2.2. 
Trial 1- A total of 640 Atlantic salmon, 320 Atlantic salmon "smolt" (brought from 
Wayatinah; SALTAS freshwater operation, (mean weight 57±7.0 g) and 320 Atlantic 
salmon "smolt" from the Aquaculture Key Centre (mean weight 62±8.2 g, the same 
stock of fish used for experiment I section 5.2) were used for evaluation of protection 
following passive and active immunisation. 
Fish were maintained in two 4000 L freshwater temperature control tanks at 16°C 
in recirculating biofilter systems at the Aquaculture Key Centre and fed daily with 
commercial trout pellets (Gibson) twice daily. 
All fish used in this study were previously unexposed (naive) to paramoebiasis. 
The experimental design for protective value of hyperimmune sera and vaccination with 
different Paramoeba antigens is shown in Table 5.3.1. Forty fish (20 from SALTAS 
and 20 from AKC) for replicate 1 in one tank and 40 fish (20 from SALTAS and 20 
from the Key Centre) for replicate 2 were allocated for each group. 
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Table 5.3.1: Experimental design for protection trial (paramoebiasis) 
Groups No. of 
fish* 
Treatment 
i.p. injection 
Exposure to 
fish infected with Paramoeba sp. 
1st 	2nd 
Control 80 PBS 1 month 45 days 
Hyper-immune 
serum 
80 0.1 ml sheep 
antiserum 
1 month 45 days 
Hyper-immune 
serum 
80 0.1 ml rabbit 
antiserum 
1 month 45 days 
OLive PA 
injection 
80 3800 live 
PA in 0.1 ml 
1 month 45 days 
0Sonicated PA 
in PBS 
80 1 mg sonicated 
P.A antigen 
1 month 45 days 
(protein content) 
0SonicatetIPA 
in PBS 
80 10 mg sonicated 
P.A antigen 
1 month 45 days 
(protein content) 
0Sonicated PA 
in FCA 
80 1 mg sonicated 
P.A antigen 
1 month 45 days 
(protein content) 
0Sonicatal PA 
in FCA 
80 10 mg sonicated 
P.A antigen 
1 month 45 days 
(protein content) 
Total number of fish (in two replicates)= 640 
* In each group 40 Atlantic salmon from SALTAS and 40 fish from the Key Centre. 
0 From studies undertaken in collaboration with Ms Kirsten Rough, MAppSc 
candidate. 
All fish were starved 12 hours before commencement of the experiment, then 
anaesthetised before tagging or/and any treatment. 
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Intraperitoneal injections: 
1- Control group: Fish were injected intraperitoneally with 0.1 PBS as described in 
section 5.2.2. 
2- Passive immunisation with sheep anti-Paramoeba sp. hyperimmune serum prepared 
in sheep and rabbit. 
Sheep and rabbit antisera were used for intraperitoneal administration into fish. 
Fish were injected with the hyperimmune serum at a rate of 0.1 ml 100g -1 fish body 
weight as described in section 5.2.2. 
3- Live Paramoeba: A pellet of Paramoeba was resuspended in the solution of 1% 
carbenicillin disodium salt (Sigma No. C-1389) in sterile seawater by vortexing gently 
and left to stand for 2 hours. The suspension was centrifuged (500 g) and the pellet 
was resuspended in sterile seawater. Paramoeba densities were determined by counting 
cells using a Neubauer haemocytometer, adjusted and suspended in 0.2 p.m filtered sea 
water so that 0.1 ml of solution of 8 x 104 amoebae was injected intraperitoneally to 
each fish. 
4- Sonicated Paramoeba with adjuvants: A cell count of washed Paramoeba was 
performed then an ultrasonic machine was used to disrupt the cell membrane. The 
suspension was filtered through an 0.2 p. filter and its protein content was determined 
(protein concentration 163 [ig m1 -1 ). Different protein contents were prepared containing 
1 mg and 10 mg with and without 50% v v -1 FCA. This solution was administered 
according to the experimental design by i.p. injection of 0.1 ml into each fish (Table 
5.3.1). 
Fish were randomly divided in two groups. All were weighed and individually 
tagged. 
Fish were acclimatised to seawater 15 days before cohabitation (from 15 days 
post-immunisation) with the diseased fish. After one month post-immunisation fish 
were cohabited with 50 infected fish (25 for each tank) and water temperature was 
maintained at 18°C. Since Paramoeba sp. could not be detected up to two weeks after 
cohabitation another batch of infected large fish (5 fish) were placed in each tank. After 
one week, fish started to show clinical signs. 
Mortalities were sampled for gill samples twice a day for histopathological survey. 
The temperature was maintained at 18°C. 
Trial 2- Immunisation of Atlantic salmon with the crude vaccine: 
Forty Atlantic salmon were injected i.p. with the crude antigen in the freshwater 
operation unit of SALTAS (Wayatinah). These fish were cohabited with infested fish 
with Paramoeba sp. at Dover (sea culture operation) two and a half months later for 
determination of the protection efficacy of the crude vaccine. 
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ELISA:  
An ELISAs were run to monitor the humoral response of experimentally and 
naturally infected fish to Paramoeba sp. as described in section 5.2.2. 
Immunisation 	 first challenge 	2nd challenge 	Blood 
(i.p. injection) 1 month (unsuccessful) collection 
(Time 0) 	30 days 	 45 days 	60 days_ 
320 fish ( Atlantic salmon) 	challenged 	>challenged—v.(B.C) 
from SALTAS 
320 fish ( Atlantic salmon)-->challenged 	>challenged--p(B.C) 
from the Aquaculture 
Key Centre 
40 fish (Atlantic salmon) 	>challenged 2.5 months post immunisation 
from SALTAS 
(Wayatinah) 
(crude antigen) 
52 fish (Atlantic salmon)—.Blood collection for serology 
2-year old fish 	 (ELISA) 
(naturally infected in sea cages) 
40 fish (Atlantic salmon)—.Blood collection for control sera 
(Naive fish, control fish) 	in ELISA 
(as described in section 5.2.2) 
B.C= blood collection+ gill samples for histopathology 
Figure 5.3.1: Flow diagram showing the time of immunisation, challenge and blood 
collection for serology of the experimental fish 
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Trial 3: Detection of local antibody (using ELISA) from mucus collected by perfusing 
gills  
Gill mucus samples supplied by Ms. Venessa Findlay had been prepared as 
follows: Gills of 10 Atlantic salmon (mean weight 200g), experimentally infected with 
AGD for 3-6 weeks were perfused and the mucus was extracted according to the 
method described by Lumsden et al. (1993). Mucus was extracted in the same way from 
six naive fish. Sera were also collected from these fish. 
5.3.3 Results 
Protection:  
Trial 1- No disease fish infested with Paramoeba was observed up to 15 days post-
cohabitation (first exposure). It was assumed that the donor fish infestation had not 
persisted. Therefore, another stock of diseased fish was obtained and placed with the 
experimental fish at 45 days post-immunisation. From one week after cohabitation 
(second exposure) fish showed considerable mortality. Paramoeba were detected on the 
gills of almost all exposed fish. The temperature was decreased to 16°C. However, 
amoebic gill disease appeared in an outbreak form (morbidity= 100%) and rendered the 
evaluation of protection unreliable. Gill samples were collected to assess the infestation 
of the parasite quantitatively in order to attempt to draw a conclusion on protection. 
However, all fish showed severe gill patches, therefore the assessment was ineffective. 
Trial 2- Forty Atlantic salmon vaccinated with the crude antigen (wild Paramoeba sp.) 
did not show any significant serological differences in comparison with those injected 
with laboratory cultured Paramoeba sp. These fish were challenged two and a half 
months post-immunisation in cohabitation with diseased fish. All the fish showed gross 
lesions of paramoebiasis and Paramoeba sp. was detected in almost all samples. 
ELISA: 
Two weeks after effective cohabitation exposure, survivors, which in fact were 
suffering severely from the disease, were euthanised for collection of gill samples for 
histopathology (in Davidson's fixative) and blood samples for serology. Antibody 
levels of fish as a result of the experimental infection after 2 weeks exposure to AGD are 
shown in Table 5.3.2. 
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Table 5.3.2: Humoral response of Atlantic salmon to the experimental infection 
with Paramoeba sp. 
Groups 	No. of fish 
of fish in two 
replicates 
% 
seropositive 
ELISA 0.D of responders 
mean ± S.E. 	Maximum Minimum 
Control 	 32 
(exposed) 
50 0.298abd±0.032 0.343 0.072 
Sheep hyper- 
immune serum 
35 45 0.345±0. 111 0.486 0.086 
Rabbit hyper- 
immune 
serum 
40 44 0.256a ±0.057 0.329 0.088 
Live P.A 
injection 
26 53 0.341bd±0.039 0.421 0.0113 
Sonicated(1 mg) 20 58 0.299abd±0.067 0.411 0.142 
P.A in PBS 
Sonicated(10 mg) 42 46 0.234a ±0.042 0.501 0.123 
P.A in PBS 
Sonicated(1 mg) 29 38 0.354 1 	+0.057 0.451 0.141 
P.A in FCA 
Sonicated(10 mg) 37 49 0.365bd ±0.023 0.467 0.086 
P.A in FCA 
Control fish (naive) 
(SALTAS and 50 - 0.101c ±0.041 0.078 0.142 
AKC fish, mean 
ELISA 0.D) 
Means with the same superscript are not significantly different (P<0.05) 
Results of histopathology of gills collected from mortalities are as follows: No 
Paramoeba or lesions were observed in the gill samples taken from the small number of 
mortalities after the first cohabitation indicating the absence of paramoebiasis. Gill 
samples collected seven to fourteen days after the second cohabitation (exposure to the 
second batch of infected fish), showed infestation with Paramoeba sp. and had mainly 
moderate to severe lesions. 
Both naturally and experimentally infected fish had significantly higher antibody 
levels than control. There was no significant difference in antibody levels between these 
groups. However, the percentage of seropositive fish in the experimentally infected 
group was higher than in the naturally infected group (Table 5.3.3) 
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Trial 3- The ELISA results measuring the gill mucus antibody of the fish infected with 
Paramoeba sp. antigens were all negative. Eighteen per cent of these fish showed 
seropositive in the ELISA (Table 5.3.3). 
Table 5.3.3: Comparative data for the immunological responses of fish exposed (or 
not exposed) to Paramoeba sp. by a variety of means 
Naturally 
infected fish 
No. 
of fish 
Percentage of 
seropositive 
ELISA 0.D of responders 
mean ± S.E. 	Maximum 	minimum 
Natural infection 
(prolonged) 52 (s) 35 0.354a± 0.123 0.865 0.089 
Natural infection 
(short) 
8 (s) 25 0.192b± 0.095 0.219 0.091 
Severe 
experimental 
infection 
261*(s) 48 0.297a±0.098 0.231 0.111 
(2 weeks) 
Moderate 
Experimental 11**(s) 18 0.207a±0.112 0.231 0.108 
infection 10(m) 0 ()123b±0096 0.132 0.106 
(3 weeks) 
Control fish 
(naive) 50(s) 0.101b±0.041 0.142 - 	0.078 
6 (m) 0.116b± 0.036 0.127 0.091 
* collected sera from survivors of experimentally challenged fish (Table 5.3.1, 640 
fish). 
** collected sera from Trial 3. s= serum, m= mucus. 
Means with the same superscript are not significantly different (P<0.05) 
5.3.4 Discussion 
Not all sera of presumed naturally-infected fish appeared to be seropositive (only 
35% seropositive). Similarly, experimentally infected fish did not show a high response 
either, even though the percentage of seropositive in this group was higher (48%) than 
those naturally infected. This is consistent with the results of Grayson etal. (1991) who 
reported that Atlantic salmon can produce antibodies to artificially injected 
Lepeophtheirus salmonis (salmon louse) components, but naturally infected Atlantic 
salmon and rainbow trout did not similarly respond. It is clear that short term infection 
of naive fish can stimulate the humoral immune system. Perhaps long term infestation, 
particularly with small number of Paramoeba on the gill may produce immune tolerance. 
However, the observed unresponsiveness still remains unresolved. 
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No significant difference was observed between the antibody levels of fish 
naturally and experimentally infected fish with paramoebiasis. Thus, long exposure of 
fish does not seem to stimulate an enhanced immune response. 
Despite the above limitations, fish ELISA results monitoring the antibody levels of 
fish exposed to Paramoeba antigens are promising for diagnostic purposes. 
Cohabitation with presumed diseased fish did not produce the disease at the first 
attempt. However, a second batch of infected fish produced severe AGD. It is possible 
that the first batch did not carry many Paramoeba sp. on their gills possibly due to the 
development of immunity during the long course of infection. 
Passively and actively immunised fish that were experimentally infected by 
cohabitation, showed humoral antibody response (measured by ELISA) to Paramoeba 
in a period of two weeks after exposure to Paramoeba sp. (Table 5.3.3). The humoral 
responses of these fish were significantly different from those of control fish (naive 
fish). This concludes that fish humoral antibody can be induced by a heavy AGD 
infection. 
Some groups of the exposed fish which previously were immunised, showed 
significant differences with each other in antibody levels post-cohabitation (Table 
5.3.2). This could be due to injection of antigen with adjuvant when they were 
immunised before cohabitation and the possible effect of adjuvant on their humoral 
responses. However this pattern was not consistent between groups of fish i.e live PA 
treated and sheep APA treated fish showed almost the same antibody level as sonicated 
P.A with FCA treated fish. 
Crude antigen (wild Paramoeba sp.) harvested directly from infected fish was not 
superior antigenically from vaccines produced from cultured organisms. Fish 
immunised with this antigen died gradually when they were cohabited with infected fish 
two and a half months post-immunisation. Administration of this crude antigen with 
FCA into Atlantic salmon did not change the unresponsiveness status of non-responding 
fish (60% of vaccinated fish were seronegative). Since the most probable reason for 
lack of immunity when cultured Paramoeba was used, was thought to be the absence of 
virulence factors in the cultured organisms it is difficult to explain why a crude vaccine 
containing antigens from virulent organisms did not work. It was shown from findings 
of Lumsden et al. (1994) who injected (i.p. with 0.1 ml) and immersed rainbow trout 
(in a 1: 10 dilution) of acetone-killed Flavobacterium branchiophilum that the level of 
antibody to the bacterium was highest in the i.p. injected group. However, the percent 
cumulative mortality was 32.1, 11.7 or 45.3% in i.p. injected, immersed and control 
fish respectively. The i.p. injected group had the highest serum antibody levels, while 
bath exposure to the highest concentration of killed bacteria produced the highest gill-
associated antibody levels. Therefore, gill associated antibodies might be the main 
protective value in immersion vaccinated fish especially against diseases which cause 
surface infections of gills. 
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Regarding the lack of protectiveness of mammalian sera in combating 
paramoebiasis, it should not be forgotten that in cohabitation, 100% mobidity was not 
expected. With such a high mortality level it is difficult to assess the protection efficacy. 
The results of this study indicate that systemic antibody is possibly less important 
for protection from AGD if the organism infect gill tissues. Therefore, local immune 
response may play an important role in naturally infected fish. However, local antibody 
to PA could not be detected by using ELISA (Table 5.3.3). 
The results obtained in this investigation have considerable potential value in 
relation to future immunisation trials, protection experiments and immunological assays. 
Further work is required to elucidate immunological aspects of AGD, possibly 
determination of antigenic components of Paramoeba sp. and genetic engineering may 
help to improve vaccines and/ or by manipulating the Paramoeba to deplete its virulence 
in near future to overcome such a problematic and important fish disease. 
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CHAPTER 6.0 
GENERAL DISCUSSION AND CONCLUSIONS 
Studies on the use of antisera to protect fish from vibriosis were pioneered by 
Harrell et a/. (1975) and Viele et al. (1980) who reported considerable protection from 
immune fish and rabbit AVA against vibriosis; since then studies have been sporadic. 
A great deal of effort has been expended to investigate the use of mammalian 
antisera against A. salmonicida with encouraging results. The most significant study 
on passive immunisation (of speckled trout and Atlantic salmon) is the report of 
Turgeon and Elazhary (1992) with an anti-A. salmonicida produced in mammals. 
However, the details of the antisera used in that report have not been released. 
Preliminary work of Cipriano (1981) on transferring rabbit and salmonid fish 
anti-A. salmonicida Ig to rainbow trout and Atlantic salmon suggested that only fish Ig 
provided protective immunity. Rabbit antisera failed to provide protective immunity 
to fish. 
The work of other people (Table 1.1) regarding the protectiveness of immune 
sera against fish diseases i.e furunculosis, edwardsiellosis, pseudotuberculosis and 
yersiniosis has shown variable results. However, some reports have been encouraging 
in relation to passive immunisation as a tool to control some fish diseases. 
In the present study, the longevities of sheep and rabbit anti-V. anguillarum 
antisera up to 70 days were well demonstrated (using ELISA) and such persistence has 
not been reported before. Protection rate of these antisera at one month post-
immunisation exceeded 90 and 86% survival rate in groups of fish vaccinated with 
sheep and rabbit AVA respectively. In another group that received fish AVA, the 
survival rate was somewhat less (RPS= 40%) but all groups were protected against 
acute vibriosis (Table 6.1). 
Table 6.1: Relative per cent of survival after challenge in fish immunised 
passively and actively against vibriosis 
Type of 1 month 2 months 3 months 
immunisation (-D75) (1_,D80) (-1373) 
Sheep AVA 93.3% 25% 13.3% 
Rabbit AVA 86.6% 18.7% 4.1% 
Fish AVA 40% 12.5% 9% 
(Active immunisation) 
Immersion 86.6% 93% 81.8% 
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Two months after immunisation, in a strong challenge (LD80), the protection 
value of different sera declined, but that of immersion vaccinated group was still 
significant (RPS= 93%). Three months post-immunisation, only sheep AVA showed a 
marginal protection for fish (Table 6.1). 
Immersion vaccinated fish showed marked protection. The survival rates in 
these experiments are consistent with other reports e.g. Hastein and Refsti (1986) 
reported only 3.5, 4.6, 6.7% mortality almost 3 months after active immunisation with 
immersion challenges of LD of 41, 54.6 and 61.7 per cent respectively. Amend and 
Johnson (1981), reported 0-7.5% mortality after one month of immersion vaccinated 
fish with immersion challenges of 1.7x10 5 cfu m14 and 8.4x105 cfu m14 respectively. 
Horne et al. (1982) reported 53% mortality at a 85 days post-vaccination challenge 
(2x107 viable cells for challenge) at a low water temperature(6-11°C). 
With injected Vibrio antigens, agglutinating antibody titres are readily detected 
and titres are closely associated with protection (Harrell et al., 1975). In contrast, 
vaccination by immersion or orally rarely result in demonstrable agglutinating titres. 
In this work these titres were monitored by ELISA (Figure 3.4.2). Nevertheless, 
despite the short period that antibodies could be detected in fish sera after immersion 
vaccination (1 month), a RPS of 81.8% was found 3 months post-immunisation. This 
explains why immersion vaccination of fish against vibriosis has been successful in 
practice all around the world. This could be due to the fact that non-specific responses 
or cell mediated immunity may have been activated with immersion vaccination. More 
research is required to elucidate this. 
For passive immunisation, protection appeared to be associated with specific 
antibodies and not non-specific components i.e a) protection correlated with the level 
of specific antibody and as sheep AVA level declined in fish sera, the protection rate 
dropped, b) complement did not appear to be involved, because immune serum 
(complement inactivated, by 30 min at 56°C) was as protective as whole immune 
serum (with complement), c) non-immune sera (complement inactivated and with 
complement) injected i.p. into fish could not confer protection against vibriosis. A 
possible explanation for the difference of these results and results of Ellis et al. 
(1988) who showed that the animals supplying the non-immune sera in that study 
were injected with FCA whereas the one supplying the non-immune sera in this study 
were not so injected. 
In this study, the feasibility of using passive immunisation with sheep and rabbit 
Ig as a protective measure and a medical treatment for vibriosis in cultured rainbow 
trout was encouraging. The maximum concentration of passive Ig in fish serum 
occurred during the first 24 hours after immunisation, but levels could be detected for 
more than three months (sheep and rabbit AVA) as measured by ELISA. Sheep and 
rabbit as well as fish hyperimmune sera made against V.anguillarum appears useful 
for passive protection of particularly valuable fish during those months when vibriosis 
is prevalent. 
176 
Furthermore, the induction of an active immune response in fish takes some time 
depending on the ambient water temperature (not less than a week or weeks from 
results of Atlantic salmon immunised and tested after one week in this study) and, 
therefore, fish vaccinated in transport tanks arriving at a site where an immediate 
epizootic is expected, will not be immune to the disease. Thus, passive immunisation 
is a real potential application especially as it has a relatively long therapeutic effect if 
it is used at strategic points. 
Oral delivery of AVA to rainbow trout using protein-G purified antiserum 
prepared in sheep and purified antibodies conjugated to LTB as protein carrier was 
promising. As LTB by itself had no protective efficacy, it was presumed that 
protection was associated with specific antibodies bound to receptors at key sites such 
as the spleen, liver and kidney. It seems that the future of oral immunisation for fish is 
promising. 
With respect to the results obtained from streptococcosis trials, it is obvious that 
this is the first time that such a work on aspects of passive immunisation of fish 
against the disease has been carried out. 
In this study, the possibility of using passive immunisation with sheep and 
rabbit immunoglobulins as a protective measure and a medical treatment for 
streptococcosis in cultured rainbow trout was investigated. It is clear now that the use 
of antisera specific to the pathogenic organism, particularly the use of mammalian 
antisera is encouraging. Longevity of sheep ASA was not less than 75 days post-
immunisation. Survival rates for 30 days challenge of fish immunised passively with 
sheep and rabbit ASA, were not less than 50% and sheep ASA protected fish 
moderately (RPS= 33.33%) up to 2 months post-immunisation (Table 6.2). Therefore, 
it can be concluded that passive immunisation of fish against streptococcosis with Ig is 
highly effective for at least one to two months after immunisation especially as Ig 
appears in fish sera within several hours after immunisation. 
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Table 6.2: Relative per cent of survival after challenge in fish immunised 
passively and actively against streptococcosis 
Type of 1 month 2 months 3 months 
immunisation (-D75) (LD85) (LD62.5 ) 
Sheep ASA 88.8% 33.3% 13.3% 
Rabbit ASA 50% 6.8% 0% 
Fish ASA 0% 6.8% 6.6% 
(Active immunisation) 
Immersion 	11.1% 4.7% 0% 
Injection 88.8% 38.1% 36% 
Regarding injection immunisation with 1 mg formalin killed bacteria (dry 
weight), the survival rates in these experiments are consistent with other reports (Iida 
et al., 1981) who reported that intraperitoneal injection, hyperosmotic infiltration and 
oral administration were effective in yellowtail vaccinated against alpha-haemolytic 
Streptococcus sp. Nevertheless, efficacy of oral vaccination using both dry and wet 
bacterin was prolonged for only two weeks after the last vaccination. The efficacy 
became more effective with an increase in frequency of oral vaccination. From this 
study, the effectiveness of active immunisation against streptococcosis with the agent 
of Streptococcus sp. (biovar 1), has been reported for the first time. 
Vaccination as a control measure against streptococcosis has been recommended 
(Iida etal., 1981, Kusuda and Takagi, 1983). Sakai etal. (1987) in a study vaccinated 
rainbow trout against B-haemolytic streptococcal disease. They used formalin killed 
cells (bacterin) and toxoid with and without Freund's complete adjuvant 
intraperitoneally, by immersion and oral delivery of the bacterin. Their results showed 
70% protection to fish following challenge with the live bacteria. Nevertheless, anti-
Streptococcus sp. agglutination antibody titres were low in intraperitoneally 
immunised fish and not detectable agglutinating antibody was demonstrated following 
the immersion and oral immunisation route. 
In comparison between injection vaccination and immersion administration the 
latter appeared the least effective although the level of protection may be acceptable in 
commercial operations when off set against the lack of stress and handling involved. 
With regard to the Paramoeba immunisation and protection trial, passively and 
actively immunised fish that were experimentally infected by cohabitation, showed 
humoral antibody response (measured by ELISA) to Paramoeba in a period of two 
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weeks after exposure to Paramoeba sp. Crude antigen (wild Paramoeba sp.) harvested 
directly from infected fish was not superior antigenically to vaccines produced from 
cultured organisms. Fish immunised with this "wild" antigen died gradually when they 
were cohabited with infected fish two and a half month after immunisation. The most 
probable explanation for lack of immunity when cultured Paramoeba was used, was 
thought to be the absence of virulence factors in the cultured organisms. It is difficult 
to explain why a crude vaccine containing antigens from virulent organisms did not 
work. However, it is possible that the antigenic determinants in the crude antigen was 
covered by gill tissue components in this vaccine. Furthermore, it is shown that high 
serum antibody level against F. branchlophilum do not relate to the degree of 
protection against the experimental disease (Lumsden et al., 1994) and the same 
situation could well apply with Paramoeba sp. Further research is needed to elucidate 
this. 
Regarding the lack of protectiveness of mammalian sera in combating 
paramoebiasis, it should not be forgotten that in cohabitation, 100% morbidity was not 
expected. With such a high mortality level it is difficult to assess the protection 
efficacy. Despite the above limitations, fish ELISA results monitoring the antibody 
levels of fish exposed to Paramoeba antigens were promising in detecting fish 
antibody due to the disease for diagnostic purposes. 
No significant difference was observed between the antibody levels of naturally 
and experimentally infected fish with paramoebiasis. Thus, long exposure of fish does 
not seem to stimulate an enhanced immune response. Therefore, the results obtained 
from Paramoeba trial investigation have considerable potential value in relation to 
future immunisation trials, protection experiments and immunological assays. Further 
work is required to elucidate immunological aspects of AGD, possibly determination 
of antigenic components of Paramoeba sp., local antibody production in gill tissues 
and secretions (by immersion vaccination) and genetic engineering may help to 
improve vaccines and/ or by manipulating the Paramoeba to deplete its virulence in 
future to overcome such a problematic and important fish disease. 
Generally, hyperimmune sera act as antimicrobials, but, unlike antibiotics that 
usually last 10 days or less, hyperimmune sera provide protection for 22 to 359 days 
against furunculosis and other diseases. As they are immunoglobulins, there is no 
danger of resistance development, residue problems, or the need for withdrawal times 
(Turgeon and Elazhary, 1992). 
Production of engineered antibodies for therapy is under investigation (Adair, 
1992). The biotechnology industry is beginning to furnish these products. The 
production of antibodies, in particular monoclonal antibodies may play a vital role in 
the future of therapeutic against infectious and non-infectious diseases. 
Regarding the cost of preparation of hyperimmune sera in mammals or on tissue 
cultures against fish pathogens and comparing the cost of bacterins for vaccination of 
fish against infectious diseases of fish, it can be concluded that passive immunisation 
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is cost-effective. Since each fish can be immunised with a small amount of immune 
serum (0.1 ml), therefore thousands of fish can be immunised by 1 litre of serum 
prepared in a mammal. 
It is obvious from this study that passive immunisation has a significant potential 
when given to the fish at strategic points where there is not enough time for active 
vaccination. Thus, there should be a future for the use of mammalian hyperimmune 
sera or genetic engineered antibodies against fish diseases, in particular, those for 
which an optimum immunity by active immunisation is not available. 
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Summary of the Thesis 
Passive immunisation of fish was carried out to determine whether anti-Vibrio 
anguillarum antibodies (AVA), anti-Streptococcus sp. (anti streptococcal) antibodies 
(ASA), and anti -Paramoeba sp. antibodies (APA) produced in sheep, rabbits and fish 
were persistent and biologically active in fish. Results of passive immunisation were 
compared with results of active immunisation in which fish were immunised by 
immersion and injection with formalin-killed cells. Assessments of passive and active 
immunisation were carried out concurrently for up to three months in order to 
demonstrate their relative efficacies and, especially, to evaluate the practical potential 
of passive vaccination. 
Experiments were conducted to determine the rate of clearance of sheep, rabbit 
and fish AVA levels, from the sera of rainbow tout (Oncorhynchus mykiss, Walbaum) 
at various periods after an intraperitoneal (i.p.) injection. A sensitive enzyme-linked 
immunosorbent assay (ELISA) was employed to detect longevity of the transferred 
antibodies. Results showed that the peak antibody level of sheep AVA appeared at 2 
hours (h) and rabbit and fish AVA at 6 h after immunisation. Both rabbit and sheep 
antibodies persisted for up to 70 days in fish sera after an i.p. injection, whereas fish 
antibodies persisted no more than 35 days. 
When the level of antibodies (sheep and rabbit AVA) from passive 
immunisation were compared with antibodies produced endogenously after active 
immunisation, it was found that the ELISA optical densities at 3-8 weeks after 
immunisation were very similar in fish immunised by either means. However, the 
actively-immunised fish maintained their antibody level while the passively-
immunised fish progressively lost theirs. 
Passive and active immunisation of Atlantic salmon (SaImo salar) against V. 
anguillarum were carried out and assessed 4 and 6 weeks after immunisation. Both 
passively and actively immunised Atlantic salmon showed antibody levels similar to 
those of rainbow trout. 
Studies were also undertaken to monitor the immune responses to the 
heterologous (sheep and rabbit) sera. Using specific ELISA's against these sera, anti-
sheep and anti-rabbit serum antibodies were detected in fish sera with the greater 
response being to the rabbit serum. However, even when multiple doses of 
heterologous sera were used there was no clinical evidence of anaphylaxis. 
Relative levels of protective immunity were determined by i.p. challenge of fish 
with virulent V. anguillarum. Regarding the protective value of anti-Vibrio antibodies, 
sheep AVA significantly protected rainbow trout one month post-immunisation, 
moderately at 2 months and marginally at three months. The relative percent survival 
(RPS) of challenged fish after an i.p. injection of sheep, rabbit or fish AVA was 93.3, 
86.6, 40.0 at one month (75% mortality in non-immunised control group = MNICG); 
25, 18.7, 12.5 at two months (80% MNICG) and 13.3, 4.1, 9.0 at three months (73% 
MNICG) post-immunisation respectively. Fish actively immunised by immersion 
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showed RPS of 86.6, 93.0, and 81.8 after one, two and three months post-
immunisation in the same trials respectively. 
In order to obtain equivalent protection to undiluted fish serum, rabbit and sheep 
sera had to be diluted 1: 8 and 1: 50 respectively. 
Protection conferred by immune sera was shown to be due to the specific 
antibodies alone. Sheep and rabbit AVA sera were purified by affinity 
chromatography using protein G and protein A respectively and were demonstrated to 
have equivalent protective effect to the whole antisera in rainbow trout. Also heat 
treatment of sera to inactivate complement had no effect on the potency of either 
immune or non-immune sera. 
Oral delivery of AVA to rainbow trout was attempted using protein G purified 
antiserum prepared in sheep and purified antibodies conjugated to the carriers Quil A, 
TraT (immuno-stimulatory carriers, an internal membrane of E. coli) and LTB (the 
GM-1-binding subunit of E. coil heat-labile toxin). No AVA were detected at 24 h, 7 
days, 30 days, and 60 days after dosing. However, fish dosed with AVA conjugated to 
LTB had a relative percentage survival of 37.5% at 15 days after dosing and 27% after 
one month. As LTB by itself had no protection effect, it was presumed that protection 
was associated with specific antibodies bound to receptors at key sites such as the 
spleen, liver and kidney. Fish response to sheep AVA and also to Quil A, TraT and 
LTB as immunostimulants was determined using specific ELISAs. No significant fish 
response to either the sheep antisera or the immunostimulants was observed. 
In the second approach of the research the clearance rates of sheep, rabbit and 
fish anti-streptococcal antibodies from rainbow trout were monitored. A sensitive 
ELISA was developed to detect longevity of transferred antibodies. Results showed 
that sheep antibodies in rainbow trout sera were more persistent than rabbit antibodies. 
The peak antibody level of sheep and rabbit ASA in the circulation was at 24 h after 
passive immunisation. Sheep antibodies persisted well up to 60 days, but were present 
at a lower level at 75 days. Rabbit antibodies persisted up to one month after an i.p. 
injection while fish antibodies could not be detected at 6 h post-immunisation. A 
similar trend for anti-Streptococcus sp. antibody was observed when it was compared 
with anti-Vibrio antibody. Both sheep and rabbit ASA showed marked persistence. 
Rainbow trout immunised against Streptococcus sp. with formalin-killed cells 
by an i.p. injection had a detectable antibody level at 6 weeks after immunisation, but 
the response in immersion-vaccinated fish was not detectable. 
Anti-streptococcal antibodies prepared in sheep and rabbits significantly 
protected fish against streptococcosis at one month after immunisation, moderately (in 
the case of sheep) at two months and marginally (also in the case of sheep) after three 
months. The relative percent survival of challenged fish after an i.p. injection of sheep, 
rabbit and fish ASA was 88.8, 50.0, 0.0 after one month (75% mortality in non-
Immunised control group = MNICG, 32-42 cfu of Streptococcus sp.); 33.3, 6.8, 6.8 
after two months (85% MNICG, 55-65 cfu of Streptococcus sp.) and 13.3, 0.0, 6.6 
182 
after three months (62.5% MNICG, 4-7 cfu of Streptococcus sp.) post-immunisation 
respectively. 
Results showed that fish immunised by i.p. injection using formalin-killed 
Streptococcus sp. cells had a high level of resistance. However, those immersed in the 
bacterin had very low or no protection. The relative percent survival for injected and 
immersed fish was 88.8 and 11.1 after one month, 38.1 and 4.7 after two months 36.0 
and 0.0 after three months post-immunisation. 
Thus, passive immunisation shows potential for protection against such a disease 
as it gives similar results to injection vaccination and would be expected to provide 
immediate protection. 
In the third approach, Atlantic salmon (Salmo salar) immunised with an immune 
sheep anti-Paramoeba antibodies (APA) were bled and tested for the rate of clearance 
of these antibodies from fish sera. Using a specific ELISA, sheep APA showed a high 
level which cleared over a 2 months period in the fish sera. 
Groups of fish were vaccinated i.p. with several Paramoeba antigens; killed 
cultured P.A with and without Freund's complete adjuvant (FCA). Fish were bled and 
tested for fish APA using specific ELISA. Results showed significant elevation of 
APA in fish sera following vaccination of fish with formalin killed and sonicated 
Paramoeba. The marked humoral response following vaccination indicated a 
significant effect of adjuvants in stimulating the fish's immune response. 
Naturally and experimentally infected fish were tested by ELISA. Naturally 
infected fish with AGD showed low APA which were not significantly different from 
experimentally infected fish. However, the fish antibody level in both groups were 
higher than that of control fish. 
A Paramoeba transmission method was established to assess the protection 
afforded by different methods of immunisation. Cohabitation of infected Atlantic 
salmon with previously-unexposed (naive) Atlantic salmon was successful. 
Seven to ten days after introducing infected fish (5% of fish population in 4000L 
tanks), classic AGD patches were observed, however the organism was hardly seen. 
With the progress of the disease Paramoeba sp. could be seen in typical form. 
However, protectiveness of sheep antibodies conferred into the fish and those 
produced by fish could not be demonstrated due to a disease outbreak (morbidity of 
100%) in the experimental challenge trial. No unequivocal protection was 
demonstrated in any of the vaccinated fish. 
It is shown in this study that passive immunisation has significant potential when 
given at strategic times especially when there is not enough time for active 
vaccination. Thus, there should be a future for the use of mammalian hyperimmune 
sera against fish diseases, in particular, those for which practical immunity by active 
immunisation is not available. 
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Appendix I: Abbreviations 
AGD 	 Amoebic gill disease 
APA Anti-Paramoeba sp. antibodies 
ASA 	 Anti-Streptococcus sp. (streptococcal) antibodies 
AVA Anti-Vibrio anguillarum antibodies 
BA 	 Blood agar 
BHI Brain heart infusion agar 
cfu 	 Colony forming unit 
DWF Distilled water+ 0.05% Tween 20 
ELISA 	 Enzyme-linked immunosorbent assay 
EMAI Elizabeth Macarthur Agricultural Institute 
FITC 	 Fluorescein isothiocyanate conjugated antibody 
Hour 
HRP 	 Horse radish peroxidase 
IFAT Immunofluorescent antibody test 
i.p. 	 Intraperitoneal injection 
litre 
LPS 	 Lipopolysaccharide 
LTB The GM-1-binding subunit of E. coli heat-labile toxin 
Month (s) 
min 	 Minute 
mm Millimetre 
0.D 	 Optical density 
P.A Paramoeba sp. 
P-N 	 Positive-negative 
PBS Phosphate-buffered saline 
PBSTG 	 Phosphate-buffered saline+ 0.05% Tween 20+0.1% Gelatin 
P.i. Post-immunisation 
r.p.m 	 Revolution per minute 
RT Room temperature 
SALTAS 	 Salmon Enterprises of Tasmania 
S.D. Standard deviation 
SDS Page 	 Sodium dodecyl sulfate - polyacrylamide gel electrophoresis 
Sec 	 Second 
S.E. Standard error 
TraT 	 An internal membrane of E. coli 
Week 
WCB 	 Whole cell bacteria 
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Sheep AVA (Agglutination titre) 
Rabbit AVA (Agglutination titre) 10 
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Appendix II: Agglutination titre and ELISA antibody levels for AVA and ASA (shown 
by area) 
Antibody levels vs dilution of sheep, rabbit and fish AVA measured by agglutination 
(Agglutination of+++ has calculated as 2.5, ++ as 1.5, + as 0.5 and - as 0) and ELISA 
0.D has been shown by area 
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0 1000 2000 3000 4000 
EJ Sheep ASA (Agglutination titre) 
O Sheep ASA (ELISA 0. D) 
▪ Rabbit ASA (Agglutination titre) 
M Rabbit ASA (ELISA 0. D) 
Fish ASA (Agglutination titre) 
IN Fish ASA (ELISA 0. D) 
An
tib
o d
y  
lev
el
s  
Antibody levels vs dilution of sheep, rabbit and fish ASA measured by agglutination 
(Agglutination of+++ has calculated as 2.5, ++ as 1.5, + as 0.5 and - as 0) and ELISA 
0.D has shown by area 
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Appendix HI: ELISA reagents 
Sera: 
Whole, ammonium sulphated precipitated or affinity purified sera 
Conjugates: 
1- KPL Rabbit anti-sheep Ig-HRP, peroxidase conjugated and affinity purified 
antibody to sheep IgG (H+L). 
2- DAKO Peroxidase-Conjugated Rabbit immunoglobulins to Mouse 
Immunoglobulins and affinity purified. 
3- DAKO Peroxidase-Conjugated Swine immunoglobulins to rabbit 
Immunoglobulins and affinity purified. 
Substrate 
ABTS (Sigma) 2,2'-Azino-bis (3-Ethyl benzen thiazoline-6-sulfonic acid) Diammonium 
salt (0.55 g) + citric phosphate buffer (1L). 
Citrate phosphate buffer: citric acid 21.0 g, Na2HPO4 14.0 g and MQ water to 
800 ml ; adjust pH to 4.2; make up to 1L. 
Substrate stop solution: 
Citric acid 10.5g. MQW to 500 ml; add 50 mg sodium azide or 1 ml of 5% 
solution. 
Other solutions:  
10x TRIS-saline  
(250 mM Tris, 1.5 M NaC1) 
15.14 g Tris 
43.83 g NaC1 
500 ml Milli-Q water 
pH 7.4 
1_231 
10 x Tris- saline pH 7.4 50 ml 
Glycerol 250 ml 
Milli Q water to make 500 ml 
Autoclave 
Add 1 ml 10% Merthiolate 
Store in dark place 
TS Methanol 
10 x Tris saline 100 ml 
Milli-Q water 	800 ml 
Methanol 
	
100 ml 
Borate coating buffer 
Boric acid 	6.18 g 
Disodium tetraborate 
Na2B407.10H20 9.54 g 
NaC1 
	
4.38 g 
MQ water to 	1L 
Autoclave 
A-4 
Phosphate buffered saline 
NaC1 	 8.0 g 
KC1 0.2 g 
Na2HPO4 	 1.15g 
ICH2PO4 0.2 g 
MQ water to 900 ml; pH to 8.0 with HC1 or NaOH; make up to 1L 
Autoclave 
PBST 	 PBSTG 
Tween 20 	0.5 ml 	 PBST 1000 ml 
PBS pH 8.0 1000 ml Gelatin 1 	g 
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Appendix IV: ELISA procedures (summarised) 
Procedures for sheep and rabbit ELISA: 
1-Coating the ELISA plate: 
Vibrio antigen (WCB) diluted 1:100 in TS Methanol; 100 pl well -1 
Spinning at 2500 rpm, for 10 min. Flicking antigen off. 
2- Blocking 1% gelatin in PBST 100 pi well-1 ; require 10 ml per plate 
Incubating for 30 min. room temperature (RT) and washing. 
3-Adding sheep/rabbit serum dilution of 1: 200 (neat and ammonium sulphate purified 
prebleed and immune serum diluted in two fold basis with PBSTG in duplicate 
wells. 
Including control +ve highly positive, medium positive, positive and negative 
(diluted in negative serum). 100 pl well 4 . 
Incubating 90 min. in RT and washing. 
4- Adding conjugate, Kirkegard Perry Laboratories (KPL) Rabbit anti-sheep Ig-HRP 
(polyclonal rabbit anti-sheep)in dilution of 1:2000 (sheep ELISA), Dako swine 
anti-rabbit in dilution of 1:750 (rabbit ELISA) and incubating 90 min.RT and 
washing. 
5- Adding ABTS substrate (1 mM 2,2'- azino-di (3-ethyl-benzthiazolin-6-sulphate) ) 
and 0.03% H202 dissolved in citrate buffer (22m1+10 p.1 H202), 100 gl well -1 
to detect bound conjugated antibodies. Incubating 20 min. RT on shaker. 
6-Stopping the reaction with ABTS stop solution, 50 pl well -1 and reading the colour 
spectrophotometrically at 405 nm by computer programmed microplate reader. 
Procedure of ELISA for rainbow trout 
In this assay all the diluents for serum, monoclonal antibody (MAb) and 
conjugate should be adjusted at pH 8.0. 
1-Coating the ELISA plate: 
Vibrio antigen (WCB) diluted 1:100 in TS Methanol 50 p.1 well 4 
Spinning at 2500 rpm, for 10 min. Flicking antigen off. 
2- Blocking 1% gelatin in PBST 100 pl we11-1 ; require 10m1 per plate 
Incubating for 30 mm. room temperature (RT) and washing. 
A-6 
3-Adding fish serum (neat prebleed and immune serum in 1:100 dilution with PBSTG 
in duplicate wells. 
Including control +ve highly positive, medium positive, positive and negative 
(diluted in negative serum). 50 p.1 well -1 . 
Incubating 90 min. in RT and washing. 
4- Adding mouse monoclonal antibody to trout IgM ; 501.11 well -1 . 
Incubating 90 mm. in RT and washing. 
5- Adding conjugate, Dako Rabbit anti-mouse-HRP; 5011.1 well -1 
Incubating 90 min.RT and washing. 
5- Adding ABTS substrate (22m1+101.1.1 11202), 50 Ill we11 -1 . Incubating 20 min. RT on 
shaker. 
6-Stopping the reaction with ABTS stop solution, 25 Ill well 4 and reading the colour at 
405 nm by computer programmed microplate reader. 
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Appendix V: Buffers and solutions for affinity chromatography (stored at 4°0 
Starting buffer: 
Tris base 	3.02 g 
NaC1 8.76 g 
Distilled water to 	900 ml 
Na azide 5% 	2.0 ml 
pH adjusted to 7.2 
Making up to 1000 ml 
Elution buffer:  
Glycine 	7.51 g 
NaC1 8.76 g 
Distilled water to 	900 ml 
Na azide 5% 
	2.0 ml . 
pH adjusted to 3 with concentrated HC1 
Making up to 1000 ml 
2M Tris buffer 
Tris base 	24.22 g 
Distilled water to 	100 ml 
Tris regeneration buffer 	 Acetate regeneration buffer 
Tris base 	12.11 g 	Na acetate 	8.20 g 
NaC1 29.22 g NaC1 
	 29.22g 
Distilled water to 	900 ml 
	 Distilled water to 	900m1 
Na azide 5% 
	2.0 ml Na azide 5% 
	2.0 ml 
pH adjusted to 8.5 with NaOH 	pH adjusted to 4.5 with HC1 
Making up to 1000 ml 	 Making up to 1000 ml 
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Appendix VI: ELISA OD results: maximum. minimum and cut-off values of fish to V.  
anguillarum and Streptococcus sp. cells 
Fish antibody responses after i.p. injection of 1 mg (dry weight) formalin killed Vibrio 
cells 
Fish 
status 
positive/negative 
 
ELISA 0.D 
  
mean 
 
S.D. 	 min 	max 
  
cut-off 
 
Control fish 
Wk-3 	0.158 
Wk-5 0.164 
Wk-8 	0.104 
Wk-10 0.093 
Immunised fish 
Wk-3 	0.439 
Wk-5 0.438 
Wk-8 	0.409 
Wk-10 
	
0.021 	0.067 	0.172 
0.030 	0.075 	0.235 
0.024 	0.071 	0.143 
0.032 	0.067 	0.108 
0.196 	0.221 	0.843 
0.253 	0.245 	0.890 
0.228 	0.172 	0.772 
0.199 
0.224 
0.152 
Fish antibody responses after i.p. injection of 1 mg (dry weight) formalin killed 
Streptococcus sp. cells in 50% v v -1 FCA 
Fish 	ELISA 0.D  
status 	 mean 	S.D. 	min 	max 	positive/negative 
	 cut-off 	 
Control 
fish 
wk-4 	0.165 	0.104 	0.067 	0.195 
wk-6 
	
0.156 	0.087 	0.163 	0.186 
Immunised 
fish 
wk-4 	0.341 	0.124 	0.222 	0.446 	0.209 
wk-6 	0.401 	0.067 	0.225 	0.445 	0.200 
A-9 
Appendix VII: Anti-microbial compounds used in Aquaculture for treatment of vibriosis and their method 
Antimicrobial Methods of administration and dai ly dosage comments Persistence 
in fish tissues 
Reference 
compound by food 	I by bath by injection 
Chloramphenicol 50-70 mg/kg b.w/ day 
for 5-10 days 
10-50 mg/L of water 
as a bath 
Austin &Austin(1993) 
Public health concerns Munday (1993) 
Flumequine 6 mg/kg b.w/day for Austin &Austin(1993) 
6 days 
20 mg/kg b.w for 10 
days in seawater 
9 mg/kg b.w for 
sharks 
256 h half life after 
single injection 
60-80 days Munday (1993) 
Furance 2-4 mg/kg b.w /day for 
3-5 days 
0.5-1 mg/L of water 
for 5-10 min, as a 
bath 
Austin &Austin(1993) 
Furazolidone 25-75 mg/kg b.w/day for 
up to 20 days 
Austin &Austin(1993) 
Deteriorates rapidly in 
wet (raw fish) diet 
Munday (1993) 
Kanamycin 50 mg/kg b.w for 7 days Austin &Austin(1993) 
b.w= body weight 
Antimicrobials against vibriosis (continued) 
Antimicrobial 
compound 
Methods of administration and dai ly dosage comments Persistence 
in fish tissues 
Reference 
by food by bath by injection 
Erythromycin 
Dxytetracycline 
_ 
Sodium nifursty- 
renate 
Tetracycline 
Nifurprazine 
hydrochloride 
. 	. 	. 	. 
75-125 mg/kg of b.w for 
10-21 days 
50-70 mg/kg b.w/day for 
10 days 
50 mg/kg b.w/day for 3-5 
days 
75-100 mg/kg b.w/day 
for 10-14 days 
10 mg/kg of food, fed 
for 3-6 days 
0.01-0.1 mg/L of 
water, as a bath for 
an undefined period 
Chelates with divalent 
cations 
May interfere with 
immune response and 
osmoregulation in 
smolts 
22 (70 days for skin) 
Munday (1993) 
Austin &Austin(1993) 
Munday (1993) 
Austin &Austin(1993) 
Austin &Austin(1993) 
Austin &Austin(1993) 
.w= tociy weight 
Antimicrobials against vibriosis (continued) 
Antimicrobial Methods of administration and dai ly dosage comments Persistence 
in fish tissues 
Reference 
compound by food by bath by injection 
Nitrofurantoin 
Dxolinic acid 
Dxytetracycline 
hydrochloride 
Sulphamerazine 
Sulphamethazine 
Sulphisoxazol 
Tribrissen 
potentiated 
sulphonamide) 
20-35 mg/kg b.w/day for 
10 days in seawater 
10-15 mg/kg b.w/day for 
10 days in freshwater 
100-200 mg/kg b.w for 
10-20 days ., 
I,  
50 mg/kg b.w/day for 
10 days 
50 mg/L of water, as 
a bath for 1 h 
lppm for 24 h or 
50 ppm 1 h 
60 mg/kg b.w as a 
single i.p. injection 
20 ppm for 5-7 days 
chelates with divalent 
cations 
May interfere with 
immune responses 
and osmoreglulation 
in smolts 
12-38 days 
22-70 days 
Austin&Austin(1993) 
Munday (1993) 
Munday (1993) 
Austin &Austin(1993) 
Munday (1993) 
b.w= body weight 
Appendix- VIII 
Immunostimulants, adjuvants and vaccine carriers (Adapted from Anderson. 19921 
Reservoirs and depots: 
Freund's Complete Adjuvant (FCA) 
Freund's Incomplete Adjuvant (ICA) 
Liposomes 
Mineral oil 
Lanolin 
Paraffin oil 
Dextran sulphate 
Ethylene-vinyl acetate 
Carriers and vehicles: 
' Bentonite 
Kaolin 
Latex beads 
Sheep Red Blood Cells (SRBC) 
Dimethylsulfoxide (DMSO) 
Inflammatory agents: 
Silica particles 
Carbon particles 
T cell stimulator: 
Mycobacterium sp. 
Muramyl dipeptide (MDP) 
Glucans (yeast extracts) 
Metallic salts 
Alum (potassium aluminum sulphate) 
Aluminum hydroxide gel 
Levamisole 
Bacille Calmette Guerin 
Corynebacterium parvum 
Polynucleotides: 
Poly A-U 
Poly I-C 
Isoprinosine 
Fluro-quindone 
B cell stimulators: 
Lipopolysaccharides 
Cell membrance modifiers 
Detergents 
Sodium dodecyl sulphate (SDS) 
Quaternary ammonium compounds (QAC) 
Saponins (plant extracts) 
Quil A 
Animal extracts: 
Ecteinascidia turbinata extract (Ete) 
Haliotis discus extract (HDe) 
Fish extract (ISK) 
Mitogens (lectins, plant extract) 
Pokeweed mitogen (PWM) 
Phytohemagglutinin (PHA) 
Concanavalin A (Con A) 
Nutritional factors: 
Vitamin C 
Vitamin E 
Cytokines: 
Interleukins: 
Leukotriene B4 
Interferon 
Heavy metals: 
Cadmium 
Germanium 
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